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Abstract
The apoptotic effects of various concentrations of ethanol-, hexane-, and ethyl acetate- 
extracted molmol (from Commiphora molmol) and haddi (from Commiphora gudiotti) on 
two cancer cell lines, S I80 and HT1080, and on a normal chick fibroblasts cell line, were 
studied. In addition, the effects of two commercially obtained molmol ethanol (Flavex) 
and haddi essential oil extracts (Aldrich) were also studied, and results compared and 
contrasted with results obtained using freshly extracted molmol and haddi preparations. 
Furthermore, the effects of two of the chemical constituents of haddi, Trans-Beta- 
ocimene and Gamma-Bisabolene (obtained commercially) were also studied, using the 
above-mentioned cell lines.
Various techniques were employed to study these effects, including growth assays, MTT 
viability assay, histological and morphological techniques for the detection of apoptosis 
(haematoxylin-eosin staining and scanning and transmission electron microscopy), 
TUNEL technique which is the detection of DNA fragmentation, and Annexin V assay to 
detect apoptotic plasma membrane change, using fluorescence microscopy.
The results showed that ethanol-extracted molmol and hexane-extracted haddi are 
apoptosis inducers in the murine S I80 sarcoma cells and HT1080 human fibrosarcoma 
cells. Morphological analysis showed that both S I80 cells and HT1080 cells exposed to 
these extracts exhibited characteristics signs of apoptosis, including the formation of 
pyknotic nuclei, apoptotic cells, apoptotic bodies, blebbing of outer membrane, 
vacuolation, breaking-up of outer membrane, and loss of microvilli and filopodial 
attachments, as well as signs of chromatin margination and chromatin condensation 
alongside the nuclear membrane. Some secondary necrosis was also seen when cells 
were treated with extracts and tested with Annexin-V, and showed positive signs for 
changes in membrane phospatidylserine asymmetry. Annexin V assay also demonstrated 
that apoptosis and death of SI 80 cells was faster than in HT1080 cells.
The results showed that both molmol and haddi extracts performed better at higher 
concentrations than at lower concentrations, and that apoptotic changes in S I80 cells and 
HT1080 cells were found to be time-dependent.
The study also demonstrated that commercial preparations of molmol (Flavex) and haddi 
essential oil (Aldrich) were effective, but less so than the natural extracts.
Molmol extracts at particular concentrations targeted cancer cells, in contrast to haddi 
extracts, which targeted both cancer and normal cell lines.
The results also demonstrated that 7><ms-/?-ocimene was more effective than y-bisabolene 
in inducing apoptosis in S I80 cells than in HT1080 cells. However, SEM results showed 
that these two chemicals acted on cancer cells in a similar way to that of haddi extracts, 
y-bisabolene was more effective at LC50 concentration ( 5 mM) in bringing about 
apoptosis in S I80 cells and HT1080 cells than 7raws-/?-ocimene, at LC50 concentration 
(100 mM).
Both chemicals were very potent inducers of apoptosis.
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Chapter One 
General Introduction
1.1 Cancer: An Overview
Kirsch & Kustan (1998) described cancer, in terms of neoplasia, as a disorder that 
allows unchecked proliferation of individual mutant cells to form tumour(s). 
However, despite the fact that the development of cancer is normally associated with 
uncontrolled proliferation, it should also be perceived as abnormal differentiation 
(Spom & Roberts, 1984). The tumour cell survives by invading the surrounding 
tissue, which finally ends up in the destruction of the whole organism.
Tumours are divided into two types: benign and malignant. The former consist of a 
slow growing mass of cells that does not generally spread into the surrounding tissues. 
Conversely, malignant tumours can give rise to secondary tumours at different sites 
(meta-astasis), consequently making the cancer difficult to eliminate. Nonetheless, 
cancers are generally divided into three types, according to the tissues they arise from: 
(i) carcinomas, the most common form of human cancer, representing around 90 per 
cent of all cancers which arise from the epithelial cells; (ii) sarcomas, representing 5 
per cent of all cancers arising from connective tissues or muscle cells; and (iii) 
leukaemias, or lymphomas, also representing 5 per cent of all cancers, which arise 
from haemopoietic and lymphatic cells (Alberts et al., 1994; Kleinsmith & Kish, 
1995).
Alberts et a l (1994) and Raven & Johnson (1999) have shown that somatic mutation 
in an individual cell is mainly responsible for the initiation of the cancer. However, 
the progeny of the mutated cells may undergo further spontaneous induced mutation
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prior to becoming cancerous. Genetic change in cells has been reported to be 
responsible for cancer formation, and the cells in a particular cancer can often share 
common abnormalities in their DNA (Ames et al., 1973). The majority of such 
changes are acquired, for instance, through viral infections, toxic agents (carcinogens) 
or ionising radiation. According to Moller (1995), potentially oncogenic viruses, 
genotoxic agents and high energy radiation are integral parts of the environment, yet 
cancers caused by acquired genomic alterations tend to appear late in life. Hence, 
compensatory mechanisms must exist, for example the immune system that plays an 
important role in the elimination of cancerous cells in an organism. Furthermore, 
Moller (1995) indicated that the affected cells may attempt to repair their own 
genomic damage, and if repair fails, the cell may commit suicide (apoptosis) for the 
welfare of the organism. Accordingly, a cancerous growth is often seen as the 
abnormal activation of the mitotic programme and/or the inactivation of programmes 
for growth-inhibition and cell death.
Liu et al. (1998) reported that head and neck squamous cell carcinoma (HNSCC) is 
one type of cancer that represents a major health problem worldwide, being the fourth 
most frequent tumour (Parkins et al., 1993). HNSCCs are principally defined as 
being those cancers in the oral cavity, pharynx and larynx. According to Vokes et al. 
(1993), the majority of head and neck squamous cell carcinoma occur in the oral 
cavity: tongue, floor of the mouth, hard palate, buccal mucosa, and lip. The largest 
percentage of head and neck cancers are those squamous cell carcinoma of the tongue 
(Mineta et al., 2000).
Farber (1984) proposed some two decades ago that head and neck carcinogenesis is a 
multi-step process that is driven by the accumulation of genetic alterations. Due to
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the fact that cancerous or pre-cancerous cells acquire proliferation-promoting 
alterations in the structure or expression of cellular oncogens, they also tend to lose 
gene functions which serve to limit cellular proliferation.
Bishop (1991) indicated the associated gain of growth-promoting proto-oncogene 
function and the loss of negative regulations of cell cycle as a result of inactivation of 
tumour: suppressor genes activate the cell towards increasingly aberrant cell-cycle 
control at the molecular level and histopathogenic changes at an anatomic level.
Oral cancer and HNSCC appear as a consequence of multiple molecular genetic 
events in many chromosomes and genes. The consequence of such chromosomal 
(that is, genetic) damage is cell dysregulation, with disruption in all signalling, the cell 
growth cycle, and/or mechanism of repair cell damage or eliminate dysfunctional 
cells. Impaired or enhanced function of genes or their products is involved in this 
carcinogenesis; cell regulatory processes are affected through transcribed proteins. 
Carcinogenesis is a multistep process associated with the expression of defects in the 
integrated control of cellular differentiation and proliferation (Weinstein, 1987; 
Sparks et a l , 1988). The accumulation of these genetic changes, often over a period 
of time, seems to lead, in some instances, to dysregulation, to the extent that growth 
becomes autonomous and invasive mechanisms develop, leading to carcinoma (Lyons 
& Clark, 1997; Scully et al., 2000).
Studies relating to the cell kinetics of human tumours have shown that the mean cycle 
time of cells within these tumours is typically between two to four days, which is a 
great deal shorter than the volume-doubling of the tumour, which is typically two to 
three months for common solid tumours. Two factors may help to explain this 
discrepancy: (i) a high proportion of non-proliferating cells; and (ii) a high rate of
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selective cell death, which may be apoptotic or non-apoptotic. Steel (1977) and 
Tannok (1989) indicated that the presence of necrosis or pyknotic cells is evidence for 
cell death in tumours, and the rate of cell death or loss from human tumour can be 
greater than cell production.
1.2 Cell Death in Tumours
Studies relating to cell death showed that controlled/programmed cell death is crucial 
for the normal development of multicellular organisms, as well as for maintenance of 
tissue and organ size (Bowen & Lockshin, 1981; Wyllie, 1987; Walker et al., 1988).
Cell death as a whole can be grouped into two types: (i) pathological and accidental 
cell death, or necrosis; and (ii) death by design; that is, programmed cell death 
(PCD) (Bowen, 1993; Kiechle & Zhang, 2002a). PCD usually forms part of a normal 
physiological programme. The term ‘programmed cell death’ was originally coined 
by Lockshin (1969) to describe a genetically controlled process in the context of 
insect development. PCD is a significant developmental and homeostatic process in 
multicellular organisms, which Bowen (1998) described as an ‘altruistic suicide’ that 
shapes and structures tissues and organs, and has a key role in normal embryological 
development, morphogenesis and metamorphosis. The term ‘apoptosis’, that is, ‘a 
falling away’, was coined by Kerr et a l (1972) to indicate this programmed and 
controlled cell death, and to define the morphologic features, including cytoplasmic 
blebbing, chromatin condensation, cell shrinkage, nuclear fragmentation, cell 
rounding, i.e., loss of adhesion, and cells shrinkage, and finally, the fragmenting of 
the cell into membrane-bound apoptotic bodies which are ingested by neighbouring 
phagocytic cells. Such morphologic changes can be observed in fixed and stained 
tissues or in cells grown in culture (Kiechle & Zhang, 2002a). This process of cell
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death, according to Geske & Gerschenson (2001) and Kiechle & Zhang (1998, 
2002a), requires time to take place after the initial insult, in contrast to necrosis, which 
has none of the cellular morphologic changes reported above for apoptosis, and occurs 
rapidly after the initial insult Bowen (1998) also indicates that apoptosis is an equal 
and opposite force to mitosis with its own distinctive morphology that occurs during 
early development and continuously through metazoan life.
Apoptosis and necrosis are two extremes of one continuous spectrum of death (Wyllie 
e ta l ,  1984).
However, some authors argue that PCD is not an appropriate synonym for apoptosis 
(Steel, 2001; Sloviter, 2002). For example, Sloviter (2002) indicates that PCD refers 
to well-controlled intracellular biochemical pathways that ultimately lead to the 
morphologic features defined by the term apoptosis, and recommends that necrosis be 
replaced with the term ‘passive cell death’, and apoptosis with the term ‘active cell 
death’, and active cell death be divided into two subgroups, immediate or delayed 
active cell death, depending on the time of onset following the initial triggering event. 
Nonetheless, Snider et a l (1999) argue that in some pathological conditions, the two 
forms of cell death may co-exist in the same tissues, and elements of both processes 
may occur in the same cells. For instance, it has been thought that necrosis is the 
mode of myocardial cell death following ischaemia for many years, and since 1994, 
apoptotic morphologic features have been described to be associated with myocardial 
ischaemia and infarction (Ohno et al., 1998; Yaoita et al., 2000; Knaapen et al, 2001). 
In addition, both apoptosis and necrosis may share common mediators. Bonfoco et al. 
(1995) reported that low levels of glutamate receptor over-activation can trigger both 
neuronal apoptosis and necrosis. A high concentration of intracellular ATP favours
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apoptosis, whereas low concentration of ATP shifts cell death toward necrosis (Los et 
al., 2002).
1.2.1 Necrosis
Necrosis is caused by physical, chemical, toxic or anoxic injury, often to the cell 
membrane. The injury brings about an alteration of the cell environment and a 
functional deficit. Necrotic cells are known to swell rather than shrink, due to the fact 
that during the early stages of necrosis the cell membrane pumps fail, leading to an 
influx of water, sodium and calcium. This is followed by acidosis and osmotic shock. 
Increased acidosis gives rise to pyknotic nuclei as the chromatin precipitates, and 
nuclei ultimately experience karyoplysis. Bowen et a l (1998) indicated that there is 
no early chromatin margination or activation of endonuclease activity as observed in 
apoptosis. Bowen (1998) reported that calcium influx during necrosis triggers 
phospholipase A, which affects the internal mitochondria membranes and this, in turn, 
causes a terminal drop in ATP production leading to an autolytic deterioration in the 
cells. Finally, the endoplasmic reticulum and lysosomes swell and burst, the latter 
releasing hydrolytic enzymes, which cause further autolytic destruction of the cells, 
which ultimately break up and produce an inflammatory response.
1.2.2 Apoptosis
Reed (2000) and Sjostrom & Bergh (2001) described programmed cell death (PCD), 
that is, apoptosis, as an evolutionary conserved pathway needed for embryonic 
development and tissues homoeostasis. Meier et al. (2000) also maintain that 
apoptosis plays an important role in the regulation of cell numbers during 
development and tissue homoeostasis. Sjostrom & Bergh (2001) refer to apoptosis as 
the normal physiological response to many stimuli, including irreparable DNA
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damage. Thompson (1995), on the other hand, reports that various diseases evolve as 
a consequence of hyperactivation or suppression of programmed death, the former 
including neurodegenerative diseases, immunodeficiency and ischaemia-reperfusion 
injury, and the latter including cancer and autoimmune disorders. Many other authors 
also indicated that that the dysregulation of apoptosis that results in increased activity 
is associated with a variety of clinical disorders, such as cancer, autoimmunity, 
neurodegenerative diseases, haematopoietic disorders and infertility (see Kiechle & 
Zhang, 1998, 2002b; Yuan & Yanker, 2000; Hanlou et al., 2001; Mirkes, 2001; 
Mullauer et al., 2001; Ameisen, 2002; Markstrom et al., 2002; Ramos et al., 2002; 
Rathmel & Thompson, 2002).
According to Sjostrom & Bergh (2001), in cancer, the balance between proliferation 
and PCD is disturbed, and defects in apoptotic pathways allow cells with genetic 
abnormalities to survive. They add that the majority of cytotoxic and hormonal 
treatments, and radiation, eventually kill cancer cells by triggering irreparable cellular 
damage which triggers apoptosis. Accordingly, the effectiveness of cancer treatment 
depends not only on the cellular damage they cause, but also on the cell’s ability to 
respond to damage and by prompting the apoptotic machinery. Researchers view 
apoptosis as a powerful kinetic concept, being an equal and opposite force to mitosis 
(e.g., see Kerr et al., 1972), and as such it plays a vital role in the maintenance of 
renewable tissues (Bowen, 1993).
Sarraf & Bowen (1986, 1988) have reported that apoptosis occurs in tumours, and is 
probably a consequence of residual, intrinsic auto-regulatory mechanisms which 
operate during the early stages of neoplastic transformation that finally fail to control 
malignant changes.
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Apoptosis is essential for the development and the maintenance of the population 
balance of cells within an organism. Apoptosis leads to cell condensation and 
shrinkage. Cells tend to lose water early on in apoptosis, leading to an increase in 
density. Bowen et al. (1998) indicated that cell membrane pumps continue 
functioning during apoptosis, and the apoptotic cells can exclude vital dyes. 
Apoptosis involves ATP production, and is usually accompanied by new mRNA and 
de novo protein synthesis. The nuclear envelope dilates during apoptosis, thus 
forming blebs that contain marginating chromatin. An important feature of apoptosis 
is that of the fragmentation of the chromatin by non-lysosomal nuclear endonuclease, 
which cuts the double-stranded DNA into oligonucleotide fragments of 180 to 200 bp 
which appear as ‘ladders’ when run on gel electrophoresis (Bowen, 1993; Bowen et 
al., 1998). However, not all apoptotic cells show DNA laddering. For example, it has 
been reported that nuclear changes during apoptosis can occur without endonuclease 
activation of oligonucleotide production (Oberhammer et a l,  1993). Bowen (1998) 
showed that at later stages of apoptosis, the plasma membrane becomes active and 
convoluted to form blebs, followed by the fragmentation of the cell into several 
membrane-bound spheres or apoptotic bodies of different sizes that are rapidly 
phagocytosed by neighbouring cells of phagocytes, without inducing an inflammatory 
response.
Tumour suppressor gene p53 , the anti-apoptotic gene Bcl-2, and the pro-apoptotic 
gene box are the most studied genes that are related to apoptosis (Sjostrom and Bergh, 
2002). Wallace-Brodeur & Lowe (1999) reported that normal wild type p53 can limit 
cell proliferation after DNA damage through two mechanisms: arresting the cell cycle 
or activating apoptosis. P53 plays a dual and complex role in chemosensitivity, in 
that it can either increase apoptosis or arrest growth and in that way increase drug
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resistance (Sjostrom and Bergh, 2002), and this may explain why promising pre- 
clinical data which indicate the presence of wild type p53 would predict 
chemosensitivity have translated into more conflicting clinical data (Schmitt & Lowe, 
1999; Hamilton & Piccart, 2000). Furthermore, drugs which do not cause DNA 
damage, such as taxanes and vinca alkaloids, may induce apoptosis through pathways 
independent ofp53 (Sjostrom and Bergh, 2002).
1.3 Morphological Techniques for Detection of Apoptosis
Apoptotic cells can be easily identified using routine histological staining methods, 
such as the haematoxylin and eosin (H&E) dyes. Histological assessments of cells 
and tissues are in the main based on rather delicate membrane and pH changes that 
result in changes in membrane permeability, and in various staining patterns (Bowen, 
1981).
One of the main characteristics of classical apoptosis is the presence of darkly stained 
hyperchromatic nuclei, known as pyknotic nuclei. Sandritter & Riede (1975) 
provided a detailed discussion of nuclear pyknosis in level cells. During the early 
stages of apoptosis, the nuclear chromatin generally clumps and aggregates at the 
nuclear membrane. This is followed by dilation of the nuclear membrane and 
chromatin condensation typical of pyknosis. In late apoptotic cells, the pyknotic 
chromatin becomes progressively less visible and is dispersed or lost. Bowen et al. 
(1991) reported nuclear pyknosis in cells undergoing necrosis, although the necrotic 
cells do not show characteristic chromatin margination.
Sandritter & Riede (1975) stated that the first changes leading to necrosis include 
degenerative swelling, caused by failure of the sodium pump, and ATP activity, which 
in turn causes inflow of charged ions such as sodium, calcium and water, and outflow
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of potassium ions into the extracellular space. This leads to changes in the cell 
membrane permeability, which at the light microscopy level could be reflected in the 
cell’s reaction to dyes. In contrast, plasma membrane changes during apoptosis are 
related to membrane bending and induction of blebbing and fragmentation. 
Furthermore, the apoptotic cells and fragments tend to lose rather than gain water that 
might lead to changes in the pH and surface permeability of the cells. Such changes 
are reflected through the reactions to histological stains (Bowen, 1981). Ballard has 
illustrated that apoptotic cell nuclei are intensively chromophilic, and could be easily 
identified in iron/haematoxylin stained sections. This hyperchromasia of pyknotic 
nuclei is caused by chromatin condensation and also by exposure to negative charge 
phosphate groups. Sandritter & Riede (1975), for instance, found that pyknotic nuclei 
bind more eosin, due to the increase in basic histone groups.
1.3.1 Haematoxylin-Eosin Staining
Haematoxylin and eosin dyes were used in the present study, since they are among the 
most widely employed routine histological stains. Haematoxylin-eosin staining is a 
relatively simple technique used to demonstrate clearly different tissue structures from 
different body areas which are prepared in various ways. These two stains provide an 
excellent contrast between the nuclear material and the cytoplasm. While 
haematoxylin stains cell nuclei blue-black with good intra-nuclear detail, the eosin 
stains cell cytoplasm in various shades of pink and red (Stevens, 1986). A number of 
researchers have adapted this technique for morphological analysis in different 
substrates, such as paraffin-embedded materials, haema-embedded materials, LR 
White resin and cell smears (Moffit, 1994; Al-Hazzaa & Bowen, 1998; Bowen, 1998; 
Szegedi et al., 1998).
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Haematoxylin-eosin staining is also routinely used in clinical and cancer research for 
the recognition and semi-quantitative assessment of apoptotic bodies. It helps detect 
low frequency apoptosis in cell cultures, which is not possible using flow cytometry 
(Fujitae/a/., 1997).
Haematoxylin is adequate as a nuclear stain only in the presence of a mordant, the 
most effective o f which include salts of aluminium, iron, tungsten, and occasionally 
lead (Stevens, 1986). In the present study, Mayer’s haematoxylin was used, which 
belongs to the group of alum haematoxylins. The mordant used was aluminium 
potassium sulphate (potash alum). Haematoxylin stains nuclei red, which is then 
changed into a blue-black colour when washed in tap water, which is slightly alkaline. 
This method is referred to as ‘blueing’.
Eosin is widely used in conjunction with alum haematoxylin to demonstrate the 
general histology structure of cells or tissues. The eosins are xanthene dyes of which 
eosin Y is the most widely used. As a cytoplasmic stain, eosin is used as 0.5-1.0% 
solution in distilled water with a crystal of thymol added to prevent the growth of 
fungi (Stevens, 1986). Tap water wash differentiates the eosin stain in the cytoplasm 
and the subsequent intensity o f both the haematoxylin and eosin stains.
1.3.2 Scanning Electron Microscopy
The morphological changes that occur during programmed cell death can be analysed 
during scanning electron microscopy (SEM). SEM allows for the collection of 
secondary electrons in the scanning mode and produces topographical images. 
Bowen (1981) indicated that fine structural changes in cells observed at electron 
microscopy level can reflect underlying biochemical changes, such as changes of the 
plasma membrane and cytomembranes which can provide reliable and early signs as
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to the probability of cell death. SEM is also employed for the cytochemical 
localisation of enzymatic activity by means of backscattered electron imaging (BEI), 
which provides atomic number contrast, and can be used to distinguish between the 
two spatially separated products of differing atomic numbers. BEI is also employed 
for the study of sub-cellular localisation, to some extent based on the backscattered 
electrons that emerge from under the surface of the specimen, that can be collected 
and analysed (Bowen et al., 1988).
SEM is regularly employed in the laboratory to study the morphological 
characteristics of cells both in solid tumours and in vitro. It is widely employed to 
study and time events in apoptotic cell cultures. In general, cells experiencing 
apoptosis primarily round off and lose contact with the neighbouring cells as they 
condense. Then, the cytoplasm becomes convoluted and blebs outwards, eventually 
giving rise to apoptotic bodies. Bowen et a l (1993) reported a substantial degree of 
membrane bending taking place during apoptotic body formation, accompanied by 
localised changes in the calcium concentration.
1.4 TUNEL Technique for Detection of DNA Fragmentation
Detection of in situ DNA fragmentation is at present one of the most frequently used 
techniques with which to highlight apoptotic cells in tissue. DNA fragmentation 
during apoptosis is induced by caspase-mediated cleavage of ICAD (inhibitor of 
caspase-activated DNAase) and ensuing activation of CAD (caspase-activated 
DNAase) which subsequently leads to the characteristic intemucleosomal DNA 
double strands breaks (Enari et al., 1998). DNA fragmentation into multiples of 180- 
200 base pairs (BP) is regarded as a feature of programmed cell death (Kerr et al., 
1972; Wyllie et al., 1980; Arends et al., 1990). Nonetheless, according to Bortner et
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al (1995) large fragments in the range of 50-150 kbp are also generated. 
Oberhammer et al. (1993) and Zakeri et al. (1993) also reported forms of programmed 
cell death that lack the prototypical intemucleosomal pattern of DNA fragmentation. 
In contrast, necrotic cell death is accompanied by late random DNA fragmentation by 
release of lysosomal DNAase, though this concept has been challenged. Techniques 
detecting fragmentation are therefore not specific for apoptosis, but also detect DNA 
damage in a variety of cell injury and cell death paradigms. In addition to the 
characteristic, orderly oligonucleosomal fragmentation, it is mainly the enormous 
amount of DNA strand breaks that is the basis for the relative specificity of in situ 
DNA fragmentation techniques for apoptotic cell death (Ansari et al., 1993).
There are a number of kits available (that can be used with flow cytometric or 
histochemical context) to assay DNA fragmentation. For example, Boehringer 
Mannheim and Oncor (Apoptosis kit), based on the TUNEL reaction, which may use 
fluoresein, alkaline phosphatase or peroxidase for immunohistological reporting.
1.5 Cancer Treatment
There are four main modes of treatment of cancer: surgery, radiotherapy, 
chemotherapy, and experimental gene therapy. These can be used singly or in 
combination (Alison & Sarraf, 1997). Natural plant or animal products have also 
been used in anticancer therapy (da Rocha et al., 2001).
Surgery involves the removal of the primary tumour alone or combined with the 
removal of its draining lymphatics and lymph nodes, either selectively or in the 
presence of nodal metastasis (Schantz et al., 1993). Radiotherapy is often used in 
combination with surgery or as an alternative to it (Peters, 1998). Radiotherapy is 
administered in two ways; by an external beam, using either (i) photons or X-rays
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produced by a linear accelerator, or as gamma rays from a cobalt source, or (ii) 
implant of radioactive source (Brach therapy). Surgery and radiotherapy often 
eliminate primary or localised disease but may eventually fail if cancer has 
metastasised to other areas of the body. Under such circumstances, chemotherapy, if 
used properly, has the potential to control or eliminate metastatic disease and reduce 
mortality. In some clinical trials, adjuvant therapy, that is, combining chemotherapy 
with surgery or radiotherapy or both, has increased survival rates for a number of 
solid tumours that have formerly been treated by only one therapeutic modality.
In several local multimodality treatment protocols, treatment often starts as local 
control, either by surgery or irradiation, followed by chemotherapy to treat metastatic 
tumour foci. However, an approach that utilises chemotherapy as the first-line 
treatment has been recently employed, which is followed by surgery or radiation 
therapy. The rationale for this so-called neoadjuvant chemotherapy, a term coined by 
Frei (1988), is that the primary tumour can be shrunk before local eradication is 
attempted, and micrometastatic foci can be attacked initially, without waiting until 
local treatment is completed.
1.6 Natural Products in Cancer Therapy
Farnsworth et a l (1985) and Cragg et a l (1997) reported that the role of natural 
products as a source for remedies has been recognised since ancient times. A survey 
of plants used against cancer carried out over three decades has listed a large number 
of such plants (Hartwell, 1968). Bindseil et a l (2001) reported that natural products 
are the most constantly successful source of drug lead, and that 39% of the 520 new 
drugs approved between 1983 and 1994 were either natural products or derived from 
natural products (Cragg et a l , 1997).
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A number of plant-derived compounds are at present successfully employed in cancer 
treatment (da Rocha et a l , 2001), as shown in Table 1.1
The vinca alkaloid family isolated from the periwinkle Catharanthus roseus, found in 
the rain forest of Madagascar, is one of the most significant examples (Noble, 1990). 
DeVita et a l (1970) reported that the introduction of the vinca alkaloid vincristine 
was responsible for an increase in the cure rates for Hodgkin’s disease and some 
forms of leukaemia. This alkaloid is reported to inhibit microtubule assembly, 
inducing tubulin self-association into coiled spiral aggregates (Noble, 1990; Wood et 
a l,  2001).
Table 1.1 Plant-derived anticancer agents
Compound Cancer Use Status
Vincristine Leukaemia, lymphoma, breast, lung, 
paediatric solid cancers and others
Phase III/IV
Vinblastine Breast, lymphoma, germ-cell and renal 
cancer
Phase III/IV
Paclitaxel Ovary, breast, lung, bladder, and head and 
neck cancer
Phase III/IV
Docetaxel Breast and lung cancer Phase III
Topotecan Ovarian, lung and paediatric cancer Phase II/III
Irinotecan Colorectal and lung cancer Phase II/III
Flavopiridol Experimental Phase I/II
Acronyciline Experimental Phase II/III
Bruceantin Experimental Preclinical/phase I
Thalicarpin Experimental Preclinical/phase I
Source: da Rocha et a l (2001, p. 366).
Etoposide, an epipodophyllotoxin, is another example of a highly active agent, 
derived from the mandrake plant Podophyllum peltatum  and the wild chervil P. emodi 
(St&helin, 1973), which has produced high cure rates in testicular cancer when used in
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combination with bleomycin, which is also derived from a natural product, and 
cisplatin (Williams et a l , 1987). Etoposide is also reported to show significant 
activity against small-cell lung carcinoma (Chabner, 1991; Perry, 1992; Harvey,
1999). Liu (1989) reported that it is a topoisomerase II inhibitor stabilising enzyme- 
DNA cleavable complexes leading to DNA breaks.
1.6.1 Flavones and Isoflavones
Flavones and isoflavones have been reported to play a prominent role in cancer 
prevention due to their existence in numerous plants associated with reduced cancer 
rates (Birt et al., 2001). Epidemiological research has always shown an inverse 
relationship between consumption of vegetables and fruits and the risk of human 
cancers at many sites (Block et al., 1992; Messina et a l , 1998; Steinmetz & Potter, 
1991a). There are a number of probable mechanisms by which intake of vegetables 
and fruit may prevent carcinogenesis (Birt et a l,  2001). Research showed that plant 
foods contain a wide variety of anticancer phytochemicals with many prospective 
biological activities that may reduce cancer susceptibility (Adlercreutz, 1990; 
Steinmetz & Potter, 1991b; Wattenberg, 1992a, b; Waladkhani & Clemens, 1998). 
Adlercreutz (1995), Knight & Eden (1996), Potter & Steinmetz (1996), Hollman et a l 
(1997), Knekt et a l (1997), Kou (1997) and Bravo (1998) showed that flavonoids and 
isoflavonoids are notably promising candidates for cancer prevention.
Flavonoids are plant secondary metabolites found in all terrestrial vascular plants, and 
defined chemically as substances composed of a common phenylchromanone 
structure (C6-C3-C6), with one or more hydroxyl substituents, including derivatives 
(Birt et a l,  2001). Isoflavonoids, in sharp contrast to flavonoids, possess a 3- 
phenylchroman skeleton which is biologically derived from the 2-phenylchroman
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skeleton of the flavonoids. Isoflavonoids are found in plants of the subfamily 
Papilionoideae of the Leguminosae, including soyabeans (Harbome, 1989; Birt et al., 
2001). Harbome (1989) indicated that both groups occur commonly as esters, ether, 
or glycoside derivatives, or mixtures thereof, embracing over 4,000 compounds. In 
mammals, both occur only through dietary intake (Birt et al., 2001).
There are several mechanisms for flavonoid and isoflavonoid inhibition of cancer, 
including oestrogenic and anti-oestrogenic activity, antiproliferation, cell cycle arrest 
and apoptosis, antioxidation, induction of detoxification enzymes, regulation of host 
immune function, and other mechanisms (Birt et al., 2001). These other mechanisms 
include the association of changes in protein phosphorylation of cancer cell lines with 
growth inhibition by flavonoids and isoflavonoids (see Kuo et al., 1994; Kuo & Yang, 
1995; Gamet-Payrastre et al., 1999), and topoisomerase antagonism by flavonoids and 
isoflavonoids (see Constantinou et al., 1994).
Dietary flavonoids and isoflavonoids are usually non-toxic. However, Czeczot et al. 
(1990) and Friedman & Smith (1984) reported some flavonoids (e.g., quercetin) to be 
toxic, and Miksicek (1993, 1995) identified some flavonoids and isoflavonoids, e.g., 
kampherol and genistein, as oestrogenic agonists at 1 pM.
In a recent review of cancer preventive effects of flavonoids, Le Merchand (2002) 
concluded that data accumulated, particularly in recent years, have demonstrated a 
wide variety of biological actions for flavonoids that may be beneficial against cancer. 
Nonetheless, he added that it is not clear whether these effects would also be present 
at physiological concentrations, and for the metabolites that are likely to be most 
relevant to humans.
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The epidemiological evidence that would support a cancer protective effect is still 
limited and has so far been rather inconsistent. Nonetheless, Le Marchand (2002) 
maintains that a few relationships have emerged, for example possible inverse 
association between soya intake (possibly early in life) and premenopausal breast 
cancer, green tea consumption and stomach cancer, and onion and apple intakes and 
lung cancer. More data are therefore required before any of such associations can be 
used to support specific health recommendations.
1.6.2 Propolis
Recently, propolis, a resinous hive product collected by honeybees from various plant 
sources, has been reported to have a broad spectrum of biological activities, namely 
anticancer, antioxidant, antiflammatory, antibiotic, antifungal activities, cytotoxic, 
hepatoprotective and free radical scavenging effects, or an antiproliferative activity 
(Burdock, 1998; Marcucci, 1995; Banskota et al., 2000a,b, 2001 a,b, 2002). The 
composition of propolis depends on the time, vegetation and the area of collection, 
thus quality evaluation is important before its use in food and drinks (Banskota et al., 
2000a). Marcucci (1995) found that propolis from temperate zones contains mainly 
phenolic compounds, including flavonoids and cinnamic acid derivatives. Bankova et 
al. (2000), on the other hand, found that diterpenes and prenylated compounds are 
present in tropical propolis of the South-American continent, which are virtually 
absent in temperate propolis, together with lignans, flavonoids, and other classes of 
compounds. This difference in composition between the two zones is mainly due to 
their different vegetations, but even with this difference, propolis from both regions 
possessed similar biological properties (Burdock, 1998; Banskota et al., 2001a). 
Basnet et al. (1996) and Banskota et a l (2000b, 2001b) isolated 31 different
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constituents from Brazilian propolis, three of which were new, and 15 others isolated 
for the first time from propolis, together with either antiproliferative activity or 
hepatoprotective activity.
1.6.3 Marine Organisms
Marine organisms have also been used as a source of new anticancer agents 
(Schwartsmann et al., 2001). C-nucleosides isolated from the Caribbean sponge, 
Cryptotheca crypta, about forty years ago, provided the basis for the synthesis of 
cytarabine, the first marine-derived anticancer agent to be developed for clinical trials, 
which is used at present in the routine treatment of patients with leukaemia and 
lymphoma (Schwartsmann et a l , 2001). Didemnin B, apilidine and ET-743 are 
derived from tunicates, which have entered phase I and II trials as antitumour agents 
(Rinehart, 2000). Didemnin B, a cyclic depsipeptide isolated from Trididemnum 
solidum, a tunicate, has shown impressive antitumour activity in human tumour 
models in vitro and in tumours growing in athymic mice (Geldof et a l,  1999). 
Nonetheless, despite the observed antitumour effects, clinical trials of didemnin B 
were discontinued due to severe neuromuscular and cardiotoxic effects (Shin et al., 
1991, Weiss et a l,  1994). Dehudrodidemnin B was then isolated from the 
Mediterranean tunicate, Aplidium albicans, which was later called aplidine. 
Antitumour activity was observed in patients with advanced solid tumours (renal-cell 
carcinoma, malignant melanoma, tumours of neuroendocrine origin, and medullary 
carcinoma of the thyroid (Izquierdo et a l,  2000; Maroun et a l,  2000; Raymond et a l,
2000). The main toxic effects include nausea and vomiting, myalgia, transient 
disturbance of liver function, and local irritation at the injection site. However, 
muscular toxicity was circumvented by the concomitant administration of L-camitine
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(Schwartsmann et al., 2001). It will start phase II trials in various solid tumours in the 
near future. Other marine-derived anticancer agents include ecteinascidins, derived 
from the Caribbean tunicate Ecteinascidia turbinate, dolastatins, cytotoxic cyclic and 
linear peptides derived from the sea hare, Dolabella auricularia (a mollusc found in 
the Indian Ocean), bryostatin, a macrocyclic natural lactone from the marine bryzoan, 
Bugula neritina, and many others. Schwartsmann et a l (2001) review provides 
further information about these antitumour agents.
1.7 Plants and Biochemicals in Cancer Therapy
A number of plants, and plant extracts, have been screened for their anticarcinogenic 
properties, one o f which is the Salvia plant species.
1.7.1 Salvia spp.
Several studies have reported the Salvia miltiorrhiza, a herbal plant widely used in 
traditional Chinese medicine for the treatment of chronic hepatitis and liver fibrosis 
(Liu et al., 2000). Substances isolated from this plant have been documented to 
exhibit antioxidant capabilities. Recent studies also indicated that this plant has anti­
tumour potential. Extract of S. miltiorrhiza noticeably prolonged the survival period 
of Ehrlich ascites carcinoma-bearing mice, and tanshione II-A sodium sulphonate, a 
compound isolated from this plant, could potentiate the cytotoxic action of 
hydroxycamptothecine against Ehrlich ascites carcinoma (see Chang & But, 1986).
Yang et a l (1981) found that pruzmaquinone A and B, two components extracted 
from S. miltrorrhiza, have anti-tumour activity in mice, while Wu et a l (1991) and 
Ryu et a l (1997) reported on the action of extracts of this plant on transformed cells 
in vitro. Ryu et a l (1997) found that methanolic extract of S. miltiorrhiza showed a
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significant anti-proliferation effect against cultured human cancer cell lines. Wu et al. 
(1991) tested fifteen tanshinone analogues isolated from chloroform extract for their 
cytotoxic activities against four types of cell lines derived from human carcinoma. 
More recently, Liu et al. (1999) suggested that S. miltiorrhiza is a potent anti-oxidant 
in protecting primary hepatocytes from oxidative damage induced by aflatoxin Bj, a 
well recognised hepatocarcinogen.
Liu et al. (2000) evaluated the molecular mechanism of S. miltiorrhiza (earlier studies 
had not investigated mechanism of action) in human hepatoma line, HepG2, and 
showed that this plant exerted clear cytotoxic effects, strongly inhibiting the 
proliferation of HepG2 cells. They also observed that treatment with this plant caused 
apoptotic cell death as evaluated by (i) morphological changes by using acridine 
orange/ethidium bromide staining; (ii) DNA fragmentation by TdT-mediated dUTP 
nick end labelling (TUNEL); and (iii) sub-Gi cell analysis. Liu et al. (2000) also 
found depletion of intracellular gluthione (GSH) and eduction of mitochondrial 
membrane potential to be involved in the initiation of apoptosis.
Frusciante et al. (2000) reported that several epidemiological studies have illustrated 
the importance of fruit and vegetables in the human diet so as to prevent the onset of 
cardiovascular disease and several forms of cancer. They reviewed two of the most 
widely grown and genetically well-known species in the world, the tomato and the 
potato.
Tomatoes are important sources of vitamin C, potassium, folic acid and carotenoids 
such as lycopene and p-carotene. Frusciante et al. (2000) indicated that it has been 
demonstrated that lycopene has anti-oxidant properties and interferes with the growth 
of cancerous cells.
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Quasney et a l (2001) demonstrated that human gastric cancer cells can be killed by 
micromolar concentrations of the plant sulpolipid sulfoquinovosyldiacylglycerol 
(SQDG), which is present in most photosynthetic organisms.
1.7.2 Allium spp.
The species Allium sativum, commonly known as garlic, has been widely studied for 
its anticancer properties. Kwon et a l (2002) reported that diallyl disulphide (DADS), 
a component of garlic (Allium sativum), has been known to exert effective 
chemopreventive activity against colon, lung, and skin cancer. They demonstrated 
that DADS induces apoptosis of human leukaemia HL-60 cells in a concentration- 
and time-dependent manner with an I C 5 0  for cell viability of less than 25 pM. They 
found that DADS activated caspase-3 as evidenced by both the proteolytic cleavage of 
the proenzyme and increased protease activity, and that activation of caspase-3 was 
maximal at 3 hr and led to the cleavage of 116 kDa poly (ADP-ribose) polymerase 
(PARP), which resulted in the accumulation of an 85 kda cleavage product. They 
found that their results indicated that DADS-induced apoptosis is triggered by the 
generation of hydrogen peroxide, activation of caspase-3, degradation of PARP, and 
fragmentation of DNA. They concluded that the induction of apoptosis by DADS may 
be the key mechanism by which its chemopreventive action against cancer is based.
1.7.3 Aspirin and Salicylic Acid
Aspirin has been studied in terms of its anticarcinogenic effect, mostly in the large 
bowel. Baron (1995) indicated that most of the studies published have reported an 
inverse association, though a few indicated otherwise. Pique et a l (2000) found that 
aspirin and other non-steroidal anti-inflammatory drugs induce apoptosis in many cell 
types. They concluded that their results demonstrated that aspirin-induced apoptosis
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involves release of cytochrome c from mitichondria preceding caspase activation and 
loss of A'Fm. They recommended undertaking further investigation.
Stark et al. (2001) found that aspirin induces activation of NF-kB, which is required 
for its anti-tumour activity and may contribute to the protective effects of aspirin 
observed in clinical trials. They added that the NF-kB and death response to aspirin 
appear relatively cell-specific since they were evident in numerous colon cancer cell 
lines, but not in cell lines of non-colonic origin.
1.7.4 Triterpenes
Recently, Ukiya et al. (2002) evaluated fifteen pentacyclic triterpene diols and triols, 
including six taraxanstanes (faradiol, heliantriol Bo, heliantriol C, 22a- 
methoxyfaradiol, amibiol, and faradiol a-epoxide), five oleananes (manildiol, 
erythrodiol, longispisnogenin, coflodiol, and heliantriol Aj), two ursanes (brein and 
uvaol), and two lupines (cakenduladiol and heliantriol B2), isolated from the non- 
saponifiable lipid fraction of the edible flower extract of Chrysanthemum morifolium, 
for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation 
induced by the tumour promoter, 12-O-teradecanoylphorbol-13-acetate, in Raji cells, 
as a primary screening test for antitumour promoters. They found that all of the 
compounds tested exhibited inhibitory effects against EBV-EA activation, with 
potencies either comparable with or stronger than those of glycerrhetic acid, a known 
natural anti-tumour-promoter. They also reported that the evaluation of the cytotoxic 
activity of six compounds, faradiol, helantriol Bo, heliantriol C, amidiol, faradiol-a- 
epoxide, and maniladiol, against human cancer cell lines revealed that faradiol-a- 
epoxide possesses a wide range of cytotoxicity, with G I 5 0  (concentration that yields 
50% growth) values of mostly less than 6pM.
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Lopez et al. (2002) reported that a crude ethanolic extract of Cupressus lusitanica 
Mill, leaves exhibited cytotoxicity in a panel of cancer cell lines. They also reported 
that cell death was due to apoptosis, assessed by morphologic features and specific 
DNA fragmentation detected in situ end-labelling of DNA breaks (TUNEL). They 
also showed that apoptotic cells death was induced timely in a dose-dependent 
manner, and despite the absence of changes in the expression levels of antiapoptotic 
protein Bcl-2, proapoptotic Bax protein variants co and 5 were increased. They 
recommended that their results warrant further research of possible antitumour 
compounds in this plant.
Saleem et al. (2002) studied the inhibition of cancer growth by crude extract and the 
phenolics of Terminalia chebula retz. Fruit. This plant, known as black myroblans, is 
indigenous in Pakistan and India, and has been studied for its homoeostatic, 
antitussive, laxative, diuretic and cardiotonic activities. Saleem et al. (2002) studied 
the effects of a 70% methanol extract of this fruit for its effect on growth in several 
malignant cells lines, including human (MCF-7) and mouse (SI 15) breast cancer cell 
line, a human osteosarcoma cell line (HOS-1), a human prostate cancer line (PC-3), 
and a non-tumorigenic, immortalised human prostate cell line (PNT1 A). They found 
that the extract decreased cell viability, inhibited cell proliferation, and induced cell 
death in a dose-dependent manner in all cell lines. They also found that flow 
cytometry and other analyses indicated that some apoptosis was induced by the 
extract at lower concentrations, though at higher concentrations necrosis was the 
major mechanism of cell death. Three components, chebulinic acid, tannic acid and 
allagic acid were found to be the most growth inhibitory phenolics of T. chebula fruit.
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1.7.5 Isoprenoids
Tatman & Mo (2002) found that volatile isoprenoid constituents of fruits, vegetables 
and herbs cumulatively suppress the proliferation of cancer cells lines (murine B16 
melanoma and human HL-60 leukaemia cells).
Melnykovych et al. (1992) and Haug et al. (1994) reported that isoprenoid famesol 
triggers growth inhibition and apoptotic death of human leukaemia CEM-C1 cells. 
Yazlovitskaya & Melnykovych (1995) studied the selective famesol toxicity amd 
translocation of protein kinase C in neoplastic HeLa-S3K and non-neoplastic CF-3 
cells. They pointed to the possible involvement of protein kinase C (PKC) in the 
toxic effect of famesol, which occurs with some degree of selectivity depending on 
cell origin.
Miquel et al. (1996) tested the effects of several isoprenoids on A549 human lung 
adenocarcinoma cells, but only famesol and geranylgeraiol induced actin cytoskeleton 
disorganisation, growth inhibition, and apoptosis. They showed that all isoprenoids 
tested are potent inhibitors of HMG CoA reductase activity, the sterols being the most 
powerful, while they induce neither F-actin disorganisation nor apoptosis. They 
concluded that the molecular mechanisms induced by famesol and geranylgeraniol 
appear independent of reductase regulation.
Flach et al. (2000) found apomine (SR-45023A), a mevalonate/isoprenoid pathway 
inhibitor, to be an antiproliferative, and that it induces apoptosis similar to famesol, 
and reported that apomine triggered apoptosis in HL50 cells in less than two hours. 
They concluded that the overall similar profile on mevalonate synthesis inhibition, 
cell growth inhibition, and apoptosis suggests that apomine acts as a synthetic 
mimetic of famesol.
25
Hamada et a l (2002) found that 1-famesylpyridinium (FPy), an analogue of farsenol, 
initially initiated morphological changes similar to those of typical apoptosis in 
human leukaemia HL-60 cells. However, FPy-treated cells were characterised by the 
complete absence of final apoptotic events, for example fragmentation into apoptotic 
bodies. These authors regarded FPy-induced cell death to be apoptotic on the basis of 
the induction of DNA fragmentation and the protection against these events by the co­
addition of a pan-caspase inhibitor. Hamada et a l (2002) also reported that the 
increase in the cytoplasmic cytochrome c level substantiated the possibility that PFy- 
treated cells should have the ability to complete the whole apoptotic process, ending 
in cell fragmentation and apoptotic body formation. They also found that PFy, 
applied at too low concentrations to induce apoptosis, could suppress the induction of 
apoptotic body formation in HL-60 cells by typical inducers of apoptosis, for example 
actinomycin D or ansiomycin. It was also found that PFy showed a cytochalasin-like 
effect on spatial arrangement of actin filament independent of its apoptosis-inducing 
activity.
1.7.6 Burseraceae
The Burseraceae are a family of trees or shrubs which are generally spiny and often 
release aromatic resins when wounded. There are some 17 genera and 560 species 
widespread in the tropic regions of both hemispheres.
In Africa, the chief economic products from this family are the gum-resins, of the two 
genera Commiphora and Boswellia.
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1.7.6.1 Boswellia spp.
The gum resin of Boswellia serrata is another plant product used against human 
leukaemia. The alcoholic extracts of the resin (boswellic acids) are reported to have 
an inhibitory activity against human leukaemia HL-60 cells in culture (Shao et al., 
1998). Shao et a l (1998) isolated four major triterpene acids, including p-boswellic 
acid, 3-0-acetyl-P-boswellic acid, 11-keto-p-boswellic acid, and 3-O-acetyl-11-keto- 
p-boswellic acid, from the gum of B. serrata, and examined them for their in vitro 
antitumour activity. They found that these acids inhibited the synthesis of DNA, 
RNA and protein in human leukaemia HL-60 cells in a dose-dependent manner, with 
I C 5 0  values ranging between 0.6 and 7.1 pM. They also found that 3-O-acetyl-l 1- 
keto-p-boswellic acid induced the most pronounced inhibitory effects of DNA, RNA 
and protein synthesis, with I C 5 0  values of 0.6, 0.5, and 4.1 pM, respectively. The 
effect of this acid on DNA was found to be irreversible, and that it significantly 
inhibited the cellular growth of HL-60 cells, but did not affect cell viability.
Huang et a l (2000) also studied the antitumour and anticarcinogenic activities of p- 
boswellic acid, extracted from B. serrata, and reported that their results showed that 
p-boswellic acid and its derivatives have anticarcinogenic, anti-tumour, and anti- 
hyperlipidemic activities.
Jing et a l (1999) reported that boswellic acid acetate (BC-4), a compound isolated 
from the herb Boswellia carterii Birds., can induce differentiation and apoptosis of 
leukaemia cells. They found that BC-4 induced monocytic differentiation of myeloid 
leukaemia HL-60, U937 and ML-1 cells at a dose less than 12.5 pg/ml (24.2 pM). 
They also reported that BC-4 was a potent inducer, with 90% of the cells showing 
morphologic changes, and 80% to 90% of cells showing NBT reduction. BC-4 also
27
led to an increase in specific and non-specific esterase, but based on benzidine 
staining assay, it failed to induce erythroid leukaemia DS-19 and K562 cell 
differentiation. Nonetheless, in contrast to its selective differentiation effects, BC-4 
strongly inhibited growth of all cell lines tested. Growth inhibition effect was dose- 
and time-dependent. Jing et al. (1999) also maintained that in HL-60 cells, 20 pg/ml 
(38.8 pM) of BC-4 decreased viable cell numbers by 60% at 24 hours, whereas at 
three days there were almost no viable cells. Morphologic and DNA fragmentation 
analysis proved that BC-4 induced apoptosis, and concluded that the dual apoptotic 
and differentiation effects of BC-4 suggest that it may be a powerful agent in treating 
leukaemia.
1.7.6.2 Commiphora spp.
The most famous of these plants is known as the myrrh tree, and belongs to the 
species known as Commiphora molmol. C. molmol has been reported to have an anti­
inflammatory activity. Tariq et al. (1985) reported that administering petroleum ether 
extract of oleo-gum resin of C. molmol, at a dose of 500 mg/kg body weight, 
produced significant inhibition of carrageenan-induced inflammation and cotton pellet 
granuloma. They also reported its significant antipyretic activity in mice.
Qureshi et al. (1993) studied the genotoxic, cytotoxic and antitumour properties of 
olego gum resin of Commiphora spp. in normal and Ehrlich ascites carcinoma cell- 
bearing mice. They evaluated the genotoxic and cytotoxic activity in normal mice on 
the bases of the frequency of micronuclei and the ratio of polychromatic to 
normochromatic cells in bone marrow, substantiated by the biochemical changes in 
hepatic cells. These authors also evaluated the antitumour activity of Commiphora 
from the total count, and the viability of Ehrlich ascites carcinoma cells and their
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nucleic acid, protein, malondialdehyde and elemental concentrations, in addition to 
observations on survival and the trend of changes in body weight. Qureshi et al. 
(1993) also reported that results obtained in the Ehrlich ascites carcinoma cell-bearing 
mice revealed the cytotoxic and antitumour activity of Myrrh, which, as they claimed, 
was equivalent to that of the standard cytotoxic drug cyclophosphamide, and that on 
the basis of the nonmutagenic, antioxidative, and cytotoxic potential of Commiphora, 
its use in cancer therapy seems to be appropriate, and suggested further investigations.
The same research group (Al-Harbi et a l, 1994) carried out further research on the 
anticarcinogenic effect of Commiphora molmol on solid tumours induced by Ehrlich 
carcinoma cells in mice. The antitumour activity was evaluated at the end of 25 and 
50 days of treatment, and it was found that treatment of C. molmol (250 and 500 
mg/kg/day) was cytotoxic in Ehrlich solid tumour. They also reported that the 
antitumour potential of C. molmol was comparable to cyclophosphamide. 
Nonetheless, they found that this effect was less evident after 50 days of treatment. 
They also indicated that their results confirmed the cytotoxicity and anticarcinogenic 
potential of C. molmol, and recommended undertaking further studies to investigate 
its mode and safety for medicinal use in cancer therapy.
More recently, Al-Harbi et al. (1997) studied the gastric antiulcer and cytoprotective 
effect of C. molmol in rats. They found that treatment of rats with 1 ml of 80% 
ethanol caused depletion of stomach wall mucus, and reduction in the concentration of 
protein, nucleic acids and non-protein (NP)-SH groups in the stomach wall. Ethanol 
treatment also caused histopathological lesions such as necrosis, erosion, congestion 
and haemorrhage of the stomach wall. They reported that pre-treatment with C. 
molmol offered a dose-dependent protection against all these effects. Likewise, it
29
affected the malondialdehyde concentration altered by ethanol treatment, and offered 
protection against mucosal damage caused by indomethacin and its combination with 
ethanol. Al-Harbi et al. (1997) attributed the protective effect of C. molmol to its 
effect on mucus production, increase in nucleic acid and NP-SH concentration, which 
seemed to be mediated through its free radical-scavenging, thyroid-stimulating and 
prostaglandin-inducing properties.
Rao et a l (2001) carried out toxicity studies of C. molmol oleo-gum-resin in mice. 
They found that there was no difference in mortality in acute or chronic treatment of 
mice as compared to controls. They found that at the end of the treatment, weight 
gain in the treated and control groups was significant. They also found a significant 
increase in weight of testes, caudae epididymides, and seminal vesicles in the 
molmol-treated group. Haematological studies revealed a significant increase in red 
blood cells and haemoglobin levels compared to the control group. They found that 
molmol failed to show any spermatotoxic effect.
Tipton et al. (2003) investigated the in vitro cytotoxic and anti-inflammatory effects 
of myrrh oil on human gingival fibroblasts and epithelial cells. They reported that 
fibroblasts resident in the gingival tissue can participate in local inflammation through 
the production of cytokines, for example IL-6 and IL-8. Their results suggest that 
myrrh oil may reduce fibroblast production of such proinflammatory cytokines, and 
consequently reduce the participation of these cells in gingival inflammation 
associated with gingivitis and periodontitis. They recommended that more in vitro 
and clinical studies are required regarding herbal remedies traditionally used to treat 
periodontal diseases.
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1.8 Aims and Objectives
The main aims of this project are to investigate the anticarcinogenic potential of two 
species of Commiphora, C. molmol (molmol) and C. guidotti (haddi), and some of the 
constituent biochemicals of these two plants, against three cells lines, one normal cell 
line, chick normal fibroblast cell line, and two cancer cell lines, S I80 murine sarcoma 
cell line, and HT1080 human fibrosarcoma cell line, and to find out whether these 
plants contain apoptotic agents, and whether they induce apoptosis or not.
The objectives specified are:
1. To investigate appropriate extracts of the two plants, using ethanol, hexane 
and ethyl acetate as the extractants.
2. To investigate the effects of ethanolic extracted molmol and hexane extracted 
haddi on the growth and proliferation of the three cell lines mentioned above.
3. To test the cytotoxicity of the two extracts on the three cell lines, with special 
reference to apoptosis.
4. To investigate the effects of two commercially available extracts of the two 
plants, Flavex molmol and haddi essential oil (Aldrich), on tumour cell growth 
and apoptosis.
5. To investigate the effects of two commercially available biochemical 
components of both plants, trans-fl-ocimene and y-bisabolene on tumour cell 
growth and apoptosis.
In order to achieve these objectives, several methods and techniques were used, as 
explained in the following chapter.
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Chapter Two 
Materials and Methods
2.1 Introduction
Many researchers have tested a large number of plants and their extracts for their anti­
carcinogenic properties (Tariq et a l,  1985; Qureshi et al., 1993; Al-Harbi et a l, 
1994). Of these plants are species belonging to the Genus Commiphora (Myrrh); for 
example C. molmol has been reported to have an anti-inflammatory activity (Tariq et 
a l,  1985).
In this study, two species of molmol, C. molmol (molmol) and C. guidotti (haddi) 
were used for the treatment of three cell lines to investigate their anti-carcinogenic 
effects. Extracts of each plant were prepared using four solvents. Methods of 
preparation are explained later in this chapter.
2.2 Cell Lines
Three types of cell lines were used to test the cytotoxic effects of the extracts obtained 
from the two experimental plants: S I80 murine sarcoma cell line, HT1080 human 
fibrosarcoma cell line, and chick normal fibroblasts (NF) cell line. These three cell 
lines proved to be excellent models for the investigation of cell death-inducing effects 
of the molmol and haddi plant extracts.
2.2.1 S180 Murine Sarcoma Cell Line
The S I80 tumour, also referred to as Crocker’s sarcoma, arose spontaneously in the 
axial region of a mouse, and was discovered in 1914. Although this is commonly 
treated as an epithelioma, there is much uncertainty with respect to the original
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phenotypic nature of this tumour (Zuckerberg, 1973). The tumour is entirely 
undifferentiated and bears no characteristics that allow it to be classified categorically 
(Dunham, 1952). S I80 is highly malignant, slightly immunogenic, and is used 
extensively as an experimental tumour model in chemotherapy screening studies.
This cell line was obtained from the European Collection of Cell Culture (EEACC). 
Results obtained using extracts from two African plants (C. molmol and C. guidotti) 
were compared with results obtained using HT1080 fibrosarcoma and chick normal 
fibroblast (NF) cell lines.
S I80 sarcoma cells were maintained in Minimum Essential Medium with Earle’s 
salts, with and without L-glutamine (GibcoBRL, UK), supplemented with 10% v/v 
foetal calf-serum (FCS, GibcoBRL, UK), and 1% v/v penicillin/streptomycin solution, 
containing 100 IU/ml penicillin and 100 pg/mg streptomycin, and 1% non-essential 
amino acids, in a humidified atmosphere of 95% trypsin and 5% CO2. Cells were 
split every 5 to 7 days after trypsinisation with trypsin-EDTA (IX) (Gibco, UK), and 
were seeded at a concentration of 5 x 104 per 25 cm2 Costar flask.
All materials and biochemicals used were pre-warmed in a water bath maintained at 
37°C prior to their use.
Cells were grown and maintained using Costar flasks, with a surface area of either 25 
cm2 or 75 cm2.
2.2.2 HT1080 Human Fibrosarcoma Cell Line
HT1080 cell line was developed by Rasheed et al. in 1974. They represent a 
pseudodiploid line with the model number of 46 chromosomes. HT1080 cell lines are 
epithelial-like adherent cells developed from a fibrosarcoma which arose adjacent to 
the acetabulum of a 35 year-old white male. This kind of tumour can spread rapidly
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to the bone through the blood stream or by direct invasion. The most commonly 
affected areas include the lower jaw, nasal sinuses, vertebrae, spine and radius. 
Nonetheless, femur and tibia are also frequently affected. Fibrosarcomas can later on 
spread or metastasise to other soft tissues such as kidney and lymph nodes.
The cells can give rise to tumours in immunosuppressed NIH Swiss mice susceptible 
to infection by RNA tumour viruses, and which are particularly well suited for the 
production of Moloney murine leukaemia virus, and are therefore used as helper cells, 
viral vector producer cells (VPCs), or retroviral packaging cells. This packaging cell 
line offers the advantage of producing high titres of retroviral vectors’ resistance to 
inactivation by human serum, enabling their use in human therapy. Reducing the viral 
sequences has also reduced the risk of producing replication component retroviruses. 
Consequently, this cell line offers great potential for the development of human gene 
therapy.
HT1080 cells do not grow well in semi-solid medium, but require Dulbecco’s 
modified Eagle medium with a high glucose and L-glutamine supplement with 10% 
FCS. The cells are highly tumorigenic in nude mice due to their possession of a 
mutant hyperactive N -ras allele which initiates a linear signal transduction cascade 
culminating in the transcriptional activation of genes involved in mitogenesis, and 
gives rise to continuous mitogenesis (Reuter et al., 1995). The hyperactive N -ras 
extracellular signal-regulated kinase is the first in a constitutively expressed pathway 
of Raf, MEK, and MPAK (also known as ERK), which activate ELK-1 in the nucleus, 
leading to gene expression and the consequential neoplastic activity and phenotype 
(disorganised actin filament) of HT1080 cells.
This cell line was kindly provided by Dr. Alvin Kwan (School of Biosciences, Cardiff 
University). They were also grown and maintained in Dulbecco’s Modified Eagle
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Medium (DMEM) without sodium pyruvate, but with L-glucose (GibcoBRL, UK).
0.5 ml gentamycin, 10% FCS, antibiotics, L-glutamine, 1% sodium pyruvate 
(GIBCO, UK), 1% HEPES buffer (GIBCO, UK), and vitamin C also added.
All materials and biochemicals used were pre-warmed in a water bath maintained at 
37°C prior to their use.
Cells were also grown and maintained using Costar flasks, as explained above.
2.2.3 Normal Chick Fibroblast (NF) Cell Line
The chick fibroblasts were kindly provided by Dr. Jim Ralphs (School of Biosciences, 
University of Cardiff). The preparation of chick fibroblasts involved the dissection of 
flexor tendons from the feet of 6-day-old chickens and internal fibroblasts extracted 
by a modification of the methods of Banes et al. (1988). Tendons were treated 
successively with 0.5% bacterial collagenase I for 3 minutes and 0.25% trypsin for 15 
minutes at 37°C, and then scraped with a rubber policeman to remove surface cells. 
The remaining tendons were chopped and digested successively with 1% protease for 
1 hour and 0.5% collagenase I for 2 hours. Cells were then centrifuged at 1000 rpm 
for 5 minutes and were resuspended and plated in high glucose DMEM containing 5% 
foetal calf serum (FCS) and antibiotic, grown to confluence and passaged.
2.3 Thawing of Frozen Cell Stocks
Cell stocks obtained for the three cell lines were kept in foetal calf serum (FCS) in 
Epindorff tubes and stored in a freezer at -80°C. The tubes containing the cells were 
thawed rapidly, when required, in a 37°C water bath for 2-3 minutes. The tube 
contents were then shaken thoroughly and added to 25 cm2 flasks containing 5-7 ml of 
the growth medium. The flasks were then left for about three days, after which period 
the medium was changed in order to remove dead cells. Flasks were then sub­
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cultured normally when cell density in the flasks had increased after about five days. 
The cells were then cultured, as described in the following section.
2.4 Maintenance of Adherent Cell Cultures
Cell stocks of all three cell lines were maintained by continuous sub-cultures from 25
2 2cm and 75 cm flasks when about 80% confluency was observed. The following 
procedure was employed for sub-culturing. The media were removed from the flask, 
using a large volume pipette, and the adherent cell monolayer was washed twice with 
1 to 2 ml phosphate buffered saline (PBS). (PBS: 1.5 mM KH2P 0 4, 6.5 mM 
NagHPOs, 137 mM NaH2P 0 4, 137 mM NaCl, 2.7 mM KC1, and pH adjusted to pH 
7.5). The prepared buffer was filtered through a 0.22 pm porosity membrane filter 
(Millipore, UK) to sterilise and remove any insoluble residue. Phosphate buffered 
saline was prepared by dissolving one PBS tablet (GIBCO, UK) in 500 ml of distilled 
water, and the solution was then filtered through a 500 ml Millipore Stericup vacuum- 
driven disposable filtration system. The phosphate buffer was removed, and 2 ml of 
pre-warmed (37°C) Trypsin-EDTA solution (IX) (GibcoBRL) were added to the cell 
monolayer in order to rinse the flasks and to remove any residual growth medium, and 
the majority of this volume was removed. 2 to 5 ml of Trypsin-EDTA solution were 
then added to the adherent cells, depending on cell number and flask size (25 cm or 
75 cm ), and the flasks were incubated at 37°C for 3 to 5 minutes to allow cells to 
detach. The cultures were examined using an inverted microscope (Zeiss ID03, 
Germany) to make sure that all cells had detached, and the cell suspension was 
dispersed by repetitive pipetting in order to obtain a single cell suspension, free of 
clumps, and the cell number was estimated using a haematocytometer (Sigma 
Chemical Co, USA). An appropriate volume was then removed such that the seeding 
density of the new culture would be 5x104 cells (S I80, HT1080 and NF) per 25 cm2
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flask in 5 to 7 ml fresh growth medium, and incubated at 37°C in a humidified 
atmosphere of 5% CO2 in air (Stericult incubator). The lids of the culture flasks were 
loosened to allow gas exchange. S I80 cultures were refed after 4 days, and HT1080 
cultures for 5 to 8 days, and were left in the incubator until reaching 80% confluency, 
when subculture was repeated as described above. Morphological changes and 
counting of the cells were performed as described above.
2.4.1 Determination of Cell Numbers
The improved Neubauer haematocytometer is a microscopic counting chamber with 
defined areas and a known depth. The cell number within this area can therefore be 
used to calculate cell concentration, using the following formula:
c = n/v,
where c is the cell concentration (cells/ml), n is the number of cells counted, and v is 
the chamber volume counted (ml). For the improved Neubauer slide, the depth of the 
chamber is 0.1 mm, and the central area used is 1 mm . Accordingly, v equals 0.1 
mm3, or lxlO-4 ml. The formula then becomes:
c = h/10*4 = n x 104 (cells/ml).
2.5 Preparation of Molmol (Commiphora molmol) Extracts
Molmol was extracted using ethanol, hexane, ethyl acetate and Flavex extract. 
Flavex, a commercially available aqueous alcoholic extract of C. molmol (20%w/v in 
96% ethanol) was obtained from Flavex International Limited (UK). It is referred to 
in this thesis as Flavex molmol.
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2.5.1 Ethanol Extracts
Ethanolic extracts were prepared by adding 20 g of molmol to 100 ml of absolute 
ethanol. The mixture was stirred for a few minutes and left for seven days at room 
temperature in a dark cupboard. After that period, the mixture was stirred for a few 
minutes to ensure complete suspension of the extract in the extracting solution, and 
the solution was filtered using a 150 ml Millipore stericups filter. To aid filtration, 
extracts were filtered under suction using a 250 ml Buchner flask. The filtrate was 
then evaporated under vacuum using a rotary evaporator (BUCHI, Germany) at a 
constant temperature of 70°C.
2.5.2 Hexane Extracts
Molmol was also extracted with hexane, by adding 20 g of molmol to 100 ml of 
hexane. The mixture was then treated as described for ethanolic extraction. 
However, because the Millipore filter becomes damaged when organic solvents such 
as hexane and ethyl acetate, the extractants, are involved, the mixture was not filtered 
through a Millipore filter, and instead filtration was carried out under vacuum using a 
250 ml Buchner flask.
2.5.3 Ethyl Acetate Extracts
Molmol was also extracted with ethyl acetate in a similar way as described for hexane 
extraction, with 100 ml of ethyl acetate replacing hexane as the extractant, and 
vacuum was used to aid filtration.
2.5.4 Flavex Extract
Flavex is a commercially available aqueous ethanolic extract of molmol obtained 
from Flavex International Limited.
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All extracts were prepared at 20%w/v. All chemicals used for extraction were 
obtained from Fisher Chemicals, UK.
2.6 Preparation of Haddi (Commiphora guidotti) Extracts
Haddi is the local name in Somalia for Commiphora guidotti. Haddi was extracted 
using ethanol, hexane and ethyl acetate solvents, and prepared as described for C. 
molmol. An essential oil extract (Opoponax oil) was obtained commercially from 
Aldrich, USA.
2.7 Preparation of Stock Extracts
For each extract, 60 mg of the plant extract was added to, and dissolved in, 120 pi of 
ethanol to give a total volume of 180 pi. From this total volume, 144 pi was added to 
36 ml of the growth medium and vortex-mixed using a Whirlmixer (Fisons). This 
was then centrifuged at 20,000 rpm for five minutes, and filtered using a 50 ml 
Millipore Stericup vacuum-driven disposable filtration system. This procedure 
resulted in a stock solution of 1333 pg/ml.
It has been noticed that when the oil was dissolved in ethanol and then added to the 
medium, a cloudy emulsion was formed.
2.8 S180 and HT1080 Cell Growth Assays
Three replicates of growth curves experiments, each containing three batches, were 
run simultaneously, as follows: control, treatment with an ethanolic molmol extract, 
and treatment with hexane haddi extract for S I80 cell line and HT1080 cell line.
The growth curves help to visualise any effects that the treatments mentioned above 
may have on the S I80 and the HT1080 cell lines, by investigating the differences 
between the control and treatment curves. For each run, 24 flasks, with 25 cm
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surface area each, were prepared with a seeding density of 4 x 104 cells per flask. Cell 
numbers in each flask were then counted twice per day, every day, using a 
haematocytometer, and an average was then calculated. This counting procedure was 
carried out for all experiments, control and treatments (nine trials for each treatment). 
For the S I80 cell line growth experiment, ethanolic molmol and hexane haddi extracts 
were added to the culture on Day 4 for a concentration of 366.63 pg/ml for ethanolic 
molmol, and 366.63 pg/ml for hexane haddi. The control medium was only replaced 
with fresh medium. Results were taken every 24 hours for 8 days for the S I80 cell 
line and 14 days for the HT1080 cell line. HT1080 medium was changed and treated 
at Day 7, instead of at Day 4 as for the SI 80 treatments.
2.9 S180, HT1080 and Normal Fibroblast MTT Assays
The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay 
procedure adopted for the S I80, HT1080 and normal cell lines was as follows:
Cells were seeded at seeding density of 2xl05 cells/ml.
100 pi of cells at 2x l05 cells/ml were added to a 96-well microtiter plate (avoiding the 
outer edge of the plate as cells would dry out, and PBS was added to outer wells to 
prevent evaporation of the media in the test wells).
The plate was then left for 4 hours in an incubator in a humidified atmosphere of 95% 
air and 5% CO2 at 37°C.
A 100 pi of medium with cells to the 1st row of the plate as it is the control (untreated 
cells).
A 100 pi of plant extract at five different concentrations. The plate was kept in an 
incubator for 24, 48 and 72 hours. 20pl of MTT were added to each well. The plate 
was wrapped in foil, as MTT is sensitive to light. Then the plate was placed into the
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incubator for 4 hours at 37°. The media were removed. 200pl of DMSO were added 
to each well. The plate was read on ELISA at 575 nm.
Calculate percentage toxicity and percentage viability using the following formulae:
3, • b
% Cytotoxicity =  x 100
a
where: a = mean absorbance of nine wells with culture medium only, 
b = mean absorbance of nine wells with plant extract dilution.
% Viability was measured using the following formula:
% Viability = 100 - % Cytotoxicity
LC50 concentrations for 666.6 pg/ml extract were calculated using the 
following formula:
LC50 = (666.60* 50)/percentage toxicity
The same steps were repeated, after 48 hours and 72 hours, to find out the percentage 
of toxicity and percentage of viability after 48 and 72 hours of incubation.
For each treatment, three wells were used per replicate, and a total of 3 triplicate runs 
were attempted, giving a total of 9 wells per experiment. In each treatment, a control 
and five test concentrations were set up.
MTT assays were carried out and repeated three times for five different 
concentrations of the following extracts:
Molmol: Ethanolic, hexane, ethyl acetate, and Flavex extracts.
Haddi: Ethanolic, hexane, ethyl acetate, and essential oil (Aldrich) extracts.
Results of the MTT viability test showed that molmol-ethanolic and haddi-hexane 
extracts had the optimum effect on the cell lines used. Accordingly, the remaining
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experiments were undertaken using molmol-ethanolic and haddi-hexane extracts.
2.9.1 Preparation of Concentrations Used in MTT Assays
Different concentrations of molmol and haddi extracts were prepared for various 
purposes of the study. The 666.60 pg/ml to 266.45 pg/ml concentrations of extracts 
were prepared as illustrated in Table 2.1.
Table 2.1 266.45-666.60 pg/ml treatment concentrations of ethanolic-, hexane-,
ethyl acetate-, flavex-, and essential oil Aldrich-extracts.
Medium
Volume
Final
Volume
(pi)
Oil
Concentration
(%v/v)
mg/ml pg/ml Final
Concentration
(pg/ml)
12,000 12,000 0.133 1.333 1333.2 666.6
600 4,000 0.113 1.133 1133.2 566.6
620 3,500 0.093 0.932 932.4 466.2
645 3,000 0.073 0.731 732. 366.0
680 2,500 0.053 0.533 532.8 266.4
In the event of greater total volume of treatment being required, multiples of this table 
were used
The 666.60 pg/ml to 0.65 pg/ml concentrations of extracts were prepared as 
illustrated in Table 2.2.
A further dilution series was prepared, covering the range of 366.60 and 466.6 pg/ml 
of the extract (Table 2.3).
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Table 2.2 0.65-666.60 fig/ml treatment concentrations of ethanolic-, hexane-
extracted molmol and haddi.
Final
Volume
M>
Oil
Concentration
(%v/v)
mg/ml Mg/ml Final Concentration 
(pg/ml)
12,000 0.133 1.333 1333.2 666.6
2,000 0.067 0.667 666.6 333.3
2,000 0.017 0.167 166.6 83.3
2,000 0.002 0.021 20.8 10.4
2,000 0.000 0.001 1.3 0.065
Table 2.3 366-466 pg/ml treatment concentrations of ethanolic molmol
Final
Volume
Oil)
Oil
Concentration
(%v/v)
mg/ml pg/ml Final Concentration 
(pg/ml)
12,000 0.093324 0.933 933.2 466.6
2,000 0.088268 0.883 882.6 441.3
2,000 0.083344 0.833 833.4 416.7
2,000 0.078224 0.782 782.2 391.1
2,000 0.073336 0.733 733.3 366.6
A higher concentration series of extracts were prepared for the treatment with haddi 
essential oil (Aldrich) (Table 2.4)
Table 2.4 Higher treatment concentrations for haddi essential oil (Aldrich).
Final
Volume
Oil)
Oil
Concentration
(%v/v)
mg/ml pg/ml Final Concentration 
(pg/ml)
36,000 0.133 1.333200 1333.200 1333.2
18,000 0.113 1.133220 1133.220 1133.2
12,150 0.093 0.932691 932.691 932.9
8,260 0.073 0.733958 733.958 733.9
8,250 0.053 0.533788 533.788 533.7
43
2.9.2 Preparation of MTT
The concentration used in the present study was 5 mg/ml, and this is the established 
optimal concentration of MTT (Cedilo-Rivera et al., 1992; Hegyesi & Csaba, 1997; 
Al-Hazzaa, 2002). MTT powder was dissolved and the stock MTT was prepared at a 
concentration of 5 mg/ml in phosphate buffered saline, then the solution was filtered 
using a 0.22 pm membrane filter (Millipore, UK) to remove any insoluble residue. 
The stock solution was then stored in bottles wrapped with foil because MTT is 
photosensitive.
Viable cell growth was determined by the MTT dye reduction microassay 
(Boehrenger Mannheim, UK). MTT [3-(4,5-dimethylthaizol-2-yl),-2,5- 
diphenyltetrazolium bromide] is a yellow, water-soluble tertrazolium dye which is 
reduced by live cells to a purple formazan product, insoluble in aqueous solutions. 
Tetrazolium reactions have a wide application in the indirect demonstration of 
dehydrogenase activity. The reaction is used as the end point in a rapid drug- 
screening assay (Plumb et al., 1989). The MTT method has been adapted for use with 
microtitre plates as a cellular viability assay (Bowen, 1998).
2.10 Haematoxylin-Eosin Staining
A. SI80 Cell Culture Preparation
S I80 cells seeded at cell density of 2x l05 cells/ml were exponentially grown on 13 
mm glass coverslips in 12-well Coming plates, incubated in Mini Essential Culture 
Medium containing 10% FCS at 37°C and 5% CO2. The cells were then treated with 
two different concentrations, 666 pg/ml and LC50 concentrations of ethanolic molmol 
or hexane haddi, and a control (untreated), for the following time points:
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Ethanolic molmol, 6 6 6 .6  pg/ml: 6 ,12, 24 hours.
Ethanolic molmol, 234 pg/ml: 6 , 12, 24 hours.
Hexane haddi, 6 6 6 .6  pg/ml: 6 ,12, 24 hours.
Hexane haddi, 201 pg/ml: 6 , 12, 24 hours.
Control -  untreated: 6 , 12, 24 hours.
After each treatment, which was carried out in duplicates, the cells on the cover slips 
were fixed with 10% neutral buffer formalin for ten to twenty minutes. The fixed 
cells were then stained in Mayer’s haematoxylin for two to three minutes, followed by 
three rinsings in tap water, and once in distilled water. The cells were then 
counterstained with eosin for 45 to 60 seconds, followed by another three rinsings in 
tap water, and once in distilled water. Finally, the cells were air dried and mounted in 
Xam. The morphology of the cells was studied using a Leitz DMRB light microscope 
at X40 and X I00 magnifications.
B. HT1080 Cell Culture Preparation
2x l0 5 HT1080 cells were exponentially grown on 13 mm glass coverslips in 12-well 
Coming plates, incubated in DMEM medium containing 10% FCS at 37°C and 5% 
CO2. The cells were then treated with 6 6 6  pg/ml and LC50 concentrations of 
ethanolic molmol or hexane haddi, and a control (untreated), for the following time 
points:
Ethanolic molmol, 6 6 6 .6  pg/ml: 6 , 12, 24 hours.
Ethanolic molmol, 234 pg/ml: 6 , 12, 24 hours.
Hexane haddi, 6 6 6 .6  pg/ml: 6 , 12, 24 hours.
Hexane haddi, 201 pg/ml: 6 , 12, 24 hours.
Control -  untreated: 6 , 12, 24 hours.
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The cells were then fixed in neutral buffer formalin, stained with haematoxylin, 
counterstained with eosin, and their morphology examined, following the procedure 
described for S I80 cells.
C. Normal Fibroblast Cell Culture Preparation
Normal fibroblast, seeded at 2xl05 cells/ml, were also exponentially grown on 13 mm 
glass coverslips in 12-well Coming plates, incubated in DMEM containing 5% FCS at 
37°C and 5% CO2. The cells were then treated with 666 pg/ml and LC50 
concentrations of ethanolic molmol and hexane haddi, and a control (untreated), for 
the following time points:
Ethanolic molmol, 666.6 pg/ml: 6, 12, 24 hours.
Ethanolic molmol, 234 pg/ml: 6, 12, 24 hours.
Hexane haddi, 666.6 pg/ml: 6, 12, 24 hours.
Hexane haddi, 201 pg/ml: 6, 12, 24 hours.
Control -  untreated: 6, 12, 24 hours.
The cells were then fixed, stained, and examined as described above.
2.11 Detection of DNA Fragmentation (TUNEL)
2.11.1 Procedure
A. HT1080 Cell Culture Preparation
2x l05 HT1080 cells were exponentially grown on 13 mm glass coverslips in 12-well
Coming plates, incubated in DMEM containing 10% FCS at 37°C and 5% CO2. The
cells were then treated with 666.6 pg/ml and LC50 concentrations of ethanolic molmol 
or hexane haddi, and a control (untreated), for the following time points:
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Ethanolic molmol, 666.6 pg/ml: 3, 6, 12, 24, 48 hours.
Ethanolic molmol, 234 pg/ml: 3, 6, 12, 24, 48 hours.
Hexane haddi, 666.6 pg/ml: 3, 6, 12, 24, 48 hours.
Hexane haddi, 201 pg/ml: 3, 6, 12, 24, 48 hours.
Control -  untreated: 3 ,6 , 12, 24, 48 hours.
The cells were washed with PBS, and were then fixed with 4 %
formaldehyde for 10 minutes at room temperature.
2.11.2 Klenow Fragmentation Procedure
The following procedure was underaken:
1. Rehydration
The coverslips were immersed in IX TBS for 15 minutes at room temperature, and 
the glass slides around the specimens, were carefully dried.
2. Permeabilisation of specimens
lpL  of 2mg/ml proteinase K (1:100 in lOmM Tris PH 8 ) was mixed with 99pl lOmM 
Tris per specimen). The entire specimen was covered with 50-100pl of 20pg/ml 
proteinase K and incubated at room temperature for 5 minutes. The slide was dipped 
2-3 times into a beaker of IX TBS. The excess liquid was gently tapped off and the 
glass slides around the specimen carefully dried.
3. Inactivation of endogenous peroxidases
lOpl of 30% H2O2 was mixed with 90pl methanol per specimen. The entire 
specimen was covered with lOOpl of 30 %H202 and incubated at room temperature 
for 5 minutes. The slides were rinsed with IX TBS, the excess liquid gently tapped 
off, and the glass slides around the specimens were carefully dried.
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4. Equilibration and Labelling Reaction
10X Klenow equilibration buffer was diluted 1 in 10 with distilled water by mixing 
lOpl of 10X buffer with 90pl of distilled water per specimen.The entire specimen 
was covered with lOOpl of IX Klenow equilibration buffer and incubated at room 
temperature for 10 to 30 minutes, while preparing the labelling reaction mixture. The 
working Klenow Labelling Reaction mixture was prepared as follows:
The contents of the Klenow labelling reaction mix tube was lightly vortexed. The 
Klenow enzyme vial was pulse-spun in a microcentrifuge. The sample was 
transferred to a clean microfuge tube, placed on ice, and 58.4pi Klenow labelling 
reaction and 1.6pl Klenow enzyme were mixed gently. The IX Klenow equilibration 
buffer from the specimens was carefully blotted, taking care not to touch the 
specimens. The specimens were covered with a piece of parafilm cut slightly larger 
than the specimen, the slides placed in a humidified chamber, and incubated at 37°C 
for 1.5 hours.
5. Termination of Labelling Reaction
The stop buffer was prewarmed to 37°C for 5 minutes. The slides were rinsed with 
IX TBS and the entire specimen covered with lOOpl of stop solution. These were 
incubated at room temperature for 5 minutes. The slides were then rinsed with IX 
TBS. The excess liquid was gently tapped off, and the glass slides around the 
specimens carefully dried.
6. Detection
The entire specimen was covered with lOOpl of blocking buffer and incubated at 
room temperature for 10 minutes. The 5X conjugate was diluted 1 in 50 in blocking 
buffer by mixing 2pl of 50X conjugate with 98pl blocking buffer per specimen. The
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blocking buffer was carefully blotted from the specimens,taking care not to touch 
them, and lOOp of diluted IX conjugate was immediately applied. The slides were 
placed in a humidified chamber and incubated at room temperature for 30 minutes. 
Five minutes before concluding incubation, the DAB solution was prepared by 
dissolving one tablet of DAB and one tablet of H2O2/ urea in 1 ml of tap water. The 
slides were rinsed with IX TBS.
The excess liquid was gently tapped off and the glass slides around the specimens 
carefully dried. The entire specimen was covered with lOOpl of DAB solution, 
incubated at room temperature for 10-15 minutes, and the slides were rinsed with 
distilled water.
7. Counterstain
The entire specimen was covered with lOOpl of Methyl Green counterstains 
solution, immediately covered, and incubated at room temperature for 3 minutes. The 
edge of the slides was pressed against an absorbent towel to draw off the most of the 
counter stain.
B. Normal Fibroblast Cell Culture Preparation
Normal fibroblasts, seeded at 2x l05 cells/ml, were also exponentially grown on 13 
mm glass coverslips in 12-well Coming plates, incubated in DMEM containing 5% 
FCS at 37°C and 5% CO2. The cells were then treated with LC50 concentration of 
ethanolic molmol and hexane haddi, and a control (untreated), for the following time 
points:
Ethanolic molmol, 234 pg/ml: 3, 6, 12, 24, 48 hours.
Hexane haddi, 201 pg/ml: 3, 6, 12, 24, 48 hours.
Control -  untreated: 3, 6, 12, 24, 48 hours.
49
The cells were then fixed, stained, and examined as described above.
2.12 Scanning Electron Microscopy
In the present study, changes in the cell surface morphology of treated cells were 
analysed and compared with the cell surface morphology of untreated cells (controls).
2.12.1 Preparation of Fixatives
Sodium cacodylate buffer. A 0.1M solution of sodium cacodylate (supplied by Agar 
Scientific Ltd., UK) buffer was prepared by adjusting 50 ml of 0.2M buffer to pH 7.3-
7.4 with 1M HC1, and then the volume was made up to 100 ml with distilled water. 
Gluteraldehyde fixative . A solution of 1.25% gluteraldehyde (supplied by Agar 
Scientific Ltd., UK) containing 0.1M buffer (pH 7.4) was prepared by adding 10 ml of 
0.25% v/v gluteraldehyde solution to 40 ml sodium cacodylate buffer solution (0.2M). 
6 ml of this stock were then further diluted with 6 ml of the DMEM growth medium.
2.12.2 Preparation of Cell Culture
S I80 murine sarcoma cells, HT1080 fibrosarcoma cells and chick normal fibroblasts 
were exponentially grown on 13-mm thermanox plastic coverslips in 12-well Coming 
plates incubated in growth medium containing 10% FCS (5% FCS) at 37°C and 5% 
carbon dioxide. This procedure was carried out for cells treated with 366 pg/ml 
ethanolic-molmol extract (two coverslips) or for cells treated with 733 pg/ml hexane- 
haddi extract (two coverslips). As hexane haddi was not available, haddi essential oil 
(Aldrich) was used at this concentration. The remaining coverslip was left untreated 
as a control. The cover slips were then placed in 12-well Coming plates in 1 ml of 
growth medium. Next, the plates were incubated for 4 hours at 37°C to allow cells to 
adhere to the cover slips. The plates were then left for 12 hours before fixation.
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2.12.3 Fixation
All types of cells used in the present study were fixed in 1.25% gluteraldehyde in 
cacodylate buffer for one hour at room temperature, and then washed twice with 0.1M 
cacodylate buffer for 10 minutes each to remove excess fixative. The cells were then 
further fixed in 1% osmium tetroxide (Agar Scientific, UK) in 0.1 M cacodylate buffer 
for one hour, in order to improve conductivity in the electron beam within the SEM, 
and also to protect the cells from possible beam damage during microscopy.
2.12.4 Dehydration
The cover slips containing fixed cells were gradually dehydrated with various 
concentrations of ethanol, starting at 50% concentration, and ending with four 
successive rinsings with absolute ethanol, using the following regime:
a) 50% ethanol for 5 minutes at room temperature.
b) 70% ethanol for 5 minutes at room temperature.
c) 90% ethanol for 5 minutes at room temperature.
d) 100% ethanol for 10 minutes at room temperature.
e) 100% ethanol for 10 minutes at room temperature.
f) 100% ethanol for 10 minutes at room temperature.
g) 100% ethanol for 10 minutes at room temperature.
2.12.5 Microscopy
The cover slips were then transferred to a Critical Point Dryer (CPD) (Balzers CPD 
30). The drying process was carried out under high pressure (1300 psi) using CO2, 
and allowing the temperature to rise to 45°C (critical point drying temperature). 
Under these conditions, the liquid CO2 was completely evaporated within 2 hours,
leaving dried crystalline cells. The coverslips were then mounted on aluminium 
stubs, using double-sided carbon tape, and were placed in an Alcatel Gold Sputterer 
Coater (EITI Scope, England) and coated with a 100 nm layer of gold. The samples 
were then examined under a Philips XL20 Scanning Electron Microscope at a 20kV 
accelerating voltage and a range of magnifications.
2.13 Transmission Electron Microscopy
HT1080 cells treated as for transmission electron microscopy preparation method 
were fixed with 1% gluteraldehyde for 24 hours at 4°C, and then washed in fresh 
cacodylate buffer overnight. The cells were removed and gradually dehydrated by 
washing in alcohol dehydrating series, as explained in Section 2.11.4. The cells were 
then removed from the thermanox using a plastic scraper, transferred into 
microcentrifuge tubes containing Araldite preparation (300 g/ml), and were spun 
down in an MSE centrifuge at 1000 rpm for five minutes to obtain a firm pellet. The 
resulting pellet was embedded in capsules with freshly prepared resin and 
polymerised in an oven at 60°C for 24 hours. Polymerised resin blocks were cut into 
90 nm thick sections using a diamond knife and a Reichert Ultracut OMU4 microtome 
(Reichert-Jung, Austria). The ultrathin sections were collected on pioloform-coated 
copper grids (10 squares), counterstained in 2% uranyl acetate for one hour, and then 
in lead citrate for 20 minutes. Finally, the grids were washed in three changes of 
0.02M NaOH solution, followed by three rinses in double-distilled water. The grids 
were examined using a JEOL 1200EXelectron microspcope operated at 80 kV 
accelerating voltage, using magnifications ranging from x2000 to x 10,000. 
Transmission electron micrographs were recorded on Kodak 4489 EM film plates 
(3.5x4 in) and developed in Kodak ID 19 solution.
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2.14 Fluorescence Microscopy
Immunohistochemical confirmation was carried out using the Apoptosis Detection Kit 
(Oncogene Research Products U.K.). This assay has been found to detect the 
apoptotic cells significantly earlier that DNA-based assay (Amin et al., 2000). In this 
work, S I80 cells, HT1080, and chick normal fibroblast cells were washed by PBS 
after staining, in order to avoid any subsesequent background fluorescence, and that 
resulted in loss of the dead cells that had been detached from the monolayer. Fixation 
with paraformaldehyde is not recommended, as the fixing would result in cell death, 
and all the cells will appear stained only with propidium iodide. In this assay, a 
fluorescein isothiocyanate (FITC) conjugate of Annexin V is used, which allows for 
the detection of apoptosis. Necrotic cells also bind Annexin V-FITC due to 
membrane permeabilisation. Propidium iodide (PI) is employed to differentiate 
between viable, early apoptotic, and late apoptotic or necrotic cells. While necrotic 
cells will bind Annexin V-FITC and stain with propidium iodide, propidium iodide 
will be excluded from viable (FITC negative) and early apoptotic (FITC positive) 
cells. Late apoptotic cells will acquire both labels due to the necrotic-like 
disintegration of the cell and the absence of phagocytosis in vitro (Oncogen Research 
Products, 1998).
A RAPID protocol has been developed by Annexin V-FITC binding directly in tissue 
culture media. This prevents the need for tedious centrifugation and wash steps that 
increase the occurrence of mechanical membrane disruption. Furthermore, since 
apoptosis is a dynamic process that is ongoing once cells are removed from culture 
conditions and continues throughout experimental processing, the RAPID protocol is 
recommended for the detection of cells in early apoptosis (Oncogyne Research 
Products, 1998).
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A. SI80 Cell Culture Preparation
S I80 cells seeded at cell density of 2x l05 cells/ml were exponentially grown on 13 
mm glass coverslips in 12-well Coming plates, incubated in Mini Essential Culture 
Medium containing 10% FCS at 37°C and 5% CO2. The cells were then treated with 
two different concentrations, 666 pg/ml and LC50 concentrations of ethanolic molmol 
or hexane haddi, and a control (untreated), for the following time points:
Ethanolic molmol, 666.6 pg/ml: 12, 24 hours.
Ethanolic molmol, 234 pg/ml: 12, 24 hours.
Hexane haddi, 666.6 pg/ml: 12, 24 hours.
Hexane haddi, 201 pg/ml: 12, 24 hours.
Control -  untreated: 12, 24 hours.
B. HT1080 Cell Culture Preparation
2xl05 HT1080 cells were exponentially grown on 13 mm glass coverslips in 12-well
Coming plates, incubated in DMEM containing 10% FCS at 37°C and 5% CO2. The
cells were then treated with 666.6 pg/ml and LC50 concentrations of ethanolic molmol 
or hexane haddi, and a control (untreated), for the following time points:
Ethanolic molmol, 666.6 pg/ml: 12, 24 hours.
Ethanolic molmol, 234 pg/ml: 12, 24 hours.
Hexane haddi, 666.6 pg/ml: 12, 24 hours.
Hexane haddi, 201 pg/ml: 12, 24 hours.
Control -  untreated: 12, 24 hours.
C. Normal Fibroblast Cell Culture Preparation
Normal fibroblast cells, seeded at 2x l05 cells/ml, were also exponentially grown on 
13 mm glass coverslips in 12-well Coming plates, incubated in DMEM containing
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5% FCS at 37°C and 5% CO2. The cells were then treated with 666.6 pg/ml and LC50 
concentrations of ethanolic molmol and hexane haddi, and a control (untreated), for 
the following time points:
Ethanolic molmol, 666.6 pg/ml: 12, 24 hours.
Ethanolic molmol, 234 pg/ml: 12, 24 hours.
Hexane haddi, 666.6 pg/ml: 12, 24 hours.
Hexane haddi, 201 pg/ml: 12, 24 hours.
Control -  untreated: 12, 24 hours.
Following the incubation after the treatment time, the medium in each well was 
pipetted off, and each well was washed twice with 1 ml of PBS. Each coverslip was 
covered with 50pl of IX binding buffer. 10 pi of Media Binding Reagents were 
added, followed by 3 pi of Annexin V-FITC. The cells were incubated for 15 minutes 
in the dark at room temperature. 10 pi of propidium iodide were added. The 
coverslips were inverted on glass slides contained mounting medium (vectra shelid) . 
The slides were examined directly by fluorescent microscopy (Leitz, Loborolux 12). 
Images of random fields of cells were captured using a digital camera (Roper 
Scientific CoolSnap, digital camera) connected to the fluorescence microscope.
2.15 Trans-/?-Ocimene and y-Bisabolene
Trans-fl-ocimenQ and y-bisabolene are two of the biochemical components of haddi 
plant. These two components were identified by Mr. Ahmed Ali, School of 
Biosciences, Cardiff University, using gas chromatography-mass spectroscopy 
technique.
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Once these two biochemicals were identified, they were ordered from R.C Treatt, 
Suffolk. Both were then confirmed to be those identified by Mr. Ahmed Ali by 
analysis of their retention times and mass spectra.
These biochemicals were selected since they make up a reasonable proportion of the 
overall extract. Accordingly, they may be the active components of the haddi 
extracts.
2.15.1 Preparation
The molecular weights of trans-fi-ocimene and y-bisabolene were first determined. 
For each biochemical, the respective weight (in mg, corresponding to the molecular 
weight) was added to 900 pi of growth medium and 100 p of DMSO, to give an 
overall stock concentration of 1M, which was further diluted to the concentrations 
required, for the various assays. When a larger amount of stock was required, 
multiples of each weight were used.
2.15.2 MTT Assay
Five concentrations of each of ocimene and bisabolene were used. The dilutions of 
the overall stock solution used to obtain the five final concentrations used in the 
assays: 50, 100, 150, 200 and 250 pM of both biochemicals, were estimated as shown 
in Tables 2.5 and 2.6.
Table 2.5 Concentrations of trans-fi-ocimene used in MTT assays
Volume of 
Stock (pL)
Volume of 
Media (pL)
Total Vol. 
(pL)
Cone.
(mM)
Final Cone. 
(mM)
Cone. 1 100 900 1000 100 50
Cone. 2 200 800 1000 200 100
Cone. 3 300 700 1000 300 150
Cone. 4 400 600 1000 400 200
Cone. 5 500 500 1000 500 250
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Table 2.6 Concentrations of y-6isaolene used in MTT assays
Volume of 
Stock (jiL)
Volume of 
Media (juL)
Total Vol.
W
Cone.
(mM)
Final Cone. 
(mM)
Cone. 1 25 475 500 100 50
Cone. 2 50 450 500 200 100
Cone. 3 75 425 500 300 150
Cone. 4 100 400 500 400 200
Cone. 5 125 375 500 500 250
The MTT procedure described in Section 2.9 was used, replacing the plant extracts 
with either ocimene or bisabolene at the concentration referred to in Tables 2.5 and 
2.6. Only S I80 and HT1080 cells were used, and not the normal fibroblast cell line.
2.15.3 Time Course Assay
For the time course assay, ocimene was added to S I80 cells and HT1080 cells at two 
concentrations of 65 and 95 Mm. Bisabolene was added at two concentrations of 10 
and 20 Mm. Calculation of these concentrations is presented in Tables 2.7 and 2.8.
Table 2.7 Concentrations of frYws-/?-ocimene used in time course assays
Volume of 
Stock (fiL)
Volume of 
Media (jaL)
Total Vol.
(M-L)
Cone.
(mM)
Final Cone. 
(mM)
Cone. 1 130 870 1000 130 65
Cone. 2 190 810 1000 190 95
Table 2.8 Concentrations of y-bisabolene used in time course assays
Volume of Volume of Total Vol. Cone. Final Cone.
Stock (p,L) Media (fiL) (HL) (mM) (mM)
Cone. 1 20 980 1000 20 10
Cone. 2 40 960 1000 40 20
LC50 values for both ocimene and bisabolene were obtained from the results of the 
time-course. LC50 concentrations were then used in Annexin-V assay and SEM.
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2.15.4 Annexin-V Assay and Scanning Electron Microscopy
Procedures for Annexin-V and SEM used earlier (Sections 2.12 and 2.14, 
respectively) were also followed with either ocimene or bisabolene instead of the 
plant extracts.
2.16 Statistical Analysis
Data were tested for normality of distribution using the Anderson-Darling test. In all 
cases, it was found that data were not normally distributed. Therefore, the data were 
tested by the non-parametric equivalent of ANOVA, the Kruskal-Wallis tests, 
followed by pairwise comparison by Mann-Whitney, using Minitab Version 13.1. 
The statistical findings are tabulated in Appendices I to V. Excel 2002 was used to 
present raw data, calculate mean readings, standard deviation and standard error, and 
to present these data graphically.
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Chapter Three 
Results
3.1 Introduction
Growth curves of S I80 sarcoma cells grown in DMEM growth medium on their own, 
and after the addition of ethanolic molmol and hexane haddi extracts, are analysed in 
this chapter. The growth curves of HT1080 grown alone, and after the addition of 
ethanolic molmol and hexane haddi extracts, are also analysed. The results for the 
MTT viability tests for the above are also illustrated, and the results of further parallel 
experiments, for example morphological techniques, electron microscopy and flow 
cytometry, are also presented here.
The S I80 sarcoma and HT1080 fibrosarcoma cell lines were chosen as they are 
representative of cancerous cells that can adhere to the walls of the containers they are 
kept in (see Chapter Two), and can be easily recovered and counted. Therefore, they 
were suitable for the purposes of the present study.
A normal chick fibroblast cell line was selected as representative of normal, non- 
cancerous cells that have the capability to divide. The effects of the extracts of the 
two experimental plants {Commiphora molmol and C. guidotti) were studied on both 
cancerous and non-cancerous cells in order to compare these effects on both cell 
types.
An increase in the number of cells in a proliferating cell line can be used as an index 
of normal behaviour, and growth curves can be determined.
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3.2 S I 80 G ro w th  A ssay
The S I80 cells were found to grow exponentially, reaching their maximum cell 
number (2,289,583±51,054) on Day 6 (see Figure 3.1). The growth then started 
declining exponentially, reaching an average total of 1,573,333 on Day 8. The initial 
seeding density o f SI 80 cells at the start of the experiment (Day 0) was 4 x 104.
S I80 Sarcoma Cell Growth Curve in DMEM Containing 10% BCS
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Figure 3.1
S 180 sarcoma cell growth in control medium (n=9, bars=standard error) (K-W test,
p<0.001).
S I80 cells were left to grow in the medium for four days, upon which (Day 4) 
ethanolic molmol extract and hexane haddi extract were added to the growing cells. 
The growth in both extracts declined sharply (p<0.001) (see Figures 3.2, 3.3 and 3.4).
The experiment using S 180 cells and ethanolic molmol extract lasted for eight days. 
Three experiments were carried out, each with three replicates, hence a total of nine 
trials were attempted, and the average cell number represents the average of nine 
trials. A similar experimental set-up was run, using hexane haddi extract instead of 
ethanolic molmol extract. In the case of adding ethanolic molmol extract on Day 4
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(Figure 3.2), the cell number dropped from an average of 579,900±12,584 cells on 
Day 4 to 129,400±4,760 cells on Day 5, declining to 25,300±1,229 cells on Day 8 
(p<0.001). This illustrated the cytotoxic action of molmol extract on S I80 sarcoma 
cells.
S I80 Sarcoma Cell Growth Curve in DMEM Containing 10% BCS and Ethanolic Molmol at Day 4
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Figure 3.2
S I80 sarcoma cell growth, adding ethanolic molmol extract to growth medium on 
Day 4 (n=9, bars=standard error) (K-W test, p<0.001).
In the case of adding hexane haddi extract on Day 4 (Figure 3.3), the cell number 
dropped from an average of 695,000±11,659 cells on Day 4 to 49,444±3,651 cells on 
Day 5, declining to 15,833±1,021 cells on Day 8. This pattern of rapid decline in cell 
number also illustrates the rapid action of haddi extract in killing SI 80 sarcoma cells.
Figure 3.4 shows the effect of adding ethanolic molmol and hexane haddi extracts on 
the growth of S I80 sarcoma cells, compared with their growth without adding them. 
Figure 3.4 also shows that the growth of SI 80 sarcoma cells during the first four days 
of the experiment, that is, before the addition of the plant extracts, was very similar in 
all experiments.
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Kruskal-Wallis test shows that there are significant differences between the results of 
the control and those of adding experimental plant extracts (p<0.001).
S 180 Sarcoma Cell Growth Curve in DMEM Containing 10% BCS and Hexane Haddi at Day 4
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Figure 3.3
SI 80 sarcoma cell growth after adding hexane haddi extract to growth medium on 
Day 4 (n=9, bars=standard error) (K-W test, p<0.001).
S I80 Sarcoma Cell Growth Curves in DMEM Medium Containing 10% FCS
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Figure 3.4
Comparison of growth curves of S 180 cells with and without addition of molmol and
haddi extracts to growth medium.
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3.3 H T 1080 G ro w th  A ssay
The HT1080 cells were found to grow exponentially, reaching their maximum cell 
number (5,258,889±37,165) on Day 12 (see Figure 3.5). The growth then declined 
sharply, reaching an average total of 2,615,833±11,1511 cells on Day 14. The initial 
seeding density of HT1080 cells at the start of the experiment was 4 x 104 cells/ml.
HT1080 cells were left to grow in the medium for seven days, upon which (Day 7), 
ethanolic molmol (C. molmol) extract and hexane haddi (C. guidotti) extract were 
added to the growing cells. The growth in both extracts declined sharply (p<0.001) 
(see Figures 3.6, 3.7 and 3.8).
HTl 080 Fibrosarcoma Cell Growth Curve in DMEM Containing 10% BCS
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Figure 3.5
H T l080 Fibrosoma cell growth in control medium (n=9, bars=standard error) (K-W
test, p<0.001).
The experiment using H Tl080 cells and ethanolic molmol extract was undertaken 
over a period of 14 days. Three experiments were carried out, each with three 
replicates, that is, a total of nine trials were attempted, and the average cell number
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represents the average of nine trials. A similar experimental set-up was also 
undertaken using hexane haddi extract instead of ethanolic molmol extract.
In the case of adding ethanolic haddi extract on Day 7 (Figure 3.6), the cell number 
dropped from an average of 3,158,333±22,197 cells on Day 7 to 2,187,778±12,849 
cells on Day 8. The sharp decline in the number of H Tl080 cells continued for the 
remaining six days of the experimental period, reaching a low count of 596,667±7.784 
cells on Day 14 (p<0.001). This is an indication that molmol extract is cytototoxic to 
H T l080 fibrosarcoma cells.
HTl 080 Fibrosarcoma Cell Growth Curve in DMEM Containing 10% BCS with
Ethanolic Molmol
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Figure 3.6
H T l080 fibrosarcoma cell growth adding ethanolic molmol extract on Day 7 (n=9, 
bars=standard error) (K-W test, p<0.001).
Prior to adding hexane haddi extract to medium containing HTl 080 fibrosarcoma 
cells, the cells were left to grow exponentially for seven days, on which day the 
hexane extract of haddi was added (Figure 3.7). The cell number then declined on 
Day 8 to 2,688,444±22,079 cells from 2,970,833± 10,467 cells Day 7. The drop in the 
number of HTl 080 cells continued to the end of the experiment, when a total number
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of 508,556±6,572 cells were counted. This pattern of rapid decline in cell number 
also illustrates the rapid action of haddi extract in killing the HT1080 fibrosarcoma 
cells.
HT1080 Fibrosarcoma Cell Growth Curve in DMEM Containing 10% BCS with
Hexane Haddi
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Figure 3.7
HT1080 fibrosarcoma cell growth, adding hexane haddi extract to growth medium on 
Day 7 (n=9, bars=standard error) (K-W test, p<0.001).
Figure 3.8 illustrates the effect of adding ethanolic molmol and hexane haddi extracts 
on the growth of HT1080 fibrosarcoma cells, compared with their normal growth 
without adding these extracts (control). Figure 3.8 also shows that the growth of 
HT1080 cells during the first seven days of the experiment, that is, before the addition 
of either ethanolic molmol or hexane haddi extracts, was very similar in all 
experiments.
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H I 1080 Fibrosarcoma Cell G row th Curves in DM EM Medium
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Figure 3.8
Comparison of growth curves of HT1080 cells with and without addition of molmol
and haddi extracts to growth medium.
3.4 M T T  V iab ility  A ssay
The S I80 cells, HT1080 cells and normal fibroblast cells were treated with different 
concentrations of molmol and haddi extracts over a period of 24, 48 and 72 hours, 
after which the MTT solution was added to the growth medium to measure the 
percentage viability to establish viability. Calculation of percentage viability is 
explained in Chapter Two (Section 2.9.3). Mean percentage viabilities have been 
plotted against control and concentrations used 24, 48 and 72 hours after treatment, to 
illustrate whether or not the addition of the various extracts at various concentrations 
may have any effect on the growth of the S I80, HT1080 and normal fibroblast cells. 
All experiments were conducted against a control consisting of the cells and the 
growth medium.
Control Eth. Mol.
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3.4.1 S180 Cell Line
The effects of the molmol and haddi extracts on the viability of S I80 cells were 
illustrated using the following treatments:
A. Molmol extracts. The viability assay of these cells was undertaken using two
different dilution series. In the first series, the concentration of the ethanolic 
and hexane molmol extracts ranged from 0.65 to 666.60 pg/ml. Results are 
presented in Figure 3.9. In the second series, the concentration of the
ethanolic, hexane, ethyl acetate and Flavex molmol extracts ranged from
266.45 to 666.60 pg/ml. Results are presented in Figures 3.10 to 3.14.
B. Haddi extracts. The viability of S I80 cells was tested in ethanolic, hexane, 
ethyl acetate and Aldrich hexane extracts, also in two series as for molmol 
extracts. Results are illustrated in Figures 3.15 to 3.20.
A. Molmol Extracts
A .l Ethanolic Molmol Extract (0.65-666.60 pg/nil)
Figure 3.9 clearly shows that the lowest viability percentage was obtained using 
ethanolic molmol extract at 666.60 pg/ml concentration, thus indicating low survival 
rates, or high toxicity rates of S I80 cells at this concentration. In contrast, higher 
mean viability than the control was obtained using the extract at 10.42 and 0.65 pg/ml 
concentrations (P<0.001), indicating that there were more viable cells in these two 
treatments than in the control. This suggests that these two concentrations are low 
enough not to have any impact on the cells, rather, growth or mitogenecity seemed to 
be enhanced at these two low levels of molmol. The percentage viability results 
(Figure 3.9) substantiate this trend, showing higher percentage viability figures than 
the control, that is, more cell survival at these two concentrations of molmol than in
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the control. Figure 3.9 also shows that cell viability decreased with time, being 
highest after 72 hours of treatment, particularly at the highest concentration of 
ethanolic molmol extract (666.60 pg/ml). However, the two lowest concentrations 
(10.42 and 0.65 pg/ml) did not have any toxic effects on the S I80 cells, even after 24 
hours of treatment. The 83.33 pg/ml concentration level had little or insignificant 
effect of the S180 cells, especially after 24 hours of treatment. The data show that at 
these two low extract concentrations a mitogenic effect can be obtained.
D eterm ination o f  Cell Viability - (MTT Assay) - Ethanolic Molmol After 2 4 ,4 8  
and 72 Hours, Using SI 80 Cells
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Figure 3.9
Percentage viability of S180 cells in control and in medium containing five different 
concentrations of ethanolic molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 1.1-1.3, Appendix I).
A2 Ethanolic Molmol Extract (266.45-666.65 jig/ml)
In these treatments, adding high concentrations of ethanolic molmol shows that this 
range of concentrations was effective in killing S I80 cells, particularly the three 
highest concentrations of 666.60, 566.61 and 466.24 pg/ml, which resulted in almost 
5% viability within 24 hours of treatment (see Figure 3.10) (P<0.001). Lowest 
viability of S I80 cells treated with 366.00 pg/ml ethanolic molmol was attained after
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72 hours of treatment. However, treatment of SI 80 cells with 266.45 pg/ml was less 
effective than the other higher concentrations, resulting in about 74%, 52% and 30% 
cell viability after 24, 48 and 72 hours, respectively.
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48 and 72 Hours, U sing SI 80
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Figure 3.10
Percentage viability of S 180 cells in control and in medium containing five high 
concentrations of ethanolic molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 2.1-2.3, Appendix I).
A.3 Hexane Molmol Extract (0.65-666.60 jig/ml)
Hexane molmol extract using this range of concentrations was not effective in its 
toxicity, compared to ethanolic molmol extract of similar concentrations (Figure 
3.11). In fact, at 10.42 pg/ml concentration of hexane molmol, growth of S180 cells 
was enhanced (mitogenetic effect) after 24 and 48 hours, as illustrated by higher 
percentage viability than the control, but showed some effect after 72 hours, when 
about 77% viability was calculated. At 0.65 pg/ml concentration, growth was 
enhanced throughout the experimental period, and no toxicity was detected in the 
S I80 cell.
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Determination o f Cell Viability - (MTT Assay) -Hexame Molmol After 24,48 and 72
Hours, using S I80 Cells
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Figure 3.11
Percentage viability of SI 80 cells in control and in medium containing five 
concentrations of hexane molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 3.1-3.3, Appendix I).
A.4 Hexane Molmol Extract (266.45-666.60 pg/ml)
Hexane molmol extract was less effective in reducing the viability of S I80 cells than 
ethanolic molmol extract using a similar concentration range. Addition of 666.60 
pg/ml hexane molmol extract produced the lowest percentage viability (about 25%) 
after 72 hours (Figure 3.12).
A.5 Ethyl Acetate Molmol Extract (266.45-666.60 jag/ml)
Treatment of S I80 cells with ethyl acetate molmol extract (with the same 
concentration ranges as those of ethanolic and hexane extract) (Figure 3.13) shows 
that the lowest concentration (266.45 pg/ml) was also not as effective as the other 
concentrations, only resulting in about 69%, 46% and 12% cell viability after 24, 48 
and 72 hours, respectively.
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Determination o f Cell Viability - (MTT Assay) - Hexane Molmol After 24, 48 and 72
Hours, Using S I80
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Figure 3.12
Percentage viability of SI 80 cells in control and in medium containing five 
concentrations of hexane molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 4.1-4.3, Appendix I).
Determination of Cell Viability - (MTT Assay) - Ethyl Acetate Molmol After 24 ,48 and 72
Hours, Using S I80
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Figure 3.13
Percentage viability of SI 80 cells in control and in medium containing five 
concentrations of ethyl acetate molmol extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 5.1-5.3, Appendix I)
It is noted that the ethyl acetate molmol extract resulted in lower percentage viability
of the S I80 cells than did ethanolic molmol extract, using similar concentrations
(P0.001). Similar observations were made regarding normal fibroblast cells treated
with ethyl acetate and ethanolic molmol acetate (see Figure 3.40). Accordingly, it
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was decided to use ethanolic molmol extract, because the aim of the study was to 
target cancerous cells and avoid any damage to normal cells, and ethyl acetate molmol 
extract is more cytotoxic to both cancerous and normal cells than ethanolic molmol 
extract.
A.6 Flavex Molmol Extract (666.60-266.45 jig/ml)
Results of the treatment of S I80 cells with Flavex molmol extract (Figure 3.14) 
indicated that this extract, at all concentrations, had higher percentage viability than 
ethanolic extracted molmol (see Figure 3.10).
^termination of Cell Viability - (MTT Assay) - Flavax Molmol After 24 ,48  and 72
Hours, Using S I80
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Figure 3.14
Percentage viability of SI 80 cells in control and in medium containing five 
concentrations of Flavex molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 6.1-6.3, Appendix I).
B. Haddi Extracts
B.l Ethanolic Haddi Extract (0.65-666.6 jig/ml)
Figure 3.15 clearly demonstrates that lower concentrations of ethanolic haddi extract 
were not very active against S I80 cells. These higher means than the control indicate 
growth promotion, as evidenced by higher percentage viability than in the control, 
that is, an increased mitogenesis has occurred at these low concentrations, resulting in
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more viable cells under these treatments than in the control. The lowest percentage 
viability was about 68% after 72 hours, and at the highest concentration.
Determination o f Cell Viability - (MTT Assay) - Ethanolic Haddi After 24, 48 and 72
Hours, Using S 180 Cells
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Figure 3.15
Percentage viability of S 180 cells in control and in medium containing five 
concentrations of Ethanolic haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 7.1-7.3, Appendix I).
B.2 Ethanolic haddi Extract (266.45-666.60)
Figure 3.16 shows that treatment with a higher range of ethanolic haddi extract was 
more active against S I80 cells than above, leading to decreasing percentage viability, 
especially after 72 hours and at the higher concentrations of 666.60 and 566.61 pg/ml. 
It is also noted that the results of the highest concentration did not match that used in 
this experiment, possibly due to different experimental batches of the plant extracts.
B.3 Hexane Haddi Extract (0.65-666.6 jig/ml)
Hexane haddi extract (Figure 3.17) performed better than ethanolic haddi extract, 
even at the lower end of the concentration spectrum (Figure 3.15) (P 0 .001), except 
after 72 hours of treatment with 0.65 pg/ml concentration treatment, where some 
S I80 cell growth led to increased percentage viability than in the control, that is, 
increased mitogenesis after 72 hours of exposure to the extract (Figure 3.17).
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Determination o f Cefl Viability - (MTT Assay) - Ethanolic Haddi After 24,48 and 72
Hours, Using S 180 Cells
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Figure 3.16
Percentage viability of SI 80 cells in control and in medium containing five 
concentrations of ethanolic haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 8.1-8.3, Appendix I).
Determination o f  Cell Viability - (MTT Assay) - Hexane Haddi After 24 ,48  and 72 
Hours, Using S 180 Cells
100
80
60
%  Viability 24 hrs 
%  Viability 48 hrs 
%  Viability 72 hrs
40
20
0
Control 10.42 83.33 333.30 666.600.65
Concentration
Figure 3.17
Percentage viability of S180 cells in control and in medium containing five 
concentrations of hexane haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 9.1-9.3, Appendix I).
B.4 Hexane Haddi Extract (266.45-666.60 jig/ml)
Results obtained (Figure 3.18) clearly show that increasing the concentration of the 
hexane haddi extracts seemed not effective in decreasing percentage viability.
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Nonetheless, there had been some effects of these concentrations, especially the lower 
ones, thus bringing about some toxicity to S I80 cells. Percentage viability at the
666.60 pg/ml concentration was lower in the previous experiment than here.
Determination of CeB Viability - (MTT Assay) - Hexane Haddi After 24,48 and 72 Hours,
Using S180 Cells
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Figure 3.18
Percentage viability of SI 80 cells in control and in medium containing five 
concentrations of hexane haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 10.1-10.3, Appendix I).
B.5 Ethyl Acetate Haddi Extract (666.60-266.45 jug/ml)
Treatment of S I80 cells with this extract was not effective after 24 and 48 hours, and 
only after 72 hours did the percentage viability decrease, particularly at the three 
highest concentrations of 666.60, 556.61 and 446.24 pg/ml (Figure 3.19). This is an 
indication of the limited effectiveness of the ethyl acetate haddi extract on the survival 
of the SI 80 cells, compared to ethyl acetate molmol (see Figure 3.13).
B.6 Haddi Essential Oil (Aldrich) Extract (266.45-666.60 pg/ml)
Haddi essential oil (Aldrich) extract was also not very effective in bringing about low 
percentage viability (Figure 3.20). Percentage viability values were around 94% at 
the lower concentration. Nonetheless, some toxicity was noted in all concentrations 
used.
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Determination of Cell Viability - (MTT Assay) - Ethyl Acetate Haddi after 24,48 and 72
Hours, UsingS 180 Cells
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Figure 3.19
Percentage viability of S 180 cells in control and in medium containing five 
concentrations of ethyl acetate haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 11.1-11.3, Appendix I).
Determination o f Cell Viability - (MTT Assay) - Aldrich Haddi After 24,48 and 72 Hours,
Using S I80 Cells
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Figure 3.20
Percentage viability of S180 cells in control and in medium containing five 
concentrations of Aldrich hexane haddi extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 12.1-12.3, Appendix I).
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3.4.2 HT1080 Cell Line
The effects of the molmol and haddi extracts on the viability of HT1080 cells were 
also illustrated using an experimental set-up similar to that of the S I80 cell line, 
described above. In addition, another series of dilutions were also tested, using higher 
and lower concentration ranges than either molmol or haddi. Results are illustrated in 
Figures 3.21 to 3.36.
A. Molmol Extracts
A.1 Ethanolic Molmol Extract (0.65-666.60 fig/ml)
Using this concentration range resulted in the lowest percentage viability after 
exposure to the highest concentration (666.60 pg/ml) (Figure 3.21), similar to that 
reported for the 666.60-266.6 pg/ml concentration range (see A2 below). The lower 
concentration range was not toxic to the HT1080 cells, rather there had been more 
growth (mitogenesis) than in the control, even after 72 hours of exposure, as 
evidenced by the higher percentage viability results, that is, more cell growth, than in 
the control.
A.2 Ethanolic Molmol Extract (266.45-666.60)
The three highest concentrations of ethanolic molmol (666.60, 566.61 and 466.24 
pg/ml) were most effective in bringing about lowest cell viability percentages, 
especially after exposure of cells for 48 and 72 hours to the molmol solution (Figure 
3.22) (P0.001). The two lower concentrations were less toxic to the HT1080 cells, 
especially after a short period of exposure (24 hours).
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Determination o f Cell Viability - (MTT Assay) - Ethanolic Molmol After 24,48 and 72
Hours, Using HT1080 Cells
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Figure 3.21
Percentage viability of HT1080 cells in control and in medium containing five 
concentrations of ethanolic molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 1.1-1.3, Appendix II).
Determination o f Cell Viability - (MTT Assay) - Ethanolic Molmol After 24 ,48  and 72
Hours, Using HT1080 Cells
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Figure 3.22
Percentage viability of HT 1080 cells in control and in medium containing five 
concentrations of ethanolic molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 2.1-2.3, Appendix II).
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A.3 Ethanolic Molmol Extract (366.68-466.62 pg/ml)
The apparent cytotoxicity of ethanolic molmol was also tested using other ethanolic 
molmol extracts (series ranging between 466.62 and 366.68 pg/ml) against a control 
(Figure 3.23), in order to obtain the optimum concentration of ethnolic molmol that is 
active against HT1080 cells, but not normal fibroblast cells. Results showed that the 
concentration range was highly active against HT1080 cells, especially after a long 
exposure period of the cells to the extract (48 and 72 hours) (PO.OOl). However, 
exposure for 24 hours showed that the three highest concentrations (466.62, 441.34 
and 416 pg/ml) were more active than the 391.12 and 366.68 pg/ml concentrations, 
resulting in about 17% to 40% cell viability.
Determination ofViability - (MTT Assay) - Ethanolic Molmol After 24 ,48 and 72 Hours,
Using HT1080 Cells
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Figure 3.23
Percentage viability of HT 1080 cells in control and in medium containing five 
concentrations of ethanolic molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 3.1-3.3, Appendix II).
A.4 Ethanolic Molmol Extract (65-1040 pg/ml)
Here, a wider range of concentrations was used as a preliminary exercise. Results for 
this ethanolic molmol concentration range were recorded after subjecting HT1080
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cells to 12, 24, 48 and 72 hours of exposure. Figure 3.24 shows that ethanolic molmol 
extract at this concentration range was active against HT1080 cells at the two highest 
concentrations of 1040 and 520 pg/ml, which were higher than the previous 
concentrations. Nonetheless, percentage viability at the lower end of the spectrum 
was very high, around 95% to 97% viability.
Detrrmination o f Cell Viability - (MTT Assay) - Ethnolic Molmol After 12,24,48 and 72
Hours, Using HT1080 Cells
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Figure 3.24
Percentage viability of HT 1080 cells in control and in medium containing five 
concentrations of ethanolic molmol extract (n = 3, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 4.1-4.4, Appendix II).
A.5 Hexane Molmol Extract (0.65-666.60 ng/ml)
The lowest percentage viability was noted in the highest concentration of 666.7 
pg/ml. In the lower concentration, it seems that the extract has enhanced growth 
(mitogenesis), particularly at the end of the experiment, when higher percentage 
viability values, that is, growth and survival of cells, than in the control were noted 
(Figure 3.25).
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Determination of Cell Viability - (MTT Assay) - Hexane Molmol After 24,48 and 72 Hours,
Using HT1080 Cells
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Figure 3.25
Percentage viability of HT1080 cells in control and in medium containing five 
concentrations of hexane molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 5.1-5.3, Appendix II).
A.6 Hexane Molmol Extract (266.45-666.60 jig/ml)
Hexane molmol extract (Figure 3.26) was not as active against HT1080 cells as 
ethanolic molmol extract (compare with Figure 3.22). A similar observation was 
noted with regard to using S 180 cells. This is further evidence of its activity against 
normal fibroblast, using the same concentration range as for S I80 cells.
Figure 3.26 clearly shows that the percentage viability was lowest at the highest 
concentration (666.60 pg/ml), but only after longer exposure of HT 1080 cells to the 
extract. However, after 24 hours of exposure, viability was very high, ranging 
between around 69% and 97%. Even at longer exposure to the extract, that is, 72 
hours, viability ranged between 26% and 51%, in contrast to using ethanolic molmol 
extract, when viability ranged between 9% and 73% after 72 hours of exposure, and 
between 9% and 86% after 24 hours. Results of using these ethanolic extract 
concentrations also support the fact that ethanolic molmol extracts out-performed 
hexane molmol extracts.
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Determination of Cell Viability - (MTT Assay) - Hexane Molmol After 24,48 and 72 Hours,
Using HT1080 Cells
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Figure 3.26
Percentage viability of HT1080 cells in control and in medium containing five 
concentrations of hexane molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 6.1-6.3, Appendix II).
A.7 Ethyl Acetate Molmol Extract (266.45-666.60 pg/ml)
Results using ethyl acetate molmol extract (Figure 3.27) produced lower percentage 
viability than using hexane molmol extract (Figure 3.26), and matched that using 
ethanolic molmol extract (Figure 3.22).
Figure 3.27 clearly shows that percentage viability values were far lower than in the 
control, even after 24 hours of exposure, except for the lowest concentration (266.45 
pg/ml), when it seems that there was high percentage viability (96%).
A.8 Flavex Molmol Extract (266.45-666.60 ^ig/ml)
Flavex molmol extract was less effective in its activity against H I080 (Figure 3.28). 
Flavex molmol extract also had the least effect on S I80 cells. On a few occasions, 
this extract had no apparent effect; instead, it seemed to enhance growth, that is, 
mitogenesis, leading to higher percentage viability than in the control, that is, more
82
viable cells than in the control. At best, viability was around 88%, and after 72 hours 
of exposure.
Determination of Cell Viability - (MTT Assay) - Ethyl Acetate Molmol After 24,48 and 72 Hours,
Using HT1080 Cells
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Figure 3.27
Percentage viability of HT 1080 cells in control and in medium containing five 
concentrations of ethyl acetate molmol extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 7.1-7.3, Appendix II).
Determination of Cell Viability - (MTT Assay) - Flavex Molmol After 24,48 and 72 Hours,
Using HT1080 Cells
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Figure 3.28
Percentage viability of HT 1080 cells in control and in medium containing five 
concentrations of Flavex molmol extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 8.1-8.3, Appendix II).
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B. Haddi Extracts
B.l Ethanolic Haddi Extract (0.65-666.60 ^g/ml)
This extract was only effective against HT1080 cells at the highest concentration of
666.60 pg/ml, when significantly lower viability than in the control was observed, in 
contrast to the lower concentrations, especially after 72 hours of exposure, when more 
cells survived than in the control, leading to higher percentage viability than in the 
control. In other words, mitogenesis occurred in these samples, leading to cell 
division and an increase in the number of cells with time (Figure 3.29).
^termination o f Cell Viability - (MTT Assay) - Ethanolic Haddi After 24 ,48 and 72 
Hours, Using HT1080 Cells
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Figure 3.29
Percentage viability of HT1080 cells in control and in medium containing five 
concentrations of ethanolic haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 9.1-9.3 Appendix II).
B.2 Ethanolic Haddi Extract (266.45-666.60 pg/ml)
Ethanolic haddi extract at this concentration range was not highly toxic to HT1080 
cells, even after 72 hours of exposure. The percentage viability ranged between 109% 
at 266.45 pg/ml extract after 24 hours, and 53.0% at 566.61 pg/ml after 72 hours of 
exposure. Ethanolic haddi extracts of the same concentrations were more effective in
84
bringing about lower viability percentages when used against S I80 cells than they 
were against HT1080 cells (see Figure 3.16 for comparison). This indicates that 
ethanolic haddi extract at these concentrations has resulted in mitogenesis in the case 
of HT1080 cells, and proves that S I80 cells are more sensitive than HT1080 cells, 
which are more resistant to the extract than S I80 cells.
Determination of Cell Viability - (MTT Assay) - Ethanolie Haddi After 24 ,48 and 72 
Hours, Using HT1080 Cells
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Figure 3.30
Percentage viability of HT1080 cells in control and in medium containing five other 
concentrations of ethanolic haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 10.1-10.3, Appendix II).
B.3 Hexane Haddi Extract (0.65-666.60pg/ml)
Hexane haddi extract was more toxic to HT1080 cells than ethanolic haddi extract, 
using a similar range of concentrations, though at the two lowest concentrations 
results did not differ. The two highest concentrations (666.90 and 333.30 pg/ml) were 
highly effective against HT1080 cells, and resulted in lower percentage viability than 
in the control (Figure 3.31) (P0.001).
85
Determination of Cell Viability - (MTT Assay) - Hexane Haddi After 24,48 and 72 Hours,
Using HT1080 Cells
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Figure 3.31
Percentage viability of HT1080 cells in control and in medium containing five 
concentrations of hexane haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 11.1-11.3, Appendix II).
B.4 Hexane Haddi Extract (266.45-666.60 pg/ml)
Results obtained using this range of concentrations were totally different from those 
reported above. This difference was persistent throughout the three sets of 
experiments. Percentage viability was high (Figure 3.32). To investigate further, 
another set of three experiments, also consisting of three replicates each, were 
undertaken, using a higher range of hexane haddi extract, in order to make sure that 
these differences were also persistent in the new set of experiments.
B.5 Hexane Haddi Extract (533.71-1333.20 pg/ml)
This high range of concentration was also used in order to obtain the optimum 
concentration of hexane haddi extract that is effective against HT1080 cells. Using 
higher concentrations of hexane haddi extract resulted in low percentage viability 
throughout the range used (Figure 3.33) (PO.OOl), thus indicating high mortality, 
compared with the other concentrations used above (Figure 3.32). Apparent toxicity
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increased with time, regarding the two lowest concentrations used (733.24 and 533.71 
pg/ml). This may suggest that for HT1080 cells, higher concentrations may be used 
to produce highest toxicity levels for these cells.
Determination o f  Cell Viability -  (M TT Assay) - Hexane Haddi After 24, 48  and 72 Hours, Using
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Figure 3.32
Percentage viability of HT 1080 cells in control and in medium containing five 
concentrations of hexane haddi extract (n=9, bars=standard error) (For statistical 
analysis o f data with this figure, see Tables 12.1-12.3, Appendix II).
Determination of Viability - (MTT Assay) - Hexane Haddi After 24,48 and 72 Hours, Using
HT1080 Cells
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Figure 3.33
Percentage viability of HT 1080 cells in control and in medium containing five 
concentrations of hexane haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 13.1-13.3, Appendix II).
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B.6 Ethyl Acetate Haddi Extract (266.45-666.60 pg/ml)
Ethyl acetate haddi extract was not effective against HT1080 cells, especially at lower 
concentrations. Results (Figure 3.34) suggest a high survival rate of cells exposed to 
these low concentrations, resulting in high percentage cell viability.
Determination o f Cell Viability - (MTT Assay) - Ethyl Acetate Haddi After 24 ,48  and 72
Hours, Using HT1080 Cells
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Figure 3.34
Percentage viability of HT 1080 cells in control and in medium containing five 
concentrations of ethyl acetate haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 14.1-14.3, Appendix II).
B.7 Essential Oil Haddi Extract (Aldrich) (266.45-666.60 pg/ml)
Essential oil haddi extract (Aldrich) at this concentration range had insignificant effect 
on the HT1080 cells. Figure 3.35 clearly shows high percentage viability, even after 
an exposure of 72 hours. Essential oil haddi extract (Aldrich) was also not effective 
against SI 80 cells (Figure 3.20).
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Determination of Cell Viability - (MTT Assay) - Aldrich Haddi After 24,48 and 72 Hours, Using
HT1080 Cells
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Figure 3.35
Percentage viability of HT1080 cells in control and in medium containing five 
concentrations of Aldrich haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 15.1-15.3, Appendix II).
B.8 Essential oil Haddi Extract (Aldrich) (600-1799.82 pg/ml)
The HT1080 cells were also exposed to a stronger essential oil haddi extract (Aldrich) 
concentration range (Figure 3.36). Results indicate that percentage viability 
decreased substantially, with time of exposure (P0.001).
Nonetheless, it seems that HT1080 cells, initially affected by the two lowest 
concentrations (600.17 and 900.26 pg/ml) resulting in about 6% viability after an 
exposure for 24 and 48 hours, reversed this reaction when signs of recovery were 
noted after 72 hours of exposure, as evidenced by high percentage viability compared 
to the previous two days of exposure, that is, survival of cells and their proliferation 
was evident.
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Determination of Cell Viability - (MTT Assay) - Aldrich Haddi Alter 24,48 and 72 Hours,
Using HT1080 Cells
%Viability 24 hr 
%Viability 48 hr 
%Viability 72 hr
100
Control 600.17 900.26 1199.23 1500.97 1799.82
Concentration (jjg/ml)
Figure 3.36
Percentage viability of HT1080 cells in control and in medium containing five higher 
concentrations of Aldrich haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 16.1-16.3, Appendix II).
3.4.3 Normal Chick Fibroblast Cell Line
The effect of the molmol and haddi extracts on the viability of normal chick fibroblast 
cells were also investigated using similar treatment protocols to those used before for 
S I80 and HT1080 cell lines. Results are illustrated in Figures 3.37 to 3.46.
A. Molmol Extracts
A.l Ethanolic Molmol Extract (266.45-666.60 pg/ml)
The three highest concentrations were most effective against normal fibroblast cells 
(Figure 3.37) (PO.OOl). Nonetheless, for the 466.24 pg/ml concentration of 
ethanolic molmol, mitogenesis occurred after 24 hours of exposure, followed by a 
substantial cell death after 48 and, especially, after 72 hours of exposure. The other 
lower concentrations were ineffective, resulting in enhanced growth, that is, 
mitogenesis, and higher percentage viability than in the control, especially after 72 
hours of exposure. Results show that the 366.00 pg/ml extract concentration was not
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effective against normal fibroblast cells, as it was against the S I80 and HT1080 cell 
lines.
Determination o f Cell Viability - (MTT Assay) - Ethanolie Molmol After 24 ,48  and 72 
Hours, Using Normal Fibroblasts
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%Viability 72 hr
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Concentration (pg/ml)
Figure 3.37
Percentage viability of normal fibroblast cells in control and in medium containing 
five concentrations of ethanolic molmol extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 1.1-1.3, Appendix III).
A.2 Ethanolic Molmol Extract (366.68-466.62 pg/ml)
Because 466.24 pg/ml extract was not highly effective against normal fibroblast cells, 
illustrated above, it was decided to run a test using a concentration range between 
366.68 and 466.62 pg/ml, in order to decide the actual concentration that is least 
effective against the normal fibroblast cells. The lowest concentration (366.68 pg/ml) 
lagged behind the others after 24 hours of exposure, when mitogenesis was noted 
(higher percentage viability than in the control) (Figure 3.38). Also, a high 
percentage cell viability (77%) was noted after 48 hours of exposure to 366.68 pg/ml.
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Determination of Cell Viability - (M U  Assay) - Ethanolic Molmol After 24,48 and 72 Hours,
Using Normal Fibroblasts
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%Viability 24 hr
%Viability 48 hr 
%Viability 72 hr
0
Control 366.68 391.12 416.72 441.34 466.62
Concentration (|jg/ml)
Figure 3.38
Percentage viability of normal fibroblast cells in control and in medium containing 
five other concentrations of ethanolic molmol extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 2.2-2..3, Appendix III).
A.3 Hexane Molmol Extract (266.45-666.60 pg/ml)
This range of concentrations was only highly toxic to normal fibroblast cells towards 
the end of the experiment. After 24 hours of exposure, growth was enhanced in 
cultures exposed to all concentrations, indicating mitogenesis, but a definite activity 
was shown after 72 hours of exposure, especially at the two highest concentrations 
(Figures 3.39).
A.4 Ethyl Acetate Molmol Extract (666.60-266.50 jig/ml)
All concentrations used, except the lowest (266.50 pg/ml), were effective against 
normal fibroblast cells, particularly after 48 and 72 hours of exposure (P0.001). In 
the lowest concentration, growth enhancement (mitogenesis) was noted, as shown by 
the higher percentage viability than in the control (Figures 3.40).
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Determination of Cell Viability - (MYTT Assay) - Hexane Molmol After 24 ,48 and 72
Hours, Using Normal Fibroblasts
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Figure 3.39
Percentage viability of normal fibroblast cells in control and in medium containing 
five concentrations of hexane molmol extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 3.1-3.3, Appendix III).
Determination o f  Cell Viability - (MTT Assay) - Ethyl Acetate Molmol After 2 4 ,4 8  
and 72 Hours, Using Normal Fibroblasts
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Figure 3.40
Percentage viability of normal fibroblast cells in control and in medium containing 
five concentrations of ethyl acetate molmol extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 4.1-4.3, Appendix III).
A.5 Flavex Molmol Extract (266.45-666.60 ng/ml)
Flavex molmol extract employed at this concentration range was also effective, 
especially at the two highest concentrations (566.61 and 666.6 pg/ml), when
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significant activity was noted at the end of the experimental period (Figure 3.41) 
(PO.OOl), resulting in the lowest percentage cell viability.
Determination o f  Cell Viability - (M TT A ssay) - Flavex Molmol After 2 4 ,4 8  and 
72 Hours, Using N orm al Fibroblasts
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Figure 3.41
Percentage viability of normal fibroblast cells in control and in medium containing 
five concentrations of Flavex molmol extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 5.1-5.3, Appendix III).
B. Haddi Extracts
B.l Ethanolic Haddi Extract (266.50-666.60 jig/ml)
Ethanolic haddi extract in this range of concentration resulted in mitogenesis (growth 
enhancement) in the three lowest concentrations after 24 hours of exposure, whereas 
apparent cytotoxity occurred with the first two highest concentrations. However, its 
activity was more evident later in the experiment, though the only significant lowest 
percentage viability was also illustrated by the two highest concentrations (666.60 and
566.61 pg/ml), particularly with the former, after 48 and 72 hours of exposure (Figure 
3.42).
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Determination of Cefl Viability - (MTT Assay) - Ethanolic Haddi After 24,48 and 72 Hours,
Using Normal F ibroblasts
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Figure 3.42
Percentage viability of normal fibroblast cells in control and in medium containing 
five concentrations of ethanolic haddi extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 6.1-6.3, Appendix III).
B.2 Hexane Haddi Extract (266.50-666.60 pg/ml)
These hexane haddi extracts were not very effective against normal fibroblast cells, as 
they were against S I80 and HT1080 cell lines, particularly in the two lowest 
concentrations where mitogenesis occurred after 48 and 72 hours of exposure, 
resulting in higher percentage cell viability than in the control (Figure 3.43). Because 
of this differential effect, hexane haddi extract has been selected to run the other 
assays.
B.3 Ethyl Acetate Haddi Extract (266.50-666.60pg/ml)
Ethyl acetate haddi extract at this concentration range was also highly ineffective in 
terms of cytotoxicity throughout the experimental period, resulting in most cases in 
higher percentage viability than in the control, that is, mitogenesis (growth 
enhancement), though there had been insignificant toxicity effect at the two highest 
concentrations at the end of the experiment (Figure 3.44).
Determination o f Cefl Viability - (MYTT Assay) - Hexane Haddi After 24,48 and 72 Hours, Using
Normal Fibroblasts
120
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466.24 566.61 666.60Control 266.50 366.00
Concentration (jjg/ml)
Figure 3.43
Percentage viability of normal fibroblast cells in control and in medium containing 
five concentrations of Hexane haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 7.1-7.3, Appendix I).
D eterm ination  o f  Cell V iability - (M TT Assay) - Ethyl Acetate Haddi A fter 24,
48 and 72 H ours, U sing N orm al Fibroblasts
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Figure 3.44
Percentage viability of normal fibroblast cells in control and in medium containing 
five concentrations of ethyl acetate haddi extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 8.1-8.3, Appendix III).
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B.4 Essential Oil Haddi Extract (Aldrich) (266.50-666.60 jig/ml)
This concentration range was also highly ineffective, resulting in mitogenesis (growth 
enhancement) in all cases, and higher percentage viability than in the control (Figure 
3.45).
Determination o f Cell Viability - (MTT Assay) - Aldrich Haddi Oil After 24 ,48  
and 72 Hours, Using Normal Fibroblasts
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Figure 3.45
Percentage viability of normal fibroblast cells in control and in medium containing 
five concentrations of Aldrich haddi extract (n=9, bars=standard error) (For statistical 
analysis of data with this figure, see Tables 9.1-9.3, Appendix III).
B.5 Essential Oil Haddi Extract (Aldrich) (533.71-1333.20 ^g/ml):
The higher concentration range of Aldrich haddi extract was highly effective against 
normal fibroblast cells, resulting in very low percentage viability compared to the 
control (Figure 3.46) (P<0.001).
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Determination of Cell Viability - (MYTT Assay) - Concentrated Aldrich Haddi Oil Afler 24,48
and 72 Hours, Using Normal Fibroblasts
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Figure 3.46
Percentage viability of normal fibroblast cells in control and in medium containing 
five higher concentrations of Aldrich haddi extract (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Tables 10.1-10.3, Appendix III).
3.5 C o m p ariso n  o f D iffe ren tia l E ffects o f  M olm ol an d  H ad d i 
E x tra c ts
Results analysed earlier showed that extracts of molmol and haddi plants, using 
ethanol, hexane and ethyl acetate, had differential effects on S I80 cells, HT1080 cells, 
and normal fibroblast cells. These differential effects are analysed below.
Figure 3.47 shows that ethanolic molmol extract was most effective in terms of its 
cytotoxic effect against S I80 cells. While the S I80 viability declines to around 5.0% 
after 72 hours at 366.6 pg/ml, compared to around 50% of the HT1080 cells, where 
this concentration had a mitogenetic effect on the normal fibroblast cells (PO.OOl). 
Higher concentrations of ethanolic molmol extracts were active against all cell lines 
used, especially the S I80 and HT1080. It can possibly be said that using this 
concentration to treat cancerous cells is appropriate, as it appears to target only 
cancerous cells rather than normal cells.
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Comparison of Differential Effects of Ethanolic Molmol Extract on SI 80 Cells, 
HT1080 Cells andNF after 72 Hours
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100 S180 —■— HT1080 - a- NFB
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Control 266.45 366.6 466.24 566.61 666.6
Concentration (pg/ml)
Figure 3.47
Differential effects of ethanolic molmol extracts on SI 80, HT1080 and normal 
fibroblast cell line after 72 hours of exposure (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Table 1.1, Appendix IV).
Figure 3.48 shows that hexane molmol extract is effective, in terms of its apparent 
cytotoxicity, against all cell lines used. It is therefore not suitable to treat cancerous 
cells because it targets normal cells and cancerous cells alike.
Comparison of Differential Effects of Hexane Molmol of SI 80 Cells, HT1080 
Cells and NFB Cells after 72 Hours
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Figure 3.48
Differential effects of hexane molmol extracts on SI 80, HT1080 and normal 
fibroblast cell line after 72 hours of exposure (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Table 2.1, Appendix IV).
99
Ethyl acetate molmol extract was most effective in terms of its apparent toxicity 
against S I80 cells and HT1080 cells at the lowest concentration of 266.5 pg/ml, and 
against S I80 cells at 366.60pg/ml (Figure 3.49). Nonetheless, there appears to be a 
mitogenic effect with increasing the concentrations regarding the S I80 and HT1080 
cell lines, but some cytotoxicity against normal fibroblast cells. With regard to the 
normal fibroblast cells, the lower end of the spectrum had a mitogenic effect, with an 
increase in the number of viable cells after 72 hours of exposure. Applying this 
extract at 266.45 pg/ml concentration provided the optimum results, in that the extract 
targeted cancerous cells, with a sharp decline in percentage cell viability but showing 
a mitogenic effect on the normal fibroblast cells.
C om parison o f  D ifferential E ffects o f  Ethyl Acetate M olm ol on  SI 80 C ells, 
H T1080 C ells and NFB C ells after 72 Hours
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S180 HT1080 NFB100
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Control 266.45 366.6 466.24 566.61 666.6
Concentration (jig/ml)
Figure 3.49
Differential effects of ethyl acetate molmol extracts on SI 80, HT1080 and normal 
fibroblast cell line after 72 hours of exposure (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Table 1.3, Appendix IV).
Ethanolic haddi extracts were effective in terms of their apparent cytotoxicity against 
S I80, HT1080 and normal fibroblast. They were more effective against the normal 
fibroblast cells at the higher concentration ranges than against HT1080 cells (Figure 
3.50). However, they were more effective preparations against S I80 cells than
100
against HT1080 and fibroblast cells, resulting in considerably lower percentage cell 
viability in S I80 than in the control.
Comparison of Differential Effects of Ethanolic Haddi Extract on SI 80 Cells, 
HT1080 Cells and NFB Cells after 72 Hours
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Figure 3.50
Differential effects of ethanolic haddi extracts on SI 80, HT1080 and normal 
fibroblast cell line after 72 hours of exposure (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Table 2.1, Appendix IV).
Hexane haddi extracts were effective against S I80 and HT1080 cells at all 
concentrations, especially to S I80 cells at higher concentrations (Figure 3.51) 
(P0.001). However, the lower concentrations had a mitogenic effect on the normal 
fibroblast cells, but higher concentrations showed an apparent progressive 
cytotoxicity to these cells. The effect was more on the S I80 than on the HT1080 
cells, which indicates that S180 cells are more sensitive to these treatments than the 
HT1080 cells.
Figure 3.52 shows that the two lower ethyl acetate concentrations were effective 
against S I80 cells, but had a mitogenic effect on the HT1080 cells and normal 
fibroblast cells. These extracts can be used at the lower concentrations to target only 
S I80 cells, but not HT1080 cells.
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Com parison o f  D ifferential E ffects o f  Hexane Haddi Extract on  SI 80 Cells, 
HT1080 C ells and NFB C ells after 72 Hours
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Figure 3.51
Differential effects of hexane haddi extracts on SI 80, HT1080 and normal fibroblast 
cell line after 72 hours of exposure (n=9, bars=standard error) (For statistical analysis 
of data with this figure, see Table 2.2, Appendix IV).
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Figure 3.52
Differential effects of ethyl acetate haddi extracts on SI 80, HT1080 and normal 
fibroblast cell line after 72 hours of exposure (n=9, bars=standard error) (For 
statistical analysis of data with this figure, see Table 2.3, Appendix IV).
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3.6 C o m p ariso n  o f D ifferen tia l E ffects o f M olm ol E x tra c t on S I 80, 
H T 1080 an d  N o rm al F ib ro b la s t Cells
Figure 3.53 illustrates that ethanolic molmol and ethyl acetate molmol extracts were 
most effective, in terms of their apparent cytotoxicity, against S I80 cells, using 
different concentrations. Percentage viabilities were very low, below 4.0% when 
treated with extracts containing between 366.6 and 666.6 pg/ml. The hexane molmol 
extract was less effective than ethanolic and ethyl acetate molmol extracts (PO.OOl). 
Hence, S I80 cells are more sensitive to ethanolic and ethyl acetate molmol extracts 
than to hexane molmol extract.
Effect o f Various Molmol Extracts on SI 80 Cells after 72 Hours
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Figure 3.53
Differential effects of different molmol extracts on SI 80 cells after 72 hours of 
exposure (n=9, bars=standard error) (For statistical analysis of data with this figure,
see Table 3.1, Appendix IV).
Figure 3.54 shows that ethnolic and ethyl acetate molmol extracts were more effective 
against HT1080 cells than hexane molmol extract (PO.OOl). However, HT1080 cells 
were sensitive to ethanolic molmol extract, though less sensitive than S I80 cells to 
this extract.
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Effect of Various Molmol Extracts on HT1080 Cells After 72 Hours
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Figure 3.54
Differential effects of different molmol extracts on HT1080 cells after 72 hours of 
exposure (n=9, bars=standard error) (For statistical analysis of data with this figure,
see Table 3.2, Appendix IV).
Normal fibroblast cells showed increased viability when treated with ethanolic and 
ethyl acetate molmol extracts at lower concentrations, even indicating mitogenetic 
effects at such low concentrations. However, they were very sensitive to all 
concentrations of hexane molmol extracts, and higher concentrations of ethnolic 
molmol than ethyl acetate molmol extract (Figure 3.55).
Normal fibroblast cells showed increased viability, when treated with ethanolic and 
ethyl acetate molmol extracts at lower concentrations, even indicating mitogenetic 
effects at such low concentrations. However, they were very sensitive to all 
concentrations of hexane molmol extracts, and higher concentrations of ethyl acetate 
molmol extract than ethanolic molmol extract. (Figure 3.55).
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Effect o f Various Molmol Extracts on Normal Fibroblast Cells After 72 Hours
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Figure 3.55
Differential effects of different molmol extracts on normal fibroblast cells after 72 
hours of exposure (n=9, bars=standard error) (For statistical analysis of data with this
figure, see Table 3.3, Appendix IV).
3.7 C o m p ariso n  o f D ifferen tia l E ffects o f H ad d i E x tra c ts  on S I 80, 
H T 1080 an d  N o rm al F ib ro b la s t Cells
S I80 cells were sensitive to various extracts of haddi (Figure 3.56), where cell 
viability declined at all concentrations, especially ethanolic haddi extract at the 
highest concentration. However, viability was almost similar in the case of the three 
extracts at the lowest concentration, and which was much higher than at the other 
higher concentrations.
Figure 3.57 shows that HT1080 cells were less sensitive to ethanolic haddi extract 
than other haddi extracts, in contrast to its apparent cytotoxic effect on S I80 cells 
(Figure 3.56). Ethyl acetate haddi extract had a mitogenic effect at the two lower 
concentrations, but was more effective than hexane haddi extracts at the two highest 
concentrations.
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Effect o f  Various Extracts o f  H addi on S 180 Cells after 72 Hours
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Figure 3.56
Differential effects of different haddi extracts on S180 cells after 72 hours of exposure 
(n=9, bars=standard error) (For statistical analysis of data with this figure, see Table
4.1, Appendix IV).
Effect o f  Various Haddi Extracts on HT1080 Cells after 72 Hours
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Figure 3.57
Differential effects of different haddi extracts on HT1080 cells after 72 hours of 
exposure (n=9, bars=standard error) (For statistical analysis of data with this figure,
see Table 4.2, Appendix IV).
Normal fibroblast cells (Figure 3.58) were more sensitive to ethanolic haddi extract 
than to the other two extracts, especially at higher concentrations (PO.OOl). Hexane
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haddi and ethyl acetate extracts had a mitogenic effect at the lower concentrations and 
some activity at the higher concentrations. This is further evidence for selecting 
hexane haddi extract between 266.45 pg/ml and 366.6 pg/ml concentrations to run 
other assays, as indicated earlier.
Effect o f Various Haddi Extracts on Normal Fibroblast Cells
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Figure 3.58
Differential effects of different haddi extracts on normal fibroblast cells after 72 hours 
of exposure (n=9, bars=standard error) (For statistical analysis of data with this figure,
see Table 4.3, Appendix IV).
3.8 S u m m ary
3.8.1 Testing Molmol Extracts against S I80 and Normal Fibroblast Cells
At selected concentrations (see Table 3.1), molmol extracts were highly specific with 
respect to their activity behaviour, targeting S180 cells only.
At these concentrations, all the molmol extracts, except hexane extracted molmol, 
showed potent cytotoxic properties against the S I80 murine carcinoma cells, but were 
not detrimental to the normal fibroblast cells.
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Table 3.1. Percentage viability of S I80 and normal fibroblast cells after 72 hours
exposure to molmol extracts
% Viability
S180 Normal fibroblasts
Ethanol extract (366 pg/ml) 4 100
Hexane extract (366 pg/ml) 63 78
Ethyl acetate extract (266pg/ml) 12 100
Flavex ethanol extract (566 pg/ml) 34 100
Exposure of S I80 and normal fibroblast cells to a further increase of the dose of the 
plant extracts generally resulted in a decrease in percentage viability of both types of 
cells, except for Flavex ethanolic extract (666 pg/ml) which did not have an effect on 
the normal fibroblast cells, as indicated in table 3.2
Table 3.2. Percentage viability of S I80 and normal fibroblast cells after 72 hours 
exposure to higher concentrations of molmol extracts
% Viability
SI 80 Normal fibroblasts
Ethanol extract (666pg/ml) 5 7
Hexane extract (666pg/ml) 20 27
Ethyl acetate extract (366 pg/ml) 4 48
Flavex ethanol extract (666 pg/ml) 24 100
Only the Flavex extract of molmol showed a differential concentration (666pg/ml), 
which killed S I80 cancer cells, whilst having no apparent cytotoxic effect on the 
normal fibroblasts. At the higher concentrations, both the ethanolic and ethyl acetate 
extracts exhibited a strong activity against S180 and normal fibroblast cells, resulting 
in lower percentage viability.
An increase in the dose application of molmol ethyl acetate extract from 266 to 366 
pg/ml resulted in a sharp increase in cell death in both cell types.
The normal fibroblast cells did not tolerate larger doses of molmol ethanolic extracts 
(666pg/ml) compared to the nil effect of the 366 pg/ml concentration.
108
On the basis of these experiments, the ethanol extract of molmol was chosen for 
further biological testing, using selected bioassays for evaluating programmed cell 
death (see further results in this chapter relating to these bioassays).
3.8.2 Testing Haddi Extracts against S180 and Normal Fibroblast Cells
At selected concentrations (see Table 3.3), the haddi plant extracts were clearly 
specific with respect to their activity, targeting S I80 cells only.
At these concentrations, only the hexane and ethyl acetate extracts of haddi showed 
potent cytotoxic properties, specifically targeting the S I80 murine carcinoma cells, 
resulting in comparatively reduced percentage viability. Normal fibroblasts were only 
affected by ethanolic haddi extract, resulting in 82% viability, whereas other extracts 
did not target normal fibroblasts
Table 3.3 Percentage viability of S I80 and normal fibroblast cells after 72 hours 
_____________exposure to haddi extracts_____________________________________
% Viability
S180 Normal fibroblasts
Ethanol extract (366pg/ml) 75 82
Hexane extract (366pg/ml) 4 100
Ethyl acetate extract (466pg/ml) 33 100
Essential oil extract (666 pg/ml) 62 100
Increasing the dose of haddi extracts had an apparent cytotoxic effect on the normal
fibroblasts, resulting in a low percentage viability. The decrease in cell viability is 
shown in Table 3.4.
Table 3.4 Percentage viability of S I80 and normal fibroblast cells after 72 hours 
exposure to higher concentrations of haddi extracts
% Viability
S180 Normal fibroblasts
Ethanol extract (666pg/ml) 6 21
Hexane extract (666pg/ml) 4 67
Ethyl acetate extract (666pg/ml) 25 97
Essential oil extract 77 100
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Increasing the dose of the plant extracts applied to the S I80 cells resulted in a 
decrease in percentage viability of both the S I80 and the normal fibroblast cells, as 
shown in Table 3.2. At these higher doses, only the ethyl acetate extracts of molmol 
(666 pg/ml) showed differential concentrations which specifically killed S I80 cancer 
cells whilst having negligible cytotoxic effects on the normal fibroblast cells.
3.8.3 Testing Molmol Extracts against HT1080 and Normal Fibroblast Cells
At selected concentrations, only the ethanolic and ethyl acetate extracts of molmol, 
showed both potent and specific cytotoxic properties against the HT1080 human 
fibrosarcoma cells, whereas they did not have detrimental effects on the normal 
fibroblast cells (see Table 3.5).
Table 3.5 Percentage viability of HT1080 and normal fibroblast cells after 72 
hours exposure to molmol extracts
% Viability
HT1080 Normal fibroblasts
Ethanol extract (366pg/ml) 7 100
Hexane extract (366pg/ml) 51 83
Ethyl acetate extract (366pg/ml) 7 100
Flavex ethanol extract (666 pg/ml) 88 100
Increasing the dose of molmol extracts increased the apparent cytotoxic behaviour 
against HT1080 cells, but decreased the viability of the normal fibroblast cells, as 
shown in Table 3.6. Although low percentage viability was observed for the ethanolic 
and ethyl acetate plant extracts, tested at the higher concentrations, their apparent 
cytotoxic activities were not specific to HT1080 cells, as they also affected normal 
fibroblast cells.
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Table 3.6 Percentage viability of HT1080 and normal fibroblast cells after 72
hours exposure to higher concentrations of molmol extracts
% Viability
HT1080 Normal fibroblasts
Ethanol extract (666pg/ml) 9 7
Hexane extract (366pg/ml) 51 61
Ethyl acetate extract (366pg/ml) 7 6
Flavex ethanol extract (666 pg/ml) 88 100
3.8.4 • Testing Haddi Extracts against HT1080 and Normal Fibroblast Cells
At selected concentrations (see Table 3.7), only the hexane plant extract of haddi 
showed potent properties against the HT1080 human fibrosarcoma cells. None of the 
concentrations tested had significant cytotoxic properties against the normal fibroblast 
cells.
Table 3.7 Percentage viability of HT1080 cells and normal fibroblast cells after 
72 hours exposure to haddi extracts
% Viability
HT1080 Normal fibroblasts
Ethanol extract (366pg/ml) 79 87
♦Hexane extract (333 and 366pg/ml) 7 100
Ethyl acetate extract (666pg/ml) 54 93
Essential oil extract (666 pg/ml) 80 100
Increasing the dose of haddi extracts increased the cytotoxic potential against HT1080 
cells, as well as increasing the incidence of cell death in normal fibroblast cells, as 
shown in Table 3.8. Again, the hexane extract of the haddi showed both potent and 
somewhat specific cytotoxic targeting of the HT1080 cells.
Table 3.8 Percentage viability of HT1080 cells and normal fibroblast cells after 
72 hours exposure to higher concentrations of haddi extracts
% Viability
HT1080 Normal Fibroblasts
Ethanol extract (666pg/ml) 9 12
Hexane extract (666pg/ml) 7 54
Ethyl acetate extract (666pg/ml) 54 93
Essential oil extract (900pg/ml) 52 9
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3.9 Haematoxylin-Eosin Staining.
S I80, HT1080 and normal fibroblast cell lines were grown exponentially, and treated 
with either ethanolic molmol or hexane haddi extracts for 6, 12 and 24 hours, as 
described in Chapter Two, Section 2.10.2
3.9.1 S180 Cells
A. Control Treatment
The control S I80 cells were epithelial-like, exhibiting a rounded or polygonal 
morphology (Figure 3.59A). The cells also appeared to be a confluent monolayer. 
The cells remained attached to the substratum, using their pseudopodial attachments 
(Figure 3.59B). The cells were uniformly stained, and nuclei appeared healthy.
B. Ethanolic Molmol Extract
The earliest changes in S I80 cells during apoptosis were visible within 6 hours of 
treatment with ethanolic molmol. In cells at this stage of treatment, the cytoplasm 
became condensed, and eventually broke up into several membrane-bound apoptotic 
bodies, with smooth surfaces (Figure 3.60). Some dying cells showed pyknotic 
nuclei. Some o f the apoptotic bodies consisted mainly of nuclear fragments (deeply 
stained), while others consisted of plasma membrane surrounding cytoplasm (lightly 
stained).
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Figure 3.59
Light microscopy images of S180 cells stained with haematoxylin and eosin. 
(A: X300, B: X750). (Orange arrows: Pseudopodia).
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Figure 3.60
Light microscopy images of SI 80 cells treated with 234pg/ml ethanolic molmol 
extract for 6 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrows), apoptotic bodies (blue arrows) 
and break-up of cell membrane (black arrow)
After 12 hours of treatment (Figure 3.61), most dying cells had pyknotic nuclei. 
Some cells showed signs of break-up of cell membrane, and apoptotic bodies 
consisted mainly of nuclear fragments (deeply stained). Vacuolisation progressed 
during this stage of treatment and was observed in most of the cells. However, some 
cells showed condensed cytoplasm.
After 24 hours of treatment (Figure 3.62), most of the dying cells had pyknotic nuclei, 
and were highly vacuolated. Apoptotic cells broke up, forming membrane-bound 
apoptotic bodies, consisting of either nuclear fragments (deeply stained) or only 
plasma membrane surrounding cytoplasm.
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/Figure 3.61
Light microscopy images of SI 80 cells treated with 234pg/ml ethanolic molmol 
extract for 12 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrows), apoptotic bodies (blue arrows), 
break-up of cell membrane (black arrow) and vacuolisation (red arrow)
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Figure 3.62
Light microscopy images of SI 80 cells treated with 666.6pg/ml ethanolic molmol 
extract for 24 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrows), apoptotic bodies (blue arrows), 
break-up of cell membrane (black arrow) and vacuolisation (red arrow)
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C. Hexane Haddi Extract
The earliest changes in S I80 cells during apoptosis were visible within 6 hours of 
treatment with hexane haddi extract (Figure 3.63).
*
Figure 3.63
Light microscopy images of SI 80 cells treated with 201pg/ml hexane haddi extract 
for 6 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrow), apoptotic bodies (blue arrow), 
break-up of cell membrane (black arrow), vacuolisation (red arrow) and blebs (green
arrow).
In cells at this stage of treatment, the cytoplasm became condensed, and eventually 
broke up into several membrane-bound apoptotic bodies, with smooth surfaces, 
consisting mainly of nuclear fragments. Some dying cells showed pyknotic nuclei. 
The cytoplasm in some cells had bulged out of the surface, forming blebs on the outer 
cell membrane. The cytoplasm of some cells had started disintegrating and become 
vacuolated.
After 12 hours of treatment (Figure 3.64), dying cells had pyknotic nuclei, some 
showing signs of break-up of cell membrane, and apoptotic bodies consisting mainly
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of nuclear fragments (deeply stained) were formed. Vacuolisation was observed in 
some cells, whereas others had condensed cytoplasm.
Figure 3.64
Light microscopy images of SI 80 cells treated with 666.6pg/ml hexane haddi extract 
for 12 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrow), apoptotic bodies (blue arrow), 
break-up of cell membrane (black arrow) and vacuolisation (red arrow)
After 24 hours of treatment (Figure 3.65), dying cells had pyknotic nuclei, and 
showed signs of cytoplasm disintegration (light staining with eosin). Apoptotic cells 
had blebs on their outer membrane.
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XFigure 3.65
Light microscopy images of SI 80 cells treated with 666.6pg/ml hexane haddi extract 
for 24 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrow), and blebs (green arrow)
3.9.2 HT1080 Cells
A. Control Treatment
The control HT1080 cells examined were epithelial-like, exhibiting polygonal 
morphology. The cells appeared as a confluent monolayer, remaining attached to the 
substratum by their pseudopodial attachments (Figure 3.66A). The nuclei appeared 
rounded or ellipsoidal. Cells undergoing mitosis could also be observed in the culture 
(Figure 3.66B)
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Figure 3.66
Light microscopy images of HT1080 cells stained with haematoxylin and eosin.
(A: X300, B: X750). (Yellow arrows: mitosis; Orange arrows: pseudopodia).
B. Ethanolic Molmol Extract
The earliest changes in HT1080 cells during apoptosis were visible within 6 hours of 
treatment with ethanolic molmol (Figure 3.67). Some cells at this stage of treatment 
had pyknotic nuclei, whereas other nuclear material had disintegrated, and apoptotic
bodies mainly consisted of nuclear fragments. Some cells had broken-up membranes, 
and cytoplasm had disintegrated, or become vacuolated.
Figure 3.67
Light microscopy images of HT1080 cells treated with 234pg/ml ethanolic molmol 
extract for 6 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrow), apoptotic bodies (blue arrow), 
break-up of cell membrane (black arrow) and vacuolisation (red arrow).
After 12 hours of treatment (Figure 3.68), dying cells had pyknotic nuclei, some with 
break-up o f cell membrane. Apoptotic bodies, consisting mainly of nuclear fragments 
(deeply stained) and cytoplasm fragments (lightly stained) were formed. While some 
cells showed condensed cytoplasm, some of which did not have pyknotic nuclei, 
others showed signs of cytoplasm disintegration (lightly stained with eosin).
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Figure 3.68
Light microscopy images of HT1080 cells treated with 234pg/ml ethanolic molmol 
extract for 12 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrows), apoptotic bodies (blue arrows), 
and break-up of cell membrane (black arrow)
After 24 hours of treatment with ethanolic molmol (Figure 3.69), the dying cells 
showed cytoplasmic disintegration with the formation of vacuoles, some with blebs 
on the outer cytoplasmic membrane. Apoptotic cells with pyknotic nuclei, but no 
apoptotic bodies, were found.
C. Hexane Haddi Extract
The earliest changes in HT1080 cells during apoptosis were visible within 6 hours of 
treatment with hexane haddi (Figure 3.70). Dying cells showed pyknotic nuclei. 
Apoptotic bodies consisted mainly of nuclear fragments (deeply stained). Dying cells 
also showed cytoplasmic disintegration with the formation of vacuoles, some with 
blebs on the outer cytoplasmic membrane.
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Figure 3.69
Light microscopy images of H T1080 cells treated with 666.6pg/ml ethanolic molmol 
extract for 24 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrows), break-up of cell membrane 
(black arrow) with high vacuolisation and blebs (green arrow)
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Figure 3.70
Light microscopy images of HT 1080 cells treated with 201pg/ml hexane haddi extract 
for 6 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrows), apoptotic bodies (blue arrows), 
break-up of cell membrane (black arrow) and blebs (green arrow).
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After 12 hours of treatment, nuclear of most apoptotic cells disintegrated, whereas 
others had pyknotic nuclei. Some cells showed cytoplasmic disintegration and 
vacuolisation. Apoptotic bodies formed consisted mainly of nuclear fragments 
(Figure 3.71).
Figure 3.71
Light microscopy images of HT 1080 cells treated with 201pg/ml hexane haddi extract 
for 12 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrow), apoptotic bodies (blue arrow), 
break-up of cell membrane (black arrow) and blebs (green arrow)
After 24 hours of treatment (Figure 3.72), almost all HT1080 cells were affected. 
They showed cytoplasmic disintegration and the formation of apoptotic bodies and 
vacuolisation, consisting of nuclear fragments, or both nuclear fragments and 
cytoplasmic fragments. Some apoptotic cells had blebs on the outer cytoplasmic 
membrane.
123
*Figure 3.72
Light microscopy images of HT1080 cells treated with 666.6pg/ml hexane haddi 
extractfor 24 hours and stained with haematoxylin and eosin (X750).
Dying cells show pyknotic nuclei (turquoise arrow), apoptotic bodies (blue arrow), 
break-up of cell membrane (black arrow) and blebs (green arrow).
3.9.3 Normal Fibroblast Cells
A. Control Treatment
The control normal fibroblast cells examined were epithelial-like, exhibiting 
polygonal morphology. The cells appeared as a confluent monolayer, remaining 
attached to the substratum by their pseudopodial attachments (Figure 3.73). The 
nuclei appeared rounded or ellipsoidal.
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AFigure 3.73
Light microscopy images of normal fibroblast cells stained with haematoxylin and
eosin.
(A: X300, B: X750). (Orange arrows: pseudopodia).
B. Ethanolic Molmol Extract
After 6 hours of treatment (Figure 3.74), all normal fibroblast cells remained intact 
and unchanged, all with normal nuclei, some possibly showing mitosis.
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Figure 3.74
Light microscopy images of normal fibroblast cells treated 234pg/ml with ethanolic 
molmol extract for 6 hours and stained with haematoxylin and eosin (X300). 
Cells show normal nuclei, some possibly show mitosis (arrows).
After 12 hours, the majority of cells were with normal nuclei (Figure 3.75), and only a 
few were apoptotic, with the formation of apoptotic bodies.
Figure 3.75
Light microscopy images of normal fibroblast cells treated with 234pg/ml ethanolic 
molmol extract for 12 hours and stained with haematoxylin and eosin (X300). 
Cells show normal nuclei, a few show apoptosis and formation of apoptotic bodies
(blue arrow).
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After 24 hours, the majority of cells were with normal nuclei (Figure 3.76), and only a 
few were apoptotic, with the formation of apoptotic bodies. The majority of cells 
show pseudopodial attachments.
Light microscopy images of normal fibroblast cells treated with 234pg/ml ethanolic 
molmol extract for 24 hours and stained with haematoxylin and eosin (X300). 
Cells show normal nuclei, a few show apoptosis and formation of apoptotic bodies
C. Hexane Haddi Extract
Normal fibroblast cells treated with haddi hexane for 6 hours (Figure 3.77) did not 
show signs o f disintegration, rather they were intact and kept adhering to each other, 
some even showing mitotic activity.
However, 12-hour treatment with this extract indicated that some cells developed 
pyknotic nuclei (Figure 3.78). Dying cells also showed signs of disintegration and the 
formation of vacuoles and apoptotic bodies, mainly consisting of nuclear fragments. 
Some dying cells had blebs on the outer cell membrane.
*
Figure 3.76
(blue arrow).
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Figure 3.77
Light microscopy images of normal fibroblast cells treated with 201pg/ml hexane 
haddi extract for 6 hours and stained with haematoxylin and eosin (X300). Cells 
show normal nuclei, some possibly show mitosis (arrows).
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Figure 3.78
Light microscopy images of normal fibroblast cells treated with 201 pg/ml hexane 
haddi extract for 12 hours and stained with haematoxylin and eosin (X300). 
Cells show normal nuclei, a few show apoptosis with pyknotic nuclei (turquoise 
arrow), vacuolisation (red arrow), formation of apoptotic bodies (blue arrow) and 
blebs on the outer cell membrane (green arrow).
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24-hours treatment indicated that some cells developed pyknotic nuclei (Figure 3.79). 
Dying cells also showed signs of disintegration and the formation of vacuoles and 
apoptotic bodies, mainly consisting of nuclear fragments. Some dying cells had blebs 
on the outer cell membrane.
Figure 3.79
Light microscopy images of normal fibroblast cells treated with 201pg/ml hexane 
haddi extract for 24 hours and stained with haematoxylin and eosin (X300).
Cells show normal nuclei, a few show apoptosis with pyknotic nuclei (turquoise 
arrow), vacuolisation (red arrow), and formation of apoptotic bodies (blue arrow).
3.10 A p o p to tic  Cells C o u n tin g  in C u ltu re  w ith  H aem ato x y lin  an d  
E osin  T ech n iq u e
3.10.1 S180 Cells
SI 80 cells grown in a control culture showed slight occurrence of apoptotic cells, a 
mean of 2.25% of a total 400 cells counted, in contrast to 97.75% normal cells . 
However, when these cells were grown in a medium containing 666 pg/ml ethanolic 
molmol extract, there was a tendency to develop more apoptotic cells with time, 
increasing from 20.75% cells after 6 hours of incubation to 76.25% after 24 hours.
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This tendency was also observed when cells were grown in medium containing 234 
Hg/ml ethanolic molmol extract, though lower percentages of apoptotic cells were 
observed, increasing from 12.25% after 6 hours of incubation to 41.75% after 24 
hours (Figure 3.80).
Results in Figure 3.80 indicate that ethanolic molmol extract at the two concentrations 
leads to higher apoptotic rates than the control after only 6 hours of exposure.
Effect of Ethanolic Molmol extracted on S1 80 
Sarcoma Cells
■ 666pg/ml
■ 234(jg/ml
Untreated 6 hours 12 hours 24 hours
T im e
Figure 3.80
S I80 cells grown in control culture and in cultures containing 666, 234 pg/ml 
ethanolic molmol extract solutions for 6, 12 and 24 hours (bars=standard error).
S I80 cells grown in a control culture showed a low occurrence of apoptotic cells, a 
mean of 2.25% of a total 400 cells counted. The remaining 97.75% of cells were non- 
apoptotic (normal) cells. When S 180 cells were grown in a medium containing 666 
pg/ml hexane haddi, the percentage of apoptotic cells after 6 hours o f exposure 
(20.75%) was higher than in the control . However, after longer periods of exposure, 
the percentages of apoptotic cells increased to 51.75% and 82.5% after 12 and 24- 
hour exposure, respectively (Figure 3.81). When these results are compared with
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those of S180 cells grown in medium containing 666 pg/ml ethanolic molmol extract, 
the percentages of apoptotic cells exposed to hexane haddi extract were higher than 
those exposed to ethanolic molmol extract after 12 and 24 hours, but equal in both 
treatments after 6 hours.
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Effect of Hexane Haddi extracted on S180 Sarcoma
Cells
■ 666 Mg/rnl 
M  201 ng/ml
Untreated 6 hours 12 hours 24 hours
T im e
Figure 3.81
S I80 cells grown in control culture and in cultures containing 666, 201 pg/ml hexane 
haddi extract solution for 6, 12 and 24 hours (bars=standard error).
3.10.2 HT1080 Cells
HT1080 cells grown in a control culture showed a slight occurrence of apoptotic cells, 
a mean of 2.5% of a total 400 cells counted, in contrast to 97.5% normal cells. 
However, when these cells were grown in a medium containing 666 qg/ml ethanolic 
molmol extract, there was a tendency to develop more apoptotic cells with time, 
increasing from 14.5% apoptotic cells after 6 hours of incubation to 69.5% after 24 
hours. This tendency was also observed when cells were grown in medium 
containing 234 pg/ml ethanolic molmol extract, though lower percentages of
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apoptotic cells were observed, increasing from 12.25% after 6 hours of incubation to 
41.75% after 24 hours (Figure 3.82).
Effect of Ethanolic Molmol extracted on HT1080 Cells
■ 666 (jg/ml
■ 234 Mg/ml
12 hours 24 hours6 hours
T im e
Figure 3.82
HT1080 cells grown in control culture and in cultures containing 666, 234 pg/ml 
ethanolic molmol extract solution for 6, 12 and 24 hours (bars=standard error).
Results in Figure 3.82 indicate that ethanolic molmol extract at the two concentrations 
led to higher apoptotic rates than the control after only 6 hours of exposure.
HT1080 cell grown in a control culture showed slight occurrence of apoptotic cells, a 
mean of 3% of a total 400 cells counted, in contrast to 97% non-apoptotic cells. 
However, when HT1080 cells were grown in a medium containing 666 pg/ml hexane 
haddi, there was a tendency to develop more apoptotic cells with time, increasing 
from 19% apoptotic cells after 6 hours of incubation to 71.25% after 24 hours. A 
similar observation was noted when cells were grown in media containing 201 pg/ml 
hexane haddi, though lower percentages of apoptotic cells were observed, increasing 
from 13.25% after 6 hours of incubation to 39% after 24 hours (Figure 3.83).
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Effect of Hexane Haddi extracted on HT 1080 Cells
■ 666 |jg/ml
■ 201 (jg/ml
Untreated 6 hours 12 hours 24 hours
T im e
Figure 3.83
HT1080 cells grown in control culture and in cultures containing 666, 201 pg/ml 
hexane haddi extracted solution for 6, 12 and 24 hours (bars=standard error).
3.10.3 Normal Fibroblast Cells
Normal fibroblast cells grown in a control culture showed slight occurrence of 
apoptotic cells, a mean of 3% of a total 400 cells counted, in contrast to 97% non- 
apoptotic cells. When normal fibroblast cells were grown in a medium containing 
666 pg/ml ethanolic molmol, the production of apoptotic cells was much less than in 
S I80 and HT1080 cell lines, increasing from 4.5% apoptotic cells after 6 hours of 
incubation to 32% after 24 hours. A similar observation was noted when cells were 
grown in media containing 234 pg/ml ethanolic molmol, though lower percentages of 
apoptotic cells were observed, increasing from 6.25% after 6 hours of incubation to 
19.25% after 24 hours (Figure 3.84).
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Effect of Ethanolic Molmol extracted on Normal
Fibroblast Cells
666|jg/m l
234pg/m l
Untreated 6 hours 12 hours 24  hours
T im e
Figure 3.84
Normal fibroblast cells grown in control culture and in cultures containing 666, 234 
pg/ml ethanolic molmol extract solution for 6, 12 and 24 hours (bars=standard error).
Normal fibroblast cells grown in a control culture also showed slight occurrence of 
apoptotic cells, a mean of 2.25% of a total 400 cells counted, in contrast to 97.75% 
non-apoptotic cells. When normal fibroblast cells were grown in a medium 
containing 666 pg/ml hexane haddi extract, the production of apoptotic cells was also 
much less than in S I80 and HT1080 cell lines, increasing from 16% apoptotic cells 
after 6 hours of incubation to 37% after 24 hours. A similar observation was noted 
when cells were grown in medium containing 201 pg/ml hexane haddi extract, though 
lower percentages of apoptotic cells were observed, increasing from 11% after 6 hours 
of incubation to 25.5% after 24 hours (Figure 3.85).
It is noted that hexane haddi extract performed slightly better in producing apoptosis 
in S 180 cells than ethanolic molmol, which showed that hexane haddi extract is more 
potent than ethanolic molmol extract.
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Effect of Hexane Haddi extracted on Normal Fibroblast
Cells
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Figure 3.85
Normal fibroblast cells grown in control culture and in cultures containing 666, 234 
pg/ml hexane haddi extract solution for 6, 12 and 24 hours (bars=standard error).
Ethanolic molmol and hexane haddi extract treatments produced very similar results 
in terms of the percentages of apoptotic cells in HT1080. The difference was not 
significant.
Both solutions were not as effective against normal fibroblast cells as they were 
against S I80 cells and HT1080 cells. Hence, it can be said that molmol and haddi 
extracts targeted cancerous cells more than normal cells.
3.11 S u m m a r y
The effects of molmol and haddi extracts on the SI 80, HT1080 and normal fibroblast 
cell lines used in this study can be illustrated as follows (Table 3.9).
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Table 3. 9 Summary of effects of molmol and haddi extracts on S I80, HT1080 and normal fibroblast cells using haematoxylin eosin 
technique
S180 Cells
Untreated Exposure Ethanolic Molmol Extract Hexane Haddi Extract
Cells
appeared
normal
6 Hours
■ Apoptosis visible.
■ Cells condensed, breaking up into ‘apoptotic bodies’.
■ Some cells with pyknotic nuclei
■ Apoptotic bodies consisting of nuclear fragments, or 
plasma membrane surrounding cytoplasm.
■ Apoptosis visible.
■ Cells condensed, breaking up into ‘apoptotic bodies’.
■ Some cells with pyknotic nuclei
■ Apoptotic bodies consisting of nuclear fragments, or 
plasma membrane surrounding cytoplasm.
■ Cytoplasm blebbing
■ Cytoplasm in some cells disintegrating and vacuolated
12 Hours
■ Most dying cells with pyknotic nuclei.
■ Cells with broken-up cell membrane
■ Apoptotic bodies consisting mainly of nuclear 
fragments.
■ Vacuoles observed in most cells
■ Some cells with condensed cytoplasm
■ Most dying cells with pyknotic nuclei.
■ Cells with broken-up cell membrane
■ Apoptotic bodies consisting mainly of nuclear 
fragments.
■ Vacuoles observed in some cells
■ Other cells with condensed cytoplasm
24 Hours
■ Most dying cells with pyknotic nuclei.
■ Cells with broken-up cell membrane
■ Apoptotic bodies consisting of nuclear fragments or 
plasma membrane surrounding cytoplasm
■ Cells with highly vacuolated cytoplasm
■ Most dying cells with pyknotic nuclei.
■ Cells with broken-up cell membrane, with signs of 
cytoplasm disintegration
■ Apoptotic bodies consisting of nuclear fragments or 
plasma membrane surrounding cytoplasm
■ Blebbing
(Continued)
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Table 3.9 (Continued) ....  1 .......  "" .......... . 1 ..........."".......—
HT1080 Cells
Untreated Exposure Ethanolic Molmol Extract Hexane Haddi Extract
Cells
appeared
normal,
some
dividing
6 Hours
■ Apoptosis visible.
■ Cells condensed, breaking up into ‘apoptotic bodies’.
■ Some cells with pyknotic nuclei, some cells with 
nuclear material disintegrating
■ Apoptotic bodies consisting mainly of nuclear 
fragments
■ Some cells with broken-up cell membrane, cytoplasm 
disintegrating, or vacuolated
■ Apoptosis visible.
■ Dying cells with pyknotic nuclei
■ Apoptotic bodies mainly consisting of nuclear 
fragments
■ Cytoplasm blebbing
■ Cytoplasm in some cells disintegrating and vacuolated
12 Hours
■ Most dying cells with pyknotic nuclei.
■ Cells with broken-up cell membrane
■ Apoptotic bodies consisting mainly of nuclear 
fragments, and cytoplasm fragments.
■ Some cells with condensed cytoplasm, some with no 
pyknotic cells, and others with disintegrated cytoplasm
■ Most apoptotic cells with disintegrated cytoplasm, 
others with pyknotic nuclei.
■ Apoptotic bodies consisting mainly of nuclear 
fragments, and cytoplasm fragments.
■ Some cells with disintegrated cells and vacuolated
24 Hours
■ Apoptotic cells with pyknotic nuclei
■ Apoptotic bodies not formed.
■ Dying cells with disintegrated cytoplasm
■ Cells vacuolated
■ Blebbing
■ Almost all cells affected
■ Apoptotic bodies formed
■ Cytoplasm disintegration
■ Apoptotic bodies consisting of nuclear fragments or 
plasma membrane surrounding cytoplasm
■ Blebbing
(Continued)
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Table 3.9 (Continued) ...... . -.... ........  1 ------
Normal Fibroblast Cells
Untreated Exposure Ethanolic Molmol Extract Hexane Haddi Extract
Cells
appeared
normal
6 Hours
■ All cells intact and unchanged
■ Some cells dividing
■ As for ethanolic molmol.
12 Hours
■ Majority of cells normal.
■ A few apoptotic cells.
■ Some cells forming apoptotic bodies
■ Some cells developing pyknotic nuclei
■ Dying cells disintegrating
■ Vacuolation.
■ Formation of apoptotic bodies.
■ Some cells blebbing
24 Hours
■ Majority of cells normal.
■ A few apoptotic cells.
■ Some cells forming apoptotic bodies
■ Majority of cells with pseudopodial attachments
■ Some cells developing pyknotic nuclei
■ Dying cells disintegrating
■ Vacuolation
■ Formation of apoptotic bodies, consisting of nuclear 
fragments
■ Some cells blebbing
Results illustrated in Table 3.9 clearly show that both plant extracts were effective against S I80 and HT1080 cell lines, even after a short 
time of exposure (6 hours). Nonetheless, hexane extracted haddi was more effective on normal fibroblast than ethanolic extracted molmol, 
an indication that the latter mainly targets cancer cells, whereas the former seemed to have targeted all three cell lines.
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3.12 D N A  F r a g m e n t a t i o n  A s s a y  ( K l e n o w  D N A  F r a g m e n t a t i o n  
D e t e c t i o n  T U N E L )
Only HT1080 and normal fibroblast cell lines were used in this experiment to show
the effect of ethanolic molmol and hexane haddi extracts on the survival of these cells.
The cells were treated with these extracts for the following periods: 3, 6, 12, 24 and 
48 hours, against a control containing no plant extract.
3.12.1 HT1080 Cell Line
Cells grown in control medium, that is, untreated with molmol or haddi extracts, 
showed normal cells, with intact nuclear material, as shown in Figure 3.86
Figure 3.86
Untreated HT1080 cells (Mag. X750).
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A. Ethanolic Molmol Extract (234 jag/ml)
HT1080 cells treated with ethanolic molmol for 3 hours did not show any sign of 
DNA break strands, which is the positive reaction indicating this break-up (Figure 
3.87).
Figure 3.87
HT1080 cells treated with ethanolic molmol extract (234 pg/ml) for 3 hrs
(Mag.X750).
However, after 6 and 12 hours, a few cells can be seen, while after treatment with this 
extract (Figure 3.88), cells showed signs of disintegration, as illustrated by the 
appearance of blebs on the outer wall of the treated cells.
Treatment with ethanolic molmol for 24 hours resulted in further cell disintegration 
and fragmentation of DNA material, as illustrated by the appearance of more blebs on 
the outer wall of the treated cells (Figure 3.89).
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Figure 3.88
HT1080 cells treated with ethanolic molmol extract (234 pg/ml) for 12 hrs , showing 
signs of DNA fragmentation in the form of DAB stained peroxidase activity 
(formation of blebs, blue arrow) (Mag. X750).
#
Figure 3.89
HT1080 cells treated with ethanolic molmol extract (234 pg/ml) for 24 hrs, showing 
further signs of DNA fragmentation ( blue arrows) (Mag. X750).
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Treatment for 48 hours resulted in complete disintegration of HT1080 cells, and 
further disintegration of the DNA material in the form of DAB stained peroxidase 
activity (Figure 3.90).
\
Figure 3.90
HT1080 cells treated with ethanolic molmol extract for 48 hrs, showing further signs 
of DNA fragmentation (further formation of blebs, blue arrow) (Mag. X750).
B. Hexane Haddi Extract
HT1080 cells treated with hexane haddi extract for 3 hours did not show any sign of 
DNA strand breaks (Figure 3.91).
Cells treated for 6 and 12 hours with hexane haddi extract (Figure 3.92) showed clear 
signs of disintegration, as illustrated by the appearance o f blebs on the outer wall of 
the treated cells.
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Figure 3.91
HT1080 cells treated with hexane haddi extract for 3 hrs (Mag. X750). 
Note lack of any sign of DNA staining
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Figure 3.92
HT1080 cells treated with hexane haddi extract for 12 hrs, showing signs of DNA 
fragmentation (formation of blebs, blue arrow) (Mag. X750), in the form of DAB
positive staining.
Treatment with hexane haddi extract for 24 hours resulted in further cell 
disintegration and fragmentation of DNA material, as illustrated by the appearance of 
more blebs on the outer wall of the treated cells (Figure 3.93).
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Figure 3.93
HT1080 cells treated with hexane haddi extract for 24 hrs, showing further signs of 
DNA fragmentation (further formation of blebs, blue arrow) (Mag. X750), and DAB
staining.
Treatment of HT1080 cells with hexane haddi extract for 48 hours resulted in a 
complete disintegration of HT1080 cells and the further disintegration of the DNA 
material (Figure 3.94).
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Figure 3.94
HT1080 cells treated with hexane haddi extract for 48 hrs, showing further signs of 
DNA fragmentation (further formation of blebs, blue arrow) (Mag. X750) in terms of
DAB staining.
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3.12.2 Normal Fibroblast Cell Line
Cells grown in control medium, that is, untreated with molmol or haddi extracts 
showed normal cells, with intact nuclear material, as in Figure 3.95.
Figure 3.95
Untreated normal fibroblast cells (Mag. X750), showing no signs of DNA
fragmentation and staining.
A. Ethanolic Molmol (234 p-g/ml)
Normal fibroblast cells treated with ethanolic molmol for 3 hours did not show any 
sign of DNA break and DAB staining, which is the positive reaction indicating DNA 
fragmentation (Figure 3.96).
Treatment for 6 and 12 hours with this ethanolic molmol extract (Figure 3.97) did not 
show any signs of cellular disintegration.
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%Figure 3.96
Normal fibroblast cells treated with ethanolic molmol extract for 3 hrs (Mag. X750).
Figure 3.97
Normal fibroblast cells treated with ethanolic molmol extract for 12 hrs. No signs of 
DNA fragmentation and no lack of DAB staining (Mag. X750).
Treatment with ethanolic molmol for 24 hours only resulted in minor signs of 
fragmentation of DNA material, as illustrated by the appearance of few blebs on the 
outer wall of the treated cells (Figure 3.98).
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/Figure 3.98
Normal fibroblast cells treated with ethanolic molmol extract for 24 hrs, showing few 
signs of DNA fragmentation (formation of blebs, blue arrow). (Mag. X750).
Treatment for 48 hours also resulted in little disintegration of the DNA material 
(Figure 3.99).
Figure 3.99
Normal fibroblast cells treated with ethanolic molmol extract for 48 hrs, showing few 
signs of DNA fragmentation in terms of brown colour (formation of blebs, blue
arrow). (Mag. X750)
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B. Hexane Haddi Extract
Normal fibroblast cells treated with hexane haddi extract for 3 hours did not show any 
sign of DNA fragmentation and DAB staining (Figure 3.100).
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Figure 3.100
Normal fibroblast cells treated with hexane extracted haddi for 3hrs. (Mag. X750).
Normal fibroblast cells treated for 6 and 12 hour with hexane haddi extract (Figure 
3.101) showed no signs of disintegration and fragmentation of DNA material.
Figure 3.101
Normal fibroblast cells treated with hexane haddi extract for 12hrs, showing no signs
of DNA fragmentation. (Mag. X750).
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Treatment with hexane haddi extract for 24 hours did not result in any cell 
disintegration and fragmentation of DNA material (Figure 3.102).
Figure 3.102
Normal fibroblast cells treated with hexane haddi extract for 24 hrs, showing no signs
of DNA fragmentation (Mag. 750X).
Figure 3.103
Normal fibroblast cells treated with hexane haddi extract for 48 hrs, showing no signs
of DNA fragmentation (Mag. X750).
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Treatment of normal fibroblast cells with hexane haddi extract for 48 hours also did 
not result in any disintegration of normal fibroblast cells and disintegration of the 
DNA material (Figure 3.103).
To sum up, the TUNEL assay showed signs of DNA fragmentation after 12 hours of 
treatment of HT1080 cells with ethanolic molmol and hexane haddi extracts, which 
increased further with time. Nonetheless, these extracts did not induce any DNA 
fragmentation in the normal fibroblast cells.
3.13 Summary
The effects of molmol and haddi extracts on HT1080 and normal fibroblast cells can 
be illustrated as follows (Table 3.10).
Table 3.10 Summary of effects of molmol and haddi extracts
Untreated Ethanolic Molmol Hexane Haddi
HT1080 Normal
■ No DNA break strands 
after 3 hours
■ Cells disintegrated after 6 
and 12 hours (blebbing).
■ Further disintegration after 
24 hours (more blebbing)
■ Complete disintegration 
after 48 hours
■ No DNA break strands 
after 3 hours
■ Cells disintegrated after 6 
and 12 hours (blebbing).
■ Further disintegration after 
24 hours (more blebbing)
■ Complete disintegration 
after 48 hours
Normal
Fibroblast Normal
■ No DNA break strands 
after 3, 6 and 12 hours
■ No fragmentation of DNA 
after 24 hours
■ No disintegration after 48 
hours
■ No DNA break strands 
after 3, 6 and 12 hours
■ Minor fragmentation of 
DNA after 24 hours (little 
blebbing)
■ Little disintegration after 
48 hours
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However, when these cells were grown in a medium containing 666 jig/ml ethano 
molmol extract, there was a tendency to develop more apoptotic cells with tin 
increasing from 10 % apoptotic cells after 6 hours of incubation to 79.75% after 
hours. This trend was also observed when cells were grown in medium containi 
234 pg/ml ethanolic molmol extract, though lower percentages of apoptotic cells w< 
observed, increasing from 9 % after 6 hours of incubation to 65 % after 48 hoi 
(Figure 3.104).
Results in Figure 3.104 indicate that ethanolic molmol extract at the t  
concentrations led to higher apoptotic rates than the control after only 6 hours 
exposure. However, there was no effect after 3 hours at both concentrations, wh: 
gave 6% and 4.75%, respectively.
HT1080 cell grown in a control culture showed slight occurrence of apoptotic cells 
mean of 3% of a total 400 cells counted, in contrast to 97% non-apoptotic ce' 
However, when HT1080 cells were grown in a medium containing 666 pg/ml hex£ 
haddi extract, there was a tendency to develop more apoptotic cells with tir 
increasing from 13.5% apoptotic cells after 6 hours of incubation to 88.25% after 
hours. A similar observation was noted when cells were grown in a medii 
containing 201 pg/ml hexane haddi, though lower percentages of apoptotic cells w< 
observed, increasing from 11.25% after 6 hours of incubation to 67% after 48 hours
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(Figure 3.105). The results showed that there was no increased response at 3 hours 
for both 666pg/ml and 201pg/ml concentrations, which gave 4.75% and 6.5%, 
respectively.
Effect of Ethanolic Molmol extracted on HT1080 Cells
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Figure 3.104
HT1080 cells grown in control culture and in cultures containing 666, 234 pg/ml 
ethanolic molmol extract solution for 3, 6, 12, 24 and 48 hours (bars=standard error).
Effect of Hexane Haddi extracted on HT1080 Cells
666 |jg/ml 
201 pg/ml
12 hours 24 hours 48 hoursUntreated 3 hours
Figure 3.105
HT1080 cells grown in control culture and in cultures containing 666, 201 pg/ml 
hexane haddi extract solution for 3, 6, 12, 24 and 48 hours (bars=standard error).
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3.14.2 Normal Fibroblast Cells
Normal fibroblast cells grown in a control culture showed slight occurrence of 
apoptotic cells, a mean of 1.5% of a total 400 cells counted, in contrast to 98.5% non- 
apoptotic cells . When normal fibroblast cells were grown in a medium containing 
234 pg/ml ethanolic molmol extract, the production of apoptotic cells was much less 
than in the HT1080 cell line, increasing from 3.75% apoptotic cells after 3 hours of 
incubation to 21.75% after 48 hours (Figure 3.106).
Effect of Ethanolic Molmol extracted on Normal 
Fibroblast Cells
80 -
60
I  I
Untreated 3 hours 6 hours 12 hours 
T im e
24 hours 48 hours
Figure 3.106
Normal fibroblast cells grown in a control culture and in cultures containing 234 
pg/ml ethanolic molmol extract for 3, 6, 12, 24 and 48 hours (bars=standard error).
Normal fibroblast cells grown in a control culture also showed slight occurrence of 
apoptotic cells, a mean of 2.25% of a total 400 cells counted, in contrast to 97.75% 
non-apoptotic cells . When normal fibroblast cells were grown in a medium 
containing 201 pg/ml hexane haddi extract, the production of apoptotic cells was also 
much less than in the HT1080 cell line, increasing from 4% apoptotic cells after 3 
hours of incubation to 22.5% after 48 hours (Figure 3.107).
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Effect of Hexane Haddi extracted on Normal Fibroblast
Cells
90 -
80 -
70 -
1 60 -
S so  - | ■  201 H9/rnl |
3? 40
30 -
20 - 
10 - 
n _ .  Q 1 i nU
Untreated 3 hours 6 hours 12 hours 24 hours 48 hours 
T im e
Figure 3.107
Normal fibroblast cells grown in control culture and in culture containing 201 pg/ml 
hexane haddi extract for 3, 6, 12, 24 and 48 hours (bars=standard error).
It is noted that hexane haddi extract performed slightly better in producing apoptosis 
in HT1080 and normal fibroblast than ethanolic molmol extract, which showed that 
hexane haddi extract is a more potent apoptotic agent than ethanolic molmol extract.
Ethanolic molmol extract and hexane haddi extract treatments produced very similar 
results in terms of the percentages of apoptotic cells in HT1080. The difference was 
not significant.
Both solutions were not as effective against nomal fibroblast cells as they were 
against HT1080 cells. Hence, it can be said that in terms of apoptosis, molmol and 
haddi extracts targeted cancerous cells more than normal cells.
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3.15 S can n in g  E lec tro n  M icroscopy
3.15.1 S180 Cells
SEM revealed normal growth of untreated cells. The cells were found adhering to the 
substratum and interdigitating with each other through filopodial attachments. 
Delicate microvilli were also noted on the surfaces of viable cells (Figure 3.108A-B).
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Figure 3.108
SEM images of untreated SI 80 cells. Cells show surface microvilli (white arrow) and
filopodial attachments (yellow arrow).
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Exposure of S I80 cells for 12 hours to an ethanolic molmol extract at a concentration 
of 366 pg/ml resulted in symptoms of apoptosis, including signs of fragmentation 
(blebbing), and apoptotic bodies (Figure 109A,B,C,D).
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Figure 3.109 (A-B)
SEM images of SI 80 cells treated for 12 hours with 366 pg/ml ethanolic molmol
extract.
(A) Showing loss of most microvilli, loss of filopodial attachments and membrane 
blebbing.
(B) Showing loss of most microvilli, loss of filopodial attachments, and formation 
of apoptotic bodies (turquoise arrow).
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Figure 3.109 (C-D)
SEM images of S I80 cells treated for 12 hours with 366 pg/ml ethanolic molmol
extract.
(C) Showing loss of microvilli, loss of filopodial attachments, membrane blebbing 
(green arrow).
(D) Showing surface blebbing and membrane pitting.
Exposure of S I80 cells for 12 hours to a hexane haddi extract at a concentration of 
733 pg/ml also resulted in symptoms of apoptosis, including signs of fragmentation 
(blebbing), and apoptotic bodies (Figure 3.110A-D).
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Figure 3.110 (A-B)
SEM images of SI 80 cells treated for 12 hours with 733 pg/ml hexane haddi extract.
(A) Showing loss of most microvilli, loss of filopodial attachments, formation of 
apoptotic cells (orange arrow) and apoptotic bodies (green arrow).
(B) Showing loss of most microvilli, loss of filopodial attachments, and formation 
of apoptotic cells (orange arrow).
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Figure 3.110 (C-D)
SEM images of SI 80 cells treated for 12 hours with 733 pg/ml hexane haddi extract.
(C) Showing loss of microvilli, loss of filopodial attachments, membrane blebbing 
(green arrow) and apoptotic cells (orange arrow).
(D) Showing surface blebbing and membrane pitting.
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3.15.2 HT1080 Cells
SEM revealed normal growth of untreated cells. The cells were found adhering to the 
substratum and interdigitating with each other through filopodial attachments. 
However, delicate microvilli were not noted on the surfaces of viable cells (Figure 
3.111A,B,C).
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Figure 3.111 (A-B)
SEM images of untreated HT1080 cells. Cells are attached to the surface and show 
filopodial attachments (yellow arrow).
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Figure 3.111 (C)
SEM images of untreated HT1080 cells. Cells are attached to the surface and show 
filopodial atachments (yellow arrow).
HT1080 cells exposed to ethanolic molmol extract at a concentration of 336 pg/ml for 
12 hours showed symptoms of apoptosis, including the formation of apoptotic cells 
and apoptotic bodies, and fragmentation (blebbing) (Figure 3.112A-E).
— -
***• « «ir J &.„  * \  * »• y <  *
.  » .  * :  * *  /  *  • • '
f :  *  " T "  •—  _ V  «
. V. ? -
• .  1 • • ■ • r *
Acc^? Spot Magn • DeT Exp J I— ^ 2 0 0  pfQ-/*
^ • 2 0 * H f e / 3  0 ^ 90x  +  5 £  *42 0 12 ^  +PTl OSO^tM Mo^nol 369f^/ml%
• f v *
. v  *
Figure 3.112 (A)
SEM images of HT1080 cells treated for 12 hours with 366 pg/ml ethanolic molmol
extract.
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Figure 3.112(B-C)
SEM images of HT1080 cells treated for 12 hours with 366 pg/ml ethanolic molmol
extract.
(A&B) Showing formation of apoptotic cells (orange arrow) and apoptotic bodies 
(green arrow), and membrane blebbing (turquoise arrow). One cell shows a filopodial
attachment (yellow arrow).
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Figure 3.112 (D-E)
SEM images of HT1080 cells treated for 12 hours with 366 pg/ml ethanolic molmol
extract.
(C&D) Showing apoptotic cells (orange arrow) and apoptotic bodies (green 
arrow), and membrane blebbing (turquoise arrow).
(E) Showing apoptotic cell (orange arrow).
Exposure of HT1080 cells to hexane haddi extract (733 pg/ml) also resulted in 
symptoms of apoptosis, including the formation of apoptotic cells and apoptotic 
bodies, loss of filopodial attachments, and surface blebbing (Figure 3.113A-E).
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Figure 3.113 (A-B).
SEM images of HT1080 cells treated for 12 hours with 733 pg/ml hexane haddi
extract.
(A&B) Showing formation of apoptotic cells (orange arrow) and apoptotic bodies 
(green arrow), and membrane blebbing (turquoise arrow).
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Figure 3.113 (C-D)
SEM images of HT1080 cells treated for 12 hours with 733 pg/ml hexane haddi
extract.
(C) Showing apoptotic cells (orange arrow) and apoptotic bodies (green arrow), and
membrane blebbing (turquoise arrow).
(D) Showing apoptotic cell (orange arrow) and surface blebbing (turquoise arrow).
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EFigure 3.113 (E)
SEM images of HT1080 cells treated for 12 hours with 733 pg/ml hexane haddi
extract.
(E) Showing apoptotic cell (orange arrow) and surface blebbing (turquoise arrow).
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3.15.3 Normal Fibroblast Cells
Untreated normal fibroblast cells were found adhering to the substratum and 
interdigitating with each other through filopodial attachments. Delicate microvilli 
were also observed on the surfaces of viable cells (Figure 114A-D).
B
Figure 3.114 (A-B)
SEM images of untreated normal fibroblast cells, showing cell attachment to the 
substratum (A), surface microvilli (white arrow) and filopodial attachments (yellow
arrow).
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Figure 3.114(C-D)
SEM images of untreated normal fibroblast cells, showing cell attachment to the 
substratum (A), surface microvilli (white arrow) and filopodial attachments (yellow
arrow).
Exposure of normal fibroblast cells to an ethanolic molmol extract (366 pg/ml) for 12 
hours did not seem to have visible effects on these cells like those shown by S I80 
cells and HT1080 cells treated with this extract for a similar period of time (Figure 
3.115A-D).
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Figure 3.115 (A-B)
SEM images of normal fibroblast cells treated with ethanolic molmol extract (366 
pg/ml), showing cell attachment to the substratum, and filopodial attachments.
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Figure 3.115(C-D)
SEM images of normal fibroblast cells treated with ethanolic molmol extract (366 
Hg/ml), also showing cell attachment to the substratum, and filopodial attachments.
Exposure of normal fibroblast cells to hexane haddi extract (733 pg/ml) for 12 hours 
also did not seem to have visible effects on these cells like those shown by S I80 cells 
and HT1080 cells treated with this extract for a similar period of time (Figure 3.116A- 
C).
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Figure 3.116 (A-B)
SEM images of normal fibroblast cells treated with hexane haddi extract (733 pg/ml), 
showing cell attachment to the substratum, and filopodial attachments.
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c
Figure 3.116(C)
SEM images of normal fibroblast cells treated with hexane haddi extract (733 pg/ml), 
showing cell attachment to the substratum, and filopodial attachments.
3.16 Summary
The effects of molmol and haddi extracts on the three cell lines used in this study can 
be illustrated as follows (Table 3.11).
Table 3.11.Summary of effects of molmol and haddi extracts
Treatments in Respect of Apoptosis Formation
Cell Line Untreated Ethanolic Molmol Hexane Haddi
Normal
Fibroblasts None
• Some low level of 
apoptosis
• Low level of apoptosis
S180 None
• Loss of most microvilli
• Loss of filopodial 
attachements
• Blebbing and membrane 
pitting
• Hence, medium 
apoptosis
• Loss of most microvilli
• Loss of filopodial 
attachements
• Blebbing and membrane 
pitting
• Formation of apoptotic 
cells and apoptotic bodies
• Hence, high apoptosis
HT1080 None
• Formation of apoptotic 
bodies
• Blebbing
• Loss of most filopodial 
attachments
• Hence, high apoptosis
• Formation of apoptotic 
bodies
• Blebbing
• Loss of most filopodial 
attachments
• Hence, high apoptosis
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3.17 Transmission Electron Microscopy (TEM): HT1080 Cells
3.17.1 Effects of Ethanolic Molmol
TEM revealed normal growth of untreated cells. The cells were found adhering to the 
substratum, and looked healthy, with clearly defined internal organelles. The cells 
interdigitated with each other through filopodial attachments, but delicate microvilli were 
not noted on the surfaces of viable cells. At higher magnification nucleus, nucleolus, 
mitochondria and lipids, as well as nuclear membrane, are clearly identified.
However, HT1080 cells exposed to ethanolic molmol extract at a concentration of 234 
pg/ml for 12 hours showed symptoms of apoptosis, including the formation of apoptotic 
bodies, and fragmentation (blebbing) (Figure 3.17). Cells also showed chromatin 
margination and loss of filopodial attachments.
Higher magnification of HT1080 cells treated with ethanolic molmol at 234 pg/ml 
(Figure 3.18) clearly illustrates the formation of apoptotic cells, blebs on these cells, and 
the formation of apoptotic bodies. It also shows the condensation of chromatin bodies 
alongside the nuclear membrane.
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Figure 3.117
Low magnification TEM showing treated HT1080 cells and an apoptotic cell with blebs 
and nucleus exhibiting highly condensed chromatin alongside the nuclear membrane. 
Magnification : 2500X Treatment: Ethanolic Molmol
Scale bar : 3jim Time :12hrs Concentration 234 p,g/ml
Figure 3.118
High magnification TEM of Figure 3.117 showing an apoptotic cell with blebs (red 
arrows) and apoptotic body (green arrow). Nucleus exhibits highly condensed chromatin 
alongside the nuclear membrane (yellow arrows).
Magnification : 5000X Treatm ent: Ethanolic Molmol
Scale bar : ljam Time :12hrs Concentration 234 jag/ml
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Figure 3.119 clearly shows the margination of the chromatin within the nuclei of HT1080 
cells treated with ethanolic molmol at a concentration of 234 pg/ml for 12 hours. It also 
shows the vacuolation of the cytoplasm, and the loss of filaments.
Figure 3.119
Low magnification TEM showing treated HT1080 cells with signs of chromatin 
margination (yellow arrows), cytoplasm vacuolation (orange arrow) and loss of filopodial
filaments.
Magnification : 2000X Treatment: Ethanolic Molmol
Scale bar : 2jLim Time :12hrs Concentration 234 pg/ml
Figure 3.120 shows an enlarged view of an apoptotic HT1080 cell treated as above, with 
blebs and condensation of the chromatin material alongside the nuclear membrane.
Figure 3.121 shows a high magnification electron micrograph illustrating detailed fine 
structure of an apoptotic cell. The nucleus clearly exhibits highly condensed chromatin 
margination alongside the nuclear membrane, swollen mitochondria, and some debris. 
The latter might be a sign of necrosis.
175
Figure 3.120
High magnification TEM of Figure 3.119 showing an apoptotic cell with blebs (orange 
arrows). Nucleus exhibits highly condensed chromatin alongside the nuclear membrane
(yellow arrows).
Magnification : 5000X Treatm ent: Ethanolic Molmol
Scale bar : lfim Time: 12hrs Concentration 234 pg/ml
_  a .-.:.., --..i.
Figure3.121
High magnification TEM showing detailed fine structure of an apoptotic cell. Nucleus 
exhibits highly condensed chromatin margination alongside the nuclear membrane 
(yellow arrows). Mitochondria appear swollen (pink arrows). Some debris can also be
noticed.
Magnification : 8000X Treatm ent: Ethanolic Molmol
Scale bar : ljim Time : 12hrs Concentration 234 jag/ml
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HT1080 cells exposed to ethanolic molmol extract at a concentration of 666 pg/ml for 12 
hours showed more advanced symptoms of apoptosis than those exposed to 234 pg/ml. 
The apoptotic cells were covered with blebbings all over the outer cell membrane, and 
several apoptotic bodies can be observed. Cytoplasmic vacuoles are also evident (Figure 
3.122).
Figure 3.122
High magnification TEM of treated HT1080 cells showing an apoptotic cell with blebs 
(red arrows), apoptotic bodies (green arrows), vacuoles (blue arrows) and condensed 
chromatin margination (yellow arrows).
Magnification : 5000X Treatm ent: Ethanolic Molmol
Scale bar : 1pm Time :12hrs Concentration 666 jag/ml
Figure 3.123 shows a damaged HT1080 cell treated with 666 pg/ml ethanolic extacted 
molmol extract with clear indication of condensed chromatin margination alongside the 
nuclear membrane, blebbings of the outer membrane, and vacuolation.
Figure 3.124 illustrates an HT1080 cell treated with ethanolic molmol at 666 pg/ml for 
12 hours showing indications of damage to the cell membrane and evident vacuolation of 
the cytoplasm. The nucleus shows some condensed chromatin. All these indications 
suggest apoptosis.
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Figure 3.123
High magnification TEM of HT1080 cells showing signs of damage with clear indication 
of condensed chromatin margination alongside the nuclear membrane (yellow arrows), 
and blebbings of the outer membrane (red arrows). Vacuolation is evident (blue arrows). 
Magnification : 6300X Treatm ent: Ethanolic Molmol
Scale bar : lpm Time : 12hrs Concentration 666 pg/ml
*
Figure 3.124
High magnification TEM showing a treated cell with some indications of damage to the 
cell membrane (light green arrows) and vacuolation (blue arrows) of the rough 
endoplasmic reticulum (black arrow). Nucleus shows some condensed chromatin (yellow 
arrows) that may suggest that the cell is apoptotic.
Magnification : 6300X Treatm ent: Ethanolic Molmol
Scale bar : 1pm Time : 12hrs Concentration 666 pg/ml
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3.17.2 Effects of Hexane Haddi
HT1080 cells treated with 201 pg/ml hexane haddi extract solution showed signs of 
extensive damage to the cells (Figure 3.125). The outer cell membranes of some cells 
show signs of disintegration, suggesting necrosis. Other cells are apoptotic, with blebs on 
the outer cell membrane. This treatment also resulted in the formation of apoptotic 
bodies. Condensed chromatin alongside the nuclear membrane can also be seen.
Figure 3.125
Low magnification TEM showing treated HT1080 cells with signs of extensive damage 
to cells. Some are necrotic with disintegrated cell membranes (orange arrows). 
Apoptotic cells, with blebs (red arrows) and apoptotic bodies are formed (green arrows). 
Condensed chromatin (yellow arrows) alongside the nucleus membrane. 
Magnification : 2000X Treatm ent: Hexane Haddi
Scale bar : 3pm Time : 12hrs Concentration 201 pg/ml
Figure 3.126 shows two apoptotic cells, in which the nuclei appear to be damaged, with 
highly condensed chromatin alongside the nuclear membrane. The figure also shows loss 
of filaments and the formation of vacuoles.
Figure 3.127 shows a damaged cell, with highly condensed chromatin alongside the 
nuclear membrane. The mitochondria seem to have swollen.
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Figure 3.126
High magnification TEM showing apoptotic cells. The nucleus appears damaged, with 
highly condensed chromatin alongside the nuclear membrane (yellow arrows). There are 
signs of loss of filopodia and the formation of vacuoles (blue arrows) 
Magnification : 5000X Treatm ent: Hexane.Haddi
Scale bar : 1pm Time :12hrs Concentration 201 pg/ml
Figure 3.127
High magnification TEM showing a damaged cell. The nucleus appears damaged with 
highly condensed chromatin alongside the membrane (yellow arrows). The mitochondria 
are swollen ( pink arrows). Note adjacent cell debris (dark red arrow) 
Magnification : 5000X Treatm ent: Hexane Haddi
Scale bar :1pm Time: 12hrs Concentration 201 pg/ml
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Figure 3.128 shows a cell with signs of phagocytosis. The nucleus appears damaged, 
with some chromatin margination. Small vacuoles are also seen in the outer layer of the 
cytoplasm.
Figure 3.128
High magnification TEM showing a cell with phagocytosis (black arrow). Nucleus 
appears damaged, with some chromatin margination (yellow arrows). Cytoplasm with
small vacuoles
Magnification : 4000X Treatm ent: Hexane Haddi
Scale bar :1pm  Time :12hrs Concentration 201 pg/ml
Figure 3.129 shows HT1080 cells treated with hexane haddi extract at a concentration of 
666 pg/ml. Cells show signs of extensive damage, some of which are necrotic cells. 
Vacuolation and some debris are clearly visible, and the nucleus shows chromatin 
margination. Some cells appear to have phagocytosed cellular debris from the medium. 
Loss of cytoplasmic material into the medium is evident across the micrograph
Figure 3.130 shows an enlarged damaged HT1080 cell treated with hexane haddi extract 
at 666 pg/ml. The cytoplasm is highly vacuolated, and the nucleus shows chromatin 
margination.
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Figure 3.129
Low magnification TEM showing treated HT1080 cells with signs of extensive damage, 
and some swollen necrotic cells (light blue arrows). Vacuolation (blue arrows) and some 
debris are clearly visible. Some chromatin margination can be seen (yellow arrows).
Loss of cytoplasmic material evident.
Magnification : 2000X Treatm ent: Hexane Haddi
Scale bar : 2pm Time : 12hrs Concentration 666 pg/ml
Figure 3.130
High magnification TEM showing a damaged cell with large clear vaculations (blue
arrows).
Magnification : 4000X Treatm ent: Hexane Haddi
Scale bar : 1pm Time :12hrs Concentration 666 pg/ml
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Figure 3.131 shows an enlarged necrotic HT1080 cell with some debris. The cell 
membrane also shows signs of disintegration. Cytoplasmic debris is also evident.
Figure 3.131
High magnification TEM of Figure 3.130 showing an enlarged necrotic cell with some 
debris. The cell membrane is disintegrated. Cytoplasmic debris is clearly seen 
Magnification : 5000X Treatm ent: Hexane Haddi
Scale bar : l^im Time :12hrs Concentration 666 jig/ml
3.18 Summary
Results of the TEM investigation are summarised in Table 3.12. It can be concluded that 
ethanolic molmol extract resulted in damaging treated HT1080 cells at both 
concentrations used. However, damage to these cells when exposed to hexane haddi 
extract seemed to have been more extensive, with the formation of much cytoplasmic 
debris and disintegration of cells membranes also, at both concentrations. Hence, hexane 
haddi extract is more effective than ethanolic molmol extract. However, it seems that 
even the lower haddi extract concentration is very potent, leading to a potentially necrotic 
impact on the cells.
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Table 3.12. Summary of effects of ethanolic molmol and hexane haddi at two 
concentrations on HT1080 cells
Treatments in Respect of Apoptosis Formation
Untreated Ethanolic Molmol Hexane Haddi
Concentration 234 pg/ml Concentration 201g/ml
• Formation of apoptotic cells • Extensive damage to cells
• Blebbing • Disintegration of cell membranes
• Condensation of chromatin • Formation of apoptotic cells
alongside nuclear membrane 
(chromatin margination) • Blebbing
• Formation of apoptotic bodies • Formation of apoptotic bodies
None • Cytoplasmic vacuolation • Chromatin margination
• Loss of filopodia • Loss of filopodia
• Swollen mitochondria • Cytoplasmic vacuolation
• Cytoplasmic debris • Swollen mitochondria
• Formation of cell debris
• Phagocytosis
• Probably secondary necrosis
Concentration 666 pg/ml Concentration 666 pg/ml
• Formation of apoptotic cells • Extensive damage to cells
• Blebbing • Cytoplasmic vacuolation
• Formation of apoptotic bodies • Formation of cell debris
• Cytoplasmic vacuolation • Chromatin margination
• Chromatin margination. • Disintegration of cell membranes
• Damaged cell membranes • Necrosis
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3.19 Annexin V Assay to Detect Apoptotic Plasma Membrane 
Changes
3.19.1 S180 Cells
Control live untreated S I80 cells did not show changes in the membrane 
phosphatidylserine asymmetry. Accordingly, they were not labelled with Annexin V- 
FITC (Figure 3.132A-B). Only a few cells showed positive Annexin V-FITC 
reaction, appearing bright apple green on the cell membrane surface. This is a very 
low percentage of apoptosis shown to occur in cells grown in control cultures. 
Control cells did not show signs of necrosis, as none appeared red with propidium 
iodide.
S I80 cells grown in culture containing 666 pg/ml ethanolic molmol extract for 12 and 
24 hours also showed signs of induced apoptosis (Figure 3.133A-B), and showed 
positive results for changes in membrane phosphatidylserine asymmetry. The 
majority of these cells appeared green with Annexin V-FITC, showing positive 
labelling on the cell surface and possibly cytoplasm and nuclear envelope. Some cells 
appeared red with PI, possibly indicating some secondary necrosis after the death of 
apoptotic cells and changes in permeability of the plasma membrane, which allowed 
the penetration of PI into the cells, staining them red.
S I80 cells grown in cultures containing 234 pg/ml (LC50) ethanolic molmol extract 
for 12 and 24 hours showed signs of apoptosis (Figure 3.134A-B) and also showed 
positive results for changes in membrane phosphatidylserine asymmetry. Most of the 
cells exposed to Annexin V-FITC showed positive labelling on the cell surface. Some 
apoptotic cells also showed Annexin V distribution within the cytoplasm. Only a few 
cells appeared red, possibly indicating some secondary necrosis, as explained above.
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Figure 3.132
Fluorescence microscope images o f untreated (control) SI 80 cells after treatment with 
fluorescein isothyiocyanate (Mag.X75) and propidium iodide (PI). A few late 
apoptotic cells can be seen labelled with FITC and appearing bright apple green on 
the cell membrane surface (white arrow). Artefact (black arrow)
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Figure 3.133
Fluorescence microscope images o f S I80 cells treated with 666 pg/ml ethanolic 
molmol extract for 12 hours (A) and 24 hours (B) after treatment with fluorescein 
isothyiocyanate and propidium iodide (IP) (Mag. X I20).
(A) 12 hour treatment: Apoptotic cells (white arrows) showing even Annexin V 
distribution on the cell membrane. A few cells show signs of secondary necrosis (red
stain with PI) (red arrows).
(B) 24 hour treatment: Apoptotic cells (white arrow), but some showing signs of
secondary necrosis (red arrows).
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Figure 3.134
Fluorescence microscope images o f S 180 cells treated with 234 pg/ml ethanolic 
molmol extract for 12 hours (A) and 24 Hours (B) after treatment with fluorescein 
isothyiocyanate (FITC) and propidium iodide (PI). (Mag.X75)
(A) 12 hour treatment. Apoptotic cells (white arrows) showing concentration of 
Annexin V on the cell membrane. One cell shows signs of secondary necrosis
(labelled red with PI) (red arrows).
(B) 24 hour treatment. Apoptotic cells (white arrows) showing concentration of
Annexin V on the cell membrane and apparent distribution within the 
cytoplasm in some cells. Only a few cells show signs of secondary necrosis
(red arrows) and ‘rafting’
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S I80 cells grown in culture containing 666 pg/ml hexane haddi extract for 12 and 24 
hours (Figures 3.135A-B) showed positive results for changes in membrane 
phosphatidylserine asymmetry. The majority of these cells appeared green with 
Annexin V-FITC, showing positive labelling on the cell surface and within the 
cytoplasm. Some cells stained red with PI, possibly indicating secondary necrosis.
S I80 cells grown in culture containing 201 pg/ml (LC50) hexane haddi extract for 12 
and 24 hours (Figures 3.136A-B) also showed positive results for changes in 
membrane phosphatidylserine asymmetry. The majority of these cells appeared green 
with Annexin V-FITC, showing positive labelling on the cell surface as well as within 
the cytoplasm. Some cells stained red with PI, possibly indicating secondary necrosis.
3.19.2 HT1080 Cells
Control live untreated HT1080 cells did not show changes in the membrane 
phosphatidylserine asymmetry. Hence, they were not labelled with Annexin V-FITC 
(Figures 3.137A-B). Only a few cells showed positive Annexin V-FITC labelling, 
appearing bright apple green on cell membrane surface. This reflects a very low 
percentage of natural apoptosis, which has also been shown to occur in these cells 
grown in control cultures. No control cells showed signs of necrosis, since none was 
stained red with propidium iodide.
HT1080 cells grown in culture containing 666 pg/ml ethanolic molmol extract for 12 
and 24 hours (Figure 3.138A-B), hence undergoing induced apoptosis, showed 
positive results for changes in membrane phosphatidylserine asymmetry. Cells 
appeared yellow green with Annexin V-FITC, showing positive labelling on the cell 
surface and possibly within the cytoplasm. None was stained red, indicating negative 
test for PI.
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Figure 3.135
Fluorescence microscope images o f DNA in S I80 cells treated with 666 pg/ml hexane 
haddi extract for 12 hours (A) and 24 hours (B) after treatment with fluorescein 
isothyiocyanate and propidium iodide (PI). Mag.X120
(A) 12 hour treatment: Apoptotic cells (white arrows) showing concentration of 
Annexin V on the cell membrane. A few cells show signs of secondary necrosis 
(red labelling with PI) (red arrows).
(B) 24 hour treatment: Apoptotic cells (white arrows), a few showing signs of
secondary necrosis (red arrows).
Figure 3.136
Fluorescence microscope images o f SI 80 cells treated with 201 pg/ml hexane haddi 
extract for 12 hours (A) and 24 hours (B) after treatment with fluorescein 
isothyiocyanate (FITC) and propidium iodide (PI). (Mag.X120)
(A) 12 hour treatment: Apoptotic cells (white arrows) showing concentration of 
Annexin V on the cell membrane. A few cells show signs of secondary necrosis (red
labelling with PI) (red arrows).
(B) 24 hour treatment: Apoptotic cells (white arrows), a few showing signs of
secondary necrosis (red arrows).
AFigure 3.137
Fluorescence microscope images of untreated (control) HT1080 cells after treatment 
with fluorescein isothyiocyanate (FITC) and propidium iodide. (Mag.X75).
A few apoptotic cells can be seen labelled with FITC, appearing bright apple green 
on cell membrane surface (white arrow).
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Figure 3.138
Fluorescent microscope images of HT1080 cells treated with 666 pg/ml ethanolic 
molmol extract for 12 hours (A) and 24 hours (B) after treatment with fluorescein 
isothyiocyanate (FITC) and propidium iodide (PI). (Mag.X120)
(A) 12 hour treatment: Apoptotic cells show Annexin V distribution on the cell 
membrane, but mainly apparent distribution within the cytoplasms.
(B) 24 hour treatment: As in A.
HT1080 cells grown in culture containing 234 pg/ml ethanolic molmol extract for 12 
and 24 hours (Figures 3.139) also showed positive results for changes in membrane 
phosphatidylserine asymmetry. Cells stained yellow green with Annexin V-FITC 
showing positive labelling on the cell surface, and the majority showed even
AnnexinV distribution within the cytoplasm. None showed positive test for PI, that 
is, necrosis was not noted. Some cells showed blebs on the outer membrane.
Fluorescence microscope images o f HT1080 cells treated with 234 pg/ml ethanolic 
molmol extract for 12 hours (A) and 24 hours (B) after treatment with fluorescein 
isothyiocyanate (FITC) and propidium iodide (PI). (Mag.X120).
(A) 12 hour treatment: Apoptotic cells showing Annexin V distribution on the cell 
membrane, but mainly apparent distribution within the cytoplasm.
(B) 24 hour treatment: As in A. Some cells show blebs on the outer membrane
(green arrow).
A
B
Figure 3.139
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HT1080 cells grown in culture containing 666 fig/ml hexane haddi for 12 and 24 
hours (Figure 3.140A-B) also showed positive results for changes in membrane 
phosphatidylserine asymmetry. Cells stained green with Annexin V FITC, showing 
positive labelling on the cell surface. None showed positive for PI, that is, necrosis 
was not noted.
HT1080 cells grown in culture containing 201 pg/ml hexane haddi extract for 12 and 
24 hours (Figures 3.141A-B) also showed positive results for changes in membrane 
phosphatidylserine asymmetry. Cells stained green with Annexin V FITC showing 
positive labelling on the cell surface. A number of cells (around 2-3% of the total) 
showed positive test for PI, suggesting secondary necrosis.
3.20 Summary
The effects of molmol and haddi extracts on the S I80 and HT1080 cell lines used in 
this study are presented in Table 3.13. Results clearly show that the extracts of both 
plants, even at the LC50 concentrations, were very effective in initiating apoptosis in 
S180 and TH1080 cell lines.
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Figure 3.140
Fluorescence microscope images of HT1080 cells treated with 666 pg/ml hexane 
haddi extract for 12 hours (A) and 24 hours (B) after treatment with fluorescein 
isothyiocyanate (FITC) and propidium iodide (PI). (Mag.75X)
(A) 12 hour treatment: Apoptotic cells showing Annexin V distribution on cell
membrane
(B) 24 hour treatment: Apoptotic cells mainly showing apparent distribution of
Annexin V within cytoplasm.
Figure 3.141
Fluorescence microscope images of HT1080 cells treated with 201 pg/ml hexane 
haddi extract for 12 hours (A) and 24 hours (B) after treatment with fluorescein 
isothyiocyanate (FITC) and propidium iodide (PI). (Mag.l20X)
(A) 12 hour treatment: Apoptotic cells showing Annexin V distribution on cell 
membrane (white arrows). Some cells show positive PI test (red arrows).
(B) 24 hour treatment: As in A.
Table 3.13 Summary of effects of molmol and haddi extracts on SI 80 and HT1080 cells using an Annexin V assay.
Untreated Ethanolic Molmol 
666 fig/ml
Ethanolic Molmol 
234 jig/ml (LCso)
Hexane Haddi 
666 iig/ml
, Hexane Haddi 
201 iig/ml (LC50)
S180
• No 
changes
■ Signs of induced 
apoptosis.
■ Positive labelling on 
cell surface (green 
yellow
fluorescence).
■ Secondary 
necrosis/changes.
■ Changes in 
phsophatidylserine 
asymmetry.
■ Signs of induced 
apoptosis.
■ Positive labelling on 
cell surface (green 
yellow fluorescence).
■ Some secondary 
necrosis.
■ Changes in 
phsophatidylserine 
asymmetry.
■ Signs of induced 
apoptosis.
■ Positive labelling on 
cell surface (green 
yellow fluorescence).
■ Some secondary 
necrosis.
■ Changes in 
phosphatidylserine 
asymmetry.
■ Signs of induced 
apoptosis.
■ Positive labelling on 
cell surface (green 
yellow fluorescence).
■ Some secondary 
necrosis.
■ Changes in 
phosphatidylserine 
asymmetry.
■ Positive test for PI 
(red fluorescence).
HT1080
■ No 
changes
■ Signs of induced 
apoptosis.
■ Some positive 
labelling on cell 
surface.
■ No necrosis.
■ Changes in 
phsophatidylserine 
asymmetry.
■ Negative test for PI
■ Positive labelling on 
cell surface.
■ No necrosis
■ Changes in phsopha­
tidylserine asymmetry.
■ Negative test for PI
■ Positive labelling on 
cell surface.
■ No necrosis
■ Changes in phsopha­
tidylserine asymmetry.
■ Negative test for PI
■ Positive labelling on 
cell surface.
■ Secondary necrosis
■ Changes in 
phsophatidylserine 
asymmetry.
■ Positive test for PI. 
(red fluorescence).
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3.21 MTT Viability Assay Using Trans-fj-Ocimene and y-Bisabolene
The S I80 cells and HT1080 cells were treated with different concentrations of trans- 
/?-ocimene and y-bisabolene, both components of haddi (C. guidotti) extracts, over 
periods of 24, 48 and 72 hours. After this time period, the MTT solution was added to 
the growth media to measure the mean optical density, and also to measure the 
percentage viability. The mean optical density was used to calculate the percentage 
toxicity, as explained in Chapter Two (Section 2.9.3), then the percentage viability 
was estimated by subtracting percentage toxicity from 100 (see Section 2.9.3). 
Therefore, mean percentage viability has been plotted against control and 
concentrations used 24, 48 and 72 hours after treatment, in order to illustrate whether 
or not the addition of the various concentration of trans-fi-ocirnQnc and y-bisabolene 
at various concentrations will have any effect on the growth of the S I80 and HT1080 
cell lines. All experiments were conducted against a control consisting of the cells 
and the growth medium.
All experiments were run three times in triplicates, i.e., nine readings were taken.
A preliminary study of the chemistry of the haddi (C. guidotti) extracts was performed 
by Mr Ahmed Ali using gc-ms (Personal communication in the School of Biosciences, 
2003). Identification of individual peaks was made by comparing their mass spectra to 
those stored in the two libraries (NIST and WILEY). Gc-ms analysis revealed a 
difference in the chemistry of the hexane and ethanol extracts of haddi. He found the 
major components in the hexane extract to be /nms-/?-ocimene, a-santalene, trans-a- 
bergamotene and a-bisabolene. The ethanol extract of haddi revealed a-santalene, trans- 
cr-bergamotene and a-bisabolene to be the major compounds. The difference in the two
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total ion current (TIC) chromatographs is the omission of the trans-fi-ocimene peak in 
the ethanol extract, as shown in Figure 3.142.
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Figure 3.142
Total Ion Current Chromatograms of (A) Haddi Ethanol Extract, and (B) Haddi
Hexane Extract 
(Reproduced by kind permission of Mr Ahmed Ali, 2003).
By comparing the two TIC chromatograms and using a process of elimination, it 
could be deduced that the presence of trans-fi-ocimene may play a significant role in 
the higher cytotoxic activity of the hexane extract of haddi compared to the ethanol 
extract. This was found to be the case for both the S I80 and the HT1080 cancer cell 
cultures (see Tables 3.14 to 3.17).
Using the MTT assay enabled us to confirm the cytotoxic properties of trans-p- 
ocimene against both the S 180 murine sarcoma and the human fibrosarcoma cancer 
cells.
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As expected, Jnms,-/?-ocimene was found to be more active against the less aggressive 
S I80 cancer cells, with a LC50 of 65mM, compared to 95mM for the HT1080 cancer 
cells.
Although y-bisabolene is a minor component of haddi, due to the commercial 
difficulties in procuring the other major components (a-santalene and a-bisabolene), 
it was decided to test the cytotoxic properties of y-bisabolene using the MTT assay. 
Surprisingly, y-bisabolene was found to be even more active against cancer cells than 
trans-fi-ocimenQ. As expected, y-bisabolene had a greater cytotoxic activity against 
S I80 cancer cells (LC50 5 mM) than the more aggressive HT1080 cancer cells (LC50 
lOmM).
It can be concluded, therefore, that these two terpenoid compounds had contributed 
significantly to the cytotoxic properties of the haddi hexane extract, against both SI 80 
and HT1080 cancer cells.
The myrrh extracts contain a lot more complicated compounds than haddi, called 
furano-sesquiterpenes (Mr Ahmed Ali, Personal communication, 2003). Again, these 
are not commercially available, and hence were unavailable for testing.
3.21.1 S180 Cell Line
The effect of trans-fi-ocimem and y-bisabolene on the viability of S I80 cells were 
illustrated using the following treatments:
A. Trans -/?-ocimene. The viability assay of these cells was undertaken using five 
different dilutions: 50, 100, 150, 200 and 250 mM. Results are presented in 
Figure 3.143.
B. y-bisabolene. The viability of S I80 cells was also tested in five concentrations, 
as indicated above. Results are presented in Figure 3.144.
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A. Trans-fl-Ocimene
Figure 3.143 clearly illustrates that the apparent cytotoxicity of trans-fi-ocimQne to 
S I80 cells increased with increasing concentrations, especially after 24 hours of 
exposure to this biochemical. After 48 and 72 hours of exposure, viability remained 
at 5% at the two highest concentrations, though it increased after this time at the 100 
mM concentration. However, apparent toxicity of the 50 mM trans-p-ocimene 
increased after 48 hours, but decreased slightly after 72 hours (though higher than 
after 24 hours).
Viability results showed, as expected, the reverse trend, decreasing with the 
increasing concentrations of trans -ft-ocimene (Table 3.14 and Figure 3.143).
Determination o f  Cell Viability (MTT Assay) Ocimene After 24, 48and 72 Hours, Using SI 80 Cells
100
■% 24hrs - * - %  48hrs - * - %  72hrs
50 100 150 200 250 300
Concentration (mM)
Figure 3.143
Percentage viability of S 180 cells in five different concentrations of trans-p-ocimene
(n=9, bars=standard error).
B. y-Bisabolene
In contrast to exposure to trans-P-ocimene, exposure of S I80 cells to y-bisabolene 
resulted in lower percentage viability at lower concentrations. Lowest percentage
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viabilities were obtained after exposure to 50 and 100 mM y-bisabolene (Figure 
3.144). However, after 72 hours of exposure to y-bisabolene, percentage viabilities 
were higher in all concentrations than at 48 hours of exposure to this biochemical, 
especially at the higher concentrations (PO.OOl).
Determination o f  Cell Viability (M TT A ssay) Gamma Bisabolene After 24, 
48and 72 Hours, Using S I 80 Cells
% 24hrs % 48hrs % 72hrs
100 150
Concentration (mM )
200 250 300
Figure 3.144
Percentage viability of SI 80 cells in five different concentrations of y-bisabolene.
(n=9, bars=standard error)
3.21.2 HT1080 Cells
The effects of trans-fi-ocimene and y-bisabolene on the viability of HT1080 cells were 
also illustrated using treatments similar to those reported for the treatment of S I80 
cells.
A. Trans-ft-Ocimene
HT1080 cell viability in medium containing trans-p-ocimene decreased with 
increasing concentration after 24 hours of exposure (Figure 3.145). Viability also 
decreased after 48 hours of exposure, except at the lowest concentration (50 mM),
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where it seems that trans-P-ocimem  at this concentration was not toxic to these cells. 
After 72 hours of exposure, viability at the two highest concentrations (200 and 250 
mM) remained at the 48 hours level, but increased at the three lowest concentrations, 
and even active growth was noted at the 50 mM trans-p-ocimene concentration 
(105% viability) (Figure 3.145). This indicates a mitogenic effect and an increase in 
the number of cells above that recorded at the start of the experiment.
Accordingly, trans-P-ooimQUQ at 50 mM concentration did not have significant toxic 
effect on HT1080 cells after 48 hours of exposure, rather it enhanced cell division and 
resulted in higher viability percentage than at the end of the 24 hour exposure.
B. y-Bisabolene
HT1080 cell viability exposed to y-bisabolene generally increased with increasing 
concentrations throughout the experimental period (Figure 3.146). However, 
exposure of HT1080 cells to all concentrations for 72 hours resulted in higher 
viabilities than after 48 hours, though still lower than after the 24 hour exposure to 
this biochemical (PO.OOl).
3.22 Summary
Results of the MTT investigation are summarised in Tables 3.14-3.17. It can be 
concluded that both of trans-p-ocimene and y-bisabolene are active against both S I80 
and HT1080 cell lines at the five different concentrations and times tested. However, 
the apparent toxicity of /nms-/?-ocimene is different when applied at low 
concentrations, and is less effective than y-bisabolene, which induces apoptosis 
earlier. Hence, y-bisabolene is more effective than trans-P-ocimene. However, it 
seems that even the lower y-bisabolene concentrations are very active in killing cells 
at the lower concentrations of 5 mM for both S I80 and HT1080.
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Determination o f  Cell Viability (M TT A ssay) Ocimene After 24, 48and 72 
Hours, U sing H T 1080 Cells
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Concentration (mM )
Figure 3.145
Percentage viability of HT1080 cells in five different concentrations of trans-p- 
ocimene. (n=9, bars=standard error)
Determination o f  Cell Viability (M TT A ssay) Gamma Bisabolene After 24, 48  
and 72 Hours, U sing H T 1080 Cells
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Figure 3.146
Percentage viability of HT1080 cells in five different concentrations of y-bisabolene.
(n=9, bars=standard error)
205
Table 3.14 Determination of Cell Viability of Trans-fi-ocimene after 24, 48 and
72 hours on S I80 Cells
Concentration
(mM) % Viability
24 hours 48 hours 72 hours
250 8±2 5 ± 0 5 ±1
200 13±2 5±0 5 ±1
150 18± 8 13±10 13 ±12
100 31=1= 6 18± 5 12 ±3
50 81±5 72 ±2 78 ±3
* n = 3 replicates of 3
Table 3.15 Determination of Cell Viability of y-bisabolene after 24, 4 
hours on S I80 Cells
Concentration
(mM) % Viability
24 hours 48 hours 72 hours
250 11±0 12±1 14±1
200 10±0 7±1 11±1
150 8 ± 0 7±1 9±1
100 7±0 5±0 6±0
50 7±1 5±0 6±0
* n = 3 replicates of 3
Table 3.16 Determination of Cell Viability of trans-/3-ocimene after  ^
72 hours on HT1080 Cells
Concentration
(mM) % Viability
24 hours 48 hours 72 hours
250 33±2 10± 0 10±1
200 38± 2 10±0 10±1
150 57±8 29±10 36 ±12
100 84± 6 67 ± 5 85 ±3
50 99±5 100 ±2 105 ±3
* n = 3 replicates of 3
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?Table 3.17 Determination of Cell Viability of y-bisabolene after 24, 48 and 72
hours on HT1080 Cells
Concentration
(mM) %  Viability
24 hours 48 hours 72 hours
250 22±2 11±1 17 ±2
200 13± 1 8±1 12±1
150 13± 1 7 ±0 10 ±0
100 10±0 6± 1 9 ±0
50 10±0 6 ± 0 8 ±0
* n = 3 replicates of 3
3.23 Time Course Assay
For time course assay S I80 cells and HT1080 cells were treated with fr-<ms-/?-ocimene 
and y-bisabolene, using the following concentrations:
A. 7>atts-/?-ocimene : S I80 cells were treated with two concentrations of 65 and 
95 mM trans-P-ocimene for 3, 6, 9, and 12 hours. HT1080 cells were also 
treated for the same periods of time, but using two concentrations of 100 and 
150 mM trans-P-ocimene.
B. y-bisabolene: Both S I80 cells and HT1080 cells were treated each with two 
concentrations of y-bisabolene: 10 and 20 mM.
A. S180 cells
Exposure of SI 80 cells to 65 mM trans-p-ocimem  was not effective in bringing about 
significant cytotoxicity to these cells (Figure 3.147). Viability ranged between 98.6% 
and 78.6% after 3 and 12 hours of exposure, respectively. In contrast, exposure of 
these cells to 95 mM trans-p-ocimene resulted in a very low percentage viability, 
ranging between 82.5% and 4.7% after 3 and 12 hours of exposure, respectively. 
Apparent cytotoxicity to S I80 cells exposed to y-bisabolene was lower at 10 mM 
concentration than at 20 mM concentration after 3 and 6 hours. However, after 6 and
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12 hours, percentage viability o f these cells exposed to both concentrations were very 
similar (Figure 3.148)
Determ ination o f  C ytotox ic ity  (M T T  A ssay) O cim ene After 3, 6, 9 and 12 
H ours, U sin g  S I 80 Cells
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Figure 3.147
Percentage cytotoxicity o f SI 80 cells in two different concentrations of trans-fi- 
ocimene. (n=9, bars=standard error)
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D eterm ination o f  C ytotoxicity  (M T T  A ssay) Gamma B isabolene A fter 3, 
6, 9  and 12 H ours, U sing S I 80 Cells
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Figure 3.148
Percentage cytotoxicity o f SI 80 cells in two different concentrations of y-bisabolene. 
Note increase in cytotoxicity with time. (n=9, bars=standard error)
208
B. HT1080 Cells
Trans-fi-ocimene at 100 mM was not active against HT1080 cells; rather it 
encouraged cell growth and resulted in higher percentage viabilities, thus indicating 
mitogenic effect. However, there are signs o f cell mortality after 9 and 12 hours of 
exposure, when percentage viabilities decreased (Figure 3.149).
Exposure o f H T1080 cells to 150 mM resulted in mitogenesis after 3 and 6 hours, but 
percentage viability decreased thereafter reaching 72.1% after 12 hours of exposure. 
It is noted that at an early stage mitogenesis occurred.
D eterm ination o f  C ytotoxicity  (M T T  A ssay) O cim ene After 3, 6, 9 and 12 
H ours, U sin g  H T 1080 Cells
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Figure 3.149
Percentage cytotoxicity of HT 1080 cells in two different concentrations of trans-fi-
ocimene. (n=9, bars=standard error)
Percentage viabilities of HT1080 cells exposed to y-bisabolene at 20 mM were lower 
than percentage viabilities o f cells exposed to 10 mM after 3 and 6 hours (Figure 
3.150). However, after 9 and 12 hours the difference in viability at these two 
concentrations was not significant.
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Determ ination o f  C ytotoxicity  (M T T  A ssay) Gamma B isaboene After 3, 6, 
9 and 12 H ours, U sin g  H T 1080 Cells
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Figure 3.150
Percentage cytotoxicity o f HT 1080 cells in two different concentrations of 
y-bisabolene. Note increase in cytotoxicity with time. (n=9, bars=standard error)
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3.24 Trans-/?-Ocimene and y-Bisabolene Using SEM Technique
3.24.1 SI80 Cells
SEM revealed normal growth of untreated cells. The cells were found adhering to the 
substratum and interdigitating with each other through filopodial attachments. 
Delicate microvilli were also noted on the surfaces of viable cells (Figures 3.151 A-B).
D el WD Exp k--------------------- —
s a t i r e  12 ^ 1 8 0  Untreated
Figure 3.151A-B
SEM images of untreated SI 80 cells. Cells show surface microvilli (white arrow) and
filopodial attachments (yellow arrow).
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S I80 cells exposed to for 12 hours to /r<ms,-/?-ocimene at a concentration of 100 mM 
resulted in symptoms of apoptosis, including signs of blebbing, the formation of 
apoptotic cells and apoptotic bodies, fragmentation, and loss of microvilli and 
filopodial attachments (Figures 3.152A-C).
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Figure 3.152A-B
SEM images of SI 80 cells treated for 12 hours with 100 mM /ra«.s-/?-ocimene.
(A) Showing loss of most microvilli, loss of filopodial attachments, membrane 
blebbing (green arrow), normal cell (white arrow), and formation of apoptotic 
cells and apoptotic bodies.
(B) Showing loss of most microvilli, loss of filopodial attachments, and formation 
of apoptotic bodies (turquoise arrow), and a normal cell (white arrow).
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Figure 3.152C
SEM image showing an apoptotic cell (orange arrow), loss of microvilli, loss of 
filopodial attachments, an apoptotic body (turquoise arrow) membrane blebbing
(green arrow).
Exposure of S I80 cells for 12 hours to y-bisabolene was not as effective as exposure 
to trans-fi-ocimene for the same period in resulting in symptoms of apoptosis (Figures 
3.153 A-C). The majority o f cells showed normal growth similar to that of untreated 
cells. These cells were found adhering to the substratum and interdigitating with each 
other through filopodial attachments. Delicate microvilli were also noted on the 
surfaces o f viable cells. Fewer than half o f the cells showed signs o f apoptosis, such 
as the formation of apoptotic cells and apoptotic bodies, and blebbing of outer 
membrane. This might be attributed to the low bisabolene concentration used in this 
experiment (5 mM), which seems not to have the cytotoxic effect of SI 80 cells.
y-bisabolene at 50 mM ‘killed’ most of the S I80 cells. Changes at 5 mM might 
suggest early necrosis rather than cytotoxicity.
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Hence it can be said that trans-p-ocimene (at LC50 concentration, 100 mM) was more 
effective in bringing about apoptosis in S I80 cells than y-bisabolene (at LC50 
concentration, 5 mM).
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Figure 3.153A-B
SEM images of SI 80 cells treated for 12 hours with 5 mM y-bisabolene.
(A) Showing fewer apoptotic cells (orange arrows) than normal cells. Only 
apoptotic cells show loss o f most microvilli, loss o f filopodial attachments, 
and membrane blebbing (green arrow).
(B) Showing both normal and apoptotic S I80 cells.
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Figure 3.153C
Enlarged view of Figure 3B left top comer, showing normal SI 80 cell and an
apoptotic S I80 cell.
3.24.2 HT1080 Cells
SEM revealed normal growth o f untreated cells. The cells were found adhering to the 
substratum and interdigitating with each other through filopodial attachments. 
Delicate microvilli were also found radiating from the surfaces of viable cells (Figure 
3.154A-B).
HT1080 cells exposed to trans-fi-ocimene (LC50 concentration, 100 mM) showed 
visible signs o f apoptosis, including loss of microvilli and filopodial attachments, 
blebbing o f outer surface membrane, and the formation of apoptotic cells and 
apoptotic bodies (Figure 3.155A-C).
215
A cc.V  S p ot Magn 
20 .0  kV 3 0 3001x
D et WD Exp I -----5- ------
S E  11 .6  12 H T1080 U ntreated
A
H T1080 U ntreated
B
Figure 3.154A-B
SEM images of untreated HT1080 cells. Cells show surface microvilli (white arrow) 
and filopodial attachments (yellow arrow).
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Figure 3.155A-B
SEM images of HT1080 cells treated for 12 hours with 100 mM trans-fi-ocimene. 
(A&B) Showing formation of apoptotic cells (orange arrow) and apoptotic bodies 
(green arrow), and membrane blebbing (turquoise arrow).
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Figure 3.155C
SEM images of HT1080 cells treated for 12 hours with 100 mM trans-p-ocimene 
showing early apoptotic cell (orange arrow), apoptotic bodies (turquoise arrow) and 
blebbing of outer membrane (green arrow).
HT1080 cells treated for 12 hours with 5mM y-bisabolene showed some signs of 
apoptosis, such as blebbing of the outer membrane (Figure 3.156A-C). However, 
these cells retained their microvilli and filopodial attachments, thus indicating 
possible early necrosis at the low bisabolene concentration (5 mM) used in this 
experiment.
Accordingly, treatment of HT1080 cells with trans-P-ocimene (100 mM) induced 
more apoptosis than in cells treated with y-bisabolene (5 mM).
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Figure 3.156A-B
SEM images of HT1080 cells treated for 12 hours with 5 mM y-bisabolene. 
(A&B) Showing some signs o f apoptosis (membrane blebbing - green arrow). 
Microvilli and filopodial attachment still visible.
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Figure 3.156C
(C) Showing some early signs of apoptosis (blebbing - green arrow)
3.25 Summary
The effects of trans-fi-ocimene and y-bisabolene on the S I80 and HT1080 cell lines 
used in this study can be summarised as follows (Table 3.18).
Table 3.18 Summary of effects of trans-ft-ocimene and y-bisabolene
Untreated 7>aws-/?-ocimene y-bisabolene
SI 80 None
■ Symptoms of apoptosis
■ Formation of apoptotic 
bodies
■ Fragmentation and loss of 
microvilli and filopodial 
attachments
■ Hence, high apoptosis
■ Not as effective as ocimene
■ Majority of cells showed 
normal growth after 12 
hours.
■ Less than half of cells 
showed signs of apoptosis
■ Changes suggest early 
necrosis, not cytotoxicity
■ Hence, low apoptosis
HT1080 None
■ Visible signs of apoptosis
■ Loss of microvilli and 
filopodial attachments
■ Formation of apoptotic 
cells and bodies
■ Blebbing
■ Hence, high apoptosis
■ Some signs of apoptosis
■ Retention of microvilli and 
filopodial attachments
■ Possible early necrosis
■ Blebbing
■ Hence, low apoptosis
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3.26 7hws-/?-Ocimene and y-Bisabolene Using Annexin V Assay
3.26.1 S180 Cells
Control untreated S I80 did not show changes in the membrane phosphatidylserine 
asymmetry. Accordingly, they were not labelled with Annexin V-FITC (Figure 
3.157). Only a few cells showed positive Annexin V-FITC staining, appearing bright 
apple green on the cell membrane surface. This indicates a very low percentage of 
apoptosis. No control cells showed signs o f necrosis, as none was stained red with 
propidium iodide.
it
Figure 3.157
Fluorescent microscope images o f untreated (control) S 180 cells after treatment with 
fluorescein isothiocyanate (FITC) and propidium iodide (PI) (X75).
A few late apoptotic cells could be seen stained with FITC appearing bright apple 
green on cell membrane surface (white arrows)
S I80 cells grown in culture containing 100 mM /raHs-/?-ocimene for 12 hours 
(Figures 3.158 A-B), hence undergoing induced apoptosis, showed positive results for 
changes in membrane phosphatidylserine asymmetry. The majority o f these cells 
stained green with Annexin V-FITC, showing positive labelling on the cell surface 
and within the cytoplasm. A number of cells, however, stained red with PI, possibly
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indicating secondary necrosis after the death of apoptotic cells and the disintegration 
of plasma membrane, which allowed the penetration of PI into the dying or dead cells, 
staining these cells red.
B
Figure 3.158
Fluorescent microscope images of S180 cells treated with 100 mM trans-fi-ocimene 
for 12 hrs after treatment with fluorescein isothiocyanate (FITC) and propidium
iodide (PI).
(A) Mag.X75. Apoptotic cells (white arrows) show even Annexin V distribution 
on the cell membrane. A large number of cells show signs of secondary 
necrosis (red stain with PI) (red Arrows).
(B) Mag.X120. Apoptotic cells (white arrows) and many showing signs of
secondary necrosis (red arrows).
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S I80 cells grown in culture containing 5 mM y-bisabolene for 12 hours (Figure 
3.159A-B) also showed positive results for changes in membrane phosphatidylserine 
asymmetry.
Figure 3.159
Fluorescent microscope images of SI 80 cells treated with 5 mM y-bisabolene for 12 
hours after treatment with (FITC) and propidium iodide (PI).
(A) Mag.75X. Apoptotic cells (white arrows) show even Annexin V distribution 
on the cell membrane. A large number of cells show signs of secondary 
necrosis (red stain with PI) (red Arrows).
(B) Mag.l20X. Apoptotic cells (white arrows) and many showing signs of
secondary necrosis (red arrows)
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Most of these cells stained green with Annexin V-FITC, showing positive labelling on 
the cell surface and within the cytoplasm. However, a number of S I80 cells also 
stained red with PI, possibly indicating secondary necrosis.
3.26.2 HT1080 Cells
Control untreated HT1080 did not show changes in the membrane phosphatidylserine 
asymmetry. They were not labelled with Annexin V-FITC (Figure 3.160). Only a 
few cells showed positive Annexin V-FITC staining, appearing bright apple green on 
the cell membrane surface. Thus a very low number of apoptotic cells were found to 
occur in control cultures. No control cells showed signs of necrosis, and none was 
stained red with propidium iodide.
Figure 3.160
Fluorescent microscope images of untreated (control) HT1080 cells after treatment 
with fluorescein isothiocyanate (FITC) and propidium iodide (PI). (X75).
A few late apoptotic cells could be seen stained with FITC, appearing bright apple 
green on cell membrane surface (white arrows)
HT1080 cells grown in culture containing 100 mM trans-fi-ocimene for 12 hours 
(Figures 3.161A-B), hence undergoing induced apoptosis, showed positive results for 
changes in membrane phosphatidylserine asymmetry. Cells stained green with
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Annexin V-FITC, showing positive labelling on the cell surface and within the 
cytoplasm. Many cells stained red (positive test for PI), possibly indicating secondary 
necrosis. Some cells showed blebbings on the outer membrane.
B
Figure 3.161
Fluorescent microscope images of HT1080 cells treated with 100 mM trans-fi- 
ocimene for 12 hours after treatment with FITC and PI.
(A) Mag.75X. Apoptotic cells (white arrows) show Annexin V distribution on the 
cell membrane. Several cells show signs of secondary necrosis (red stain with
PI) (red arrows).
(B) Mag.l20X. Apoptotic cells (white arrows) and several showing signs of
secondary necrosis (red arrows)
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HT1080 cells grown in culture containing 5 mM y-biasbolene for 12 hours (Figure 
3.162A-B) also showed positive results for changes in membrane phosphatidylserine 
asymmetry.
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Figure 3.162
Fluorescent microscope images of HT1080 cells treated with 5 mM y-bisabolene for 
12 hours after treatment with FITC and PI.
(A)Mag.75X. Apoptotic cells (white arrows) show Annexin V distribution on the 
cell membrane. Several cells show signs of secondary necrosis (red stain with
PI) (red arrows).
(B) Mag.l20X. Apoptotic cells (white arrows) and several showing signs of
secondary necrosis (red arrows).
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Cells stained green with Annexin V-FITC, showing positive labelling on the cell 
surface and within the cytoplasm. Many cells also stained red (positive for PI), 
indicating possible necrosis or secondary necrosis.
3.27 Summary
The effects of trans-p-ocimene and y-bisabolene on SI 80 and HT1080 cells can be 
illustrated as follows, in Table 3.19.
Table 3.19 Summary of effects of /ra/w-/?-ocimene and y-bisabolene
Untreated Trans-fi-Ocimene ('100 mM) y-Bisabolene (S mM)
S180
■ No changes
■ A few cells showed 
changes in phosphatidyl­
serine asymmetry
■ Very low percentage of 
apoptosis
■ No necrosis
■ Changes occurred (green yellow 
fluorescence).
■ Positive changes in phosphatidylserine 
asymmetry
■ Some cells showed positive test with PI 
(red fluorescence).
■ Secondary necrosis after death of 
apoptotic cells and disintegration of 
plasma membrane
■ Changes occurred (green yellow 
fluorescence).
■ Positive changes in phosphatidylserine 
asymmetry
■ Some cells showed positive test with PI (red 
fluorescence).
■ Secondary necrosis after death of apoptotic 
cells and disintegration of plasma 
membrane
HT1080
■ No changes
■ A few cells showed 
changes in phosphatidyl­
serine asymmetry
■ Very low percentage of 
apoptosis
■ No necrosis
■ Changes occurred
■ Positive changes in phosphatidylserine 
asymmetry (green yellow fluorescence)
■ Some cells showed positive test with PI 
(red fluorescence).
■ Secondary necrosis
■ Some cells with blebbings
■ Changes occurred
■ Positive changes in phosphatidylserine 
asymmetry (green yellow fluorescence).
■ Some cells showed positive test with PI (red 
fluorescence).
■ Necrosis/secondary necrosis
Results above clearly illustrated that y-bisabolene at 5 mM concentration was as effective as Trans-fi-ocimem at 100 mM concentration.
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Chapter Four 
General Discussion
4.1 ~ Introduction
4.1.1 Modes of Cell Death
The end-point of apoptosis and necrosis is similar (Bowen, 1999), and hence it may not 
always be easy to differentiate between them, although some apparently diagnostic tools 
have been developed.
From a comparative perspective, apoptosis leads to cell condensation and shrinkage, 
whereas necrosis leads to cellular swelling. Other distinctions include apoptotic cells 
losing water, whilst necrosis leads to gaining water. Membrane pumps continue 
functioning during apoptosis, but fail early on in necrosis. Necrotic cells experience an 
increasing acidosis leading to dense pyknotic nuclei. In apoptosis, a dilation of the 
nuclear envelope occurs, leading to nuclear blebbing, and the blebs tend to fill up with 
marginating chromatin.
During the later stages, the lysosomes of necrotic cells fragment, and hydrolytic enzymes 
are released which further lyse the cells, leading to a complete breakdown of subcellular 
compartmentalisation. The necrotic cell finally bursts, often eliciting an inflammatory 
response. In contrast, apoptotic cells usually undertake a discreet but florid 
fragmentation into membrane-bound spheres or apoptotic bodies which are rapidly 
phagocytosed by neighbouring cells or phagocytes, which elicits an immune response 
(Bowen, 1999). Notwithstanding the priority of the above descriptions, three types of 
cell death have been envisaged (Clarke, 1990):
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Type 1 Cell death, which accords with classical apoptosis, and is also described in 
morphological terms as Type 1 cell death.
Type 2 Cell death, or programmed cell death, is characterised by an increasing level of 
autophagotic activity. The dying cell fills up with active secondary lysosomes. There is 
no clear chromatin margination, and the nucleus survives until it is finally extruded from 
the cells or becomes autolysed. This type of programmed cell death usually involves 
changes in the subcellular distribution of hydrolases.
Type 3 Cell death, which can be induced by withdrawal of nerve growth factor, and as 
such, could be thought of as an atrophic cell death. Morphologically, it is characterised 
by dilation of the endoplasmic reticulum, Golgi and nuclear envelope, leading to 
extensive vacuolation. There is no chromatin margination, as seen in apoptosis.
Recetly, Lockshin and Zakeri (1996) have referred to apoptosis as Type 1 cell death, and 
non-apoptotic programmed cell death as Type 2. A vascular non-apoptotic form of cell 
death has been described in human breast cancer cells (Amin et al., 2000). This appears 
to occur where caspase activity is inhibited, and thus the DNA cannot become 
fragmented. Such cells are Annexin V positive, but negative in terms of TUNEL assays. 
The cells also appear to swell and to be vacuolated in a similar way to that found with 
bisabolene treatment. It is possible that bisabolene therefore induces Type 2 cell death, 
and may inhibit caspase activity.
4.1.2 Myrrh and Cell Death
The three cell lines used in this study, namely murine S I80 sarcoma, HT1080 human 
fibrosarcoma, and normal chick fibroblast, were selected because they proved to be an 
excellent model for the investigation of the cell death-inducing effects of molmol and
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haddi plant extracts. The cells showed a high sensitivity to the cytotoxic activity of these 
extracts.
SI80 cells are highly malignant, slightly immunogenic, and are used extensively as an 
experimental tumour model in chemotherapy screening studies.
The HT1080 cells, on the other hand, offer the advantage of producing high titres of 
retroviral vector resistant to inactivation by human serum, enabling their use in human 
therapy. Reducing the viral sequences has also reduced the risk of producing replication 
component retroviruses. Accordingly, in the future, this line cell offers great potential for 
the development of human gene therapy.
The normal chick fibroblast cells were used as a control to compare the effects of the 
molmol and haddi plant extracts on the S I80 cells and HT1080 cells with their effects on 
available normal cells.
Myrrh, extracted from the stem of Commiphira molmol (family Burseraceae), has been 
used extensively for therapeutic applications, as well as in food and perfume. The U.S. 
Food and Drug Administration (21 Code of Federal Registration -  CFR 172.510) 
approved it for food use, and the Flavor Extract Manufacturers’ Association (FEMA) has 
given it generally recognised as safe (GRAS) status as a flavour ingredient (No. 2765) 
(Hall and Oser, 1965; Ford et al. (1992). It is therefore largely non-toxic.
Myrrh has been traditionally used as a treatment for many ailments for thousands of 
years. For example, the Sumerians and the Greeks used it to treat ‘worms’ (Mitchie & 
Cooper, 1991), and by the Chinese to relieve pain and swelling due to traumatic injury 
(Lee and Lam, 1993). The Somalis used it to treat stomach complaints, diarrhoea and
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wounds (Cleason et al., 1991). In modem times, myrrh has been used as a drug, and 
tested for its efficacy in various applications. It has, for example, been used for the 
therapy of aphthous ulcer (Pesko, 1990), and for the reduction of cholesterol and 
triglycerides (Michie & Cooper; Jain, 1994).
Myrrh has also been found to have anti-carcinogenic potential (Al-Harbi et al., 1994), 
and gastric antiulcer and cytoprotective potentials (Al-Harbi et a l , 1997). Qureshi et al. 
(1993) evaluated the genotoxic, cytotoxic, and anti-tumour properties of myrrh, and 
found that the cytotoxic and anti-tumour activity of C.molmol was equivalent to those of 
the standard cytotoxic drug cyclophosphamide. They concluded that its use in cancer 
therapy seems to be appropriate, though they recommended further investigation.
Myrrh has been reported to be effective in the treatment of schistosomiasis (Massoud et 
al., 1998). Massoud et a l (2001) administered a myrrh formulation, consisting of 8 parts 
of resin and 3.5 parts of volatile oil, extracted from myrrh, to seven patients passing 
Fasciola eggs in their stools. Patients were administered the formulation at a dose of 12 
mg/kg/day for six successive days, in the morning, on an empty stomach. Patients were 
then followed-up for three months, and the therapy proved effective, with pronounced 
improvement of the general condition and amelioration of all symptoms and signs. 
Massoud et al. (2001) also noted a marked decrease in the number of eggs passed at the 
end of the six-day treatment. They also found that eggs were not detected in the faeces 
three weeks after the treatment, and after three months’ follow-up period. Massoud et al. 
(2001) also did not notice any signs of toxicity or adverse effects, concluding that, despite 
the small number of patients involved in the study, myrrh has proven to be an effective
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drug in patients who experienced marked improvement in the clinical and laboratory 
results.
Sheir et al. (2001) studied the effects of an antischistosomal therapy derived from myrrh 
in an attempt to find an alternative drug to praziquantel, the drug of choice to treat 
schistosomiasis, since resistance to this drug has been demonstrated. They involved 204 
patients with schistosomiasis and 20 healthy volunteers (control). The drug derived from 
myrrh was administered at a dose of 10 mg/kg of body weight/day for three days, and 
induced a cure rate of 91.7%. Re-treatment of patients who did not respond with the 10 
mg/kg/day treatment for six days resulted in a cure rate of 76.5%, increasing the overall 
cure rate to 98.09%. They concluded that myrrh has been shown to be a safe and 
effective anti-schistosomal drug at the dose indicated above for six days. Twenty cases 
provided biopsy specimens six months after the treatment, but none of them showed 
living eggs.
The Egyptian Pharmaceutical Company (Pharco) has launched a new antihelmith drug, 
Mirazid, derived from myrrh, as a treatment for schistosomiasis (Pharco Pharmaceuticals, 
2003).
More recently, El Baz et al. (2003) studied the clinical and parasitological efficacy of 
Mirazid in treatment of schistosomiasis haematobium in Egypt, and found that Mirazid, 
administered in a dose of two capsules (600 mg) on an empty stomach before breakfast, 
for six consecutive days, proved to be very effective and safe in the treatment of 
schistosomiasis haematobium. Botros et al. (2004), however, have published a detailed 
paper demonstrating a lack of evidence for an antischistosomal activity of Myrrh in 
experimental animals.
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The discussion above clearly shows that myrrh has been, and is still used as a therapy for 
a wide range of pathological cases, and that human patients tolerate treatment with Myrrh 
very well. The findings of the present study showed the efficacy of extracts obtained 
from C. molmol (myrrh) and C. guidotii (haddi) in treating human cancer cell lines (SI80 
and HT1080 cell lines), as discussed in the following sections.
4.2 Growth Assays
Untreated S I80 cells were shown to increase exponentially, attaining their highest 
concentration by day 6 from the start of the experiment. On day 7, the cells reached a 
plateau but started declining in number on day 8, when the growth curve experiment was 
stopped. S I80 cells were seeded initially on day 0 at 4 x 104 cells/ml. On day 6, the cell 
numbers increased sharply to more than 230 x 104, and on day 8, the cell numbers 
dropped to more than 150 x 104. Growth was somewhat slow during the first three days, 
but showed an increase on day 4. This increase in the cell numbers in a proliferating cell 
line such as the S I80 cell line can be considered as an index of normal behaviour (Al- 
Hazzaa, 2000; Amin, 2001).
The addition of each of the ethanolic molmol and hexane haddi extracts to SI 80 cultures 
on day 4 of growth (when cell concentrations in the control showed a definite increase) 
induced a rapid decline on day 5, reaching its lowest on day 8. The results showed that 
both plant extracts had significant effect on the growth of this cell line only 24 hours after 
the culture exposure to these extracts, which resulted in sharp decline in cell numbers 
compared to the growth in control cultures. This may, at this experimental stage, suggest 
that the extracts of both plants were either cytostatic or were effective in inducing 
apoptosis and death of the S 180 cells. This decline in cell number also suggests that the
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two extracts may have anticancerous and cytotoxic activities. The anticancerous and 
cytotoxic activities of molmol have been demonstrated against several cancerous cell 
lines (for example, Tariq et al., 1985; Qureshi et a l , 1993; Al-Harbi et al., 1994, 1997; 
Rao et al., 2001; Tipton et al., 2003).
The study results also showed that hexane haddi extract was more effective against S I80 
than ethanolic molmol extract in reducing growth of S180 cells.
Growth assays using HT1080 showed that these cells proliferate exponentially, reaching 
their maximum concentration on day 12, rather than day 6, as was the case for S I80. 
After day 12, growth declined abruptly. HT1080 cells were grown in their medium, 
which was then changed with a new medium containing each of ethanolic molmol and 
hexane haddi extracts, each being added on day 7 of the growth period, and the cells 
declined in numbers for the following seven days. In the case of HT1080, ethanolic 
extracted molmol was more effective than hexane extracted haddi in inducing cell death.
4.3 MTT Viability Assay
The S I80, HT1080 and normal fibroblast cell lines were treated with different 
concentrations of molmol and haddi extracts over a period of 24, 48 and 72 hours before 
MTT solution was added to the growth media to measure the mean optical density (and 
hence estimate percentage toxicity), and also to establish percentage viability. Two series 
of dilutions for each of the ethanolic molmol, ethyl acetate molmol, ethanolic, haddi, 
hexane molmol, hexane haddi, and ethyl acetate haddi extracts were used in the MTT 
viability assay. Furthermore, Flavex molmol and essential oil haddi (Aldrich) were also 
used, both of which are commercial products.
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4.3.1 Effects of Molmol and Haddi Extracts on S180 cells
Molmol extract inhibited the growth of SI80 cells in cultures in a dose and time- 
dependent fashion, whilst in the control cultures, all the cells were viable throughout the 
experimental period. However, the treatment of SI80 cells with a different series of 
molmol extract resulted in the death of cells, which reacted upon the addition of MTT 
reagent. Dead cells were those cells not producing formazan product. The results 
suggest that molmol at the lower concentration (83.3 pg/ml) was a growth promoter and 
that mitogenesis has occurred, resulting in increasing the number of viable cells above 
that of the control (100%). With further increase in the molmol concentration, there were 
fewer viable S I80 cells observed. Results also showed that increasing the incubation 
period also reduced the viability of SI80, especially at the highest molmol 
concentrations, and after 48 and 72 hours of exposure to the molmol extract. This 
substantiates the notion that growth inhibition was both dose- and time-dependent. It also 
suggests that mitosis and apoptosis may be closely linked, since low concentrations 
increase mitosis whilst high concentrations induce apoptosis. Recently, Zhao et al. 
(2003) found that boswellic acid acetate (BC-4), isolated from the resin of Boswellia 
carteri Birdw (family Burseraceae like that of Commiphora), inhibited the growth of 
B16F10 mouse melanoma cells in culture in a dose- and time-dependent fashion. Shao et 
al. (1998) reported the alcoholic extract of the resin (Boswellic acids) had an inhibitory 
activity against human leukaemia HL-60 cells in culture. They isolated four major 
triterpene acids (p-boswellic acid, 3-O-acetyl-p-boswellic acid, 11-keto-P-boswellic acid, 
and 3-O-acetyl-11-keto-p-boswellic acid) from the gum of B. serrata and examined them 
for their in vitro antitumour activity. They found that these acids inhibited the synthesis
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of DNA, RNA and protein in human leukaemia HL-60 cells in a dose-dependent manner, 
with IC50 values ranging between 0.6 and 7.1 mM. They also found that 3-O-acetyl-l 1- 
keto-p-boswellic acid induced the most pronounced inhibitory effects of DNA, RNA and 
protein synthesis, with IC50 values of 0.6, 0.5, and 4.1 mM, respectively. The effect of 
this acid on DNA was found to be irreversible, and it significantly inhibited the cellular 
growth of HL-60 cells, but did not affect cell viability. The effect of ethanolic molmol 
extract at all concentrations seemed to be irreversible, since cell viability declined 
throughout the experimental periods used in the present study. As indicated above, the 
anticancerous and cytotoxic activities of molmol have been demonstrated against several 
cancerous cell lines (for example, Tariq et al., 1985; Qureshi et al., 1993; Al-Harbi et al., 
1994, 1997; Rao et al., 2001; Tipton et al., 2003), and the results of the MTT assay 
further substantiate these reports. At the higher series of concentration, the viability of 
S I80 declined substantially with time.
Hexane molmol extract seemed to be less effective in treating S180 cells, in which case 
percentage cell viability was less than that reported above for ethanolic molmol extract. 
In fact, mitogenesis was noted at the lower concentration, even after 72 hours of 
exposure.
The ethyl acetate molmol extract resulted in a lower percentage viability of the SI 80 cells 
than did ethanolic molmol extract, using similar concentrations; but on the whole, its 
action was similar.
Treatment of S I80 cells with Flavex molmol extract indicated that this commercially 
available extract had the least toxic effect on these cells, and the percentage viability was 
generally the highest among the four types of extracts used.
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The effects of haddi extracts on the viability of S I80 cells were also dose and time- 
dependent, though the effects varied according to the nature of the extractants used. 
Ethanolic haddi extract was not found to be effective for the treatment of S I80. Treating 
these cells with this extract resulted in higher percentage viability than in the case of 
ethanolic molmol extract.
However, the results of the second series (concentrations ranging between 266.45 and
666.6 pg/ml) were rather contradictory, possibly due to the different experimental 
batches of the plant extract.
Hexane haddi extract was superior to ethanolic haddi extract, even at the lower end of the 
concentration spectrum. On the whole, its action was dose and time-dependent. 
Mitogenesis was only found at the lowest concentration (6.65 p/ml), after 72 hours of 
exposure. Hexane haddi extract, though it performed better that the ethanolic haddi 
extract, did not perform as effectively against S I80 cells as did the ethanolic molmol 
extract.
Ethyl acetate haddi extract also performed better against S I80 cells than the ethanolic 
haddi extract, although higher concentrations were required to be effective (466pg/ml).
The essential oil (Aldrich) haddi extract performed poorly against S I80 cells, compared 
to the hexane haddi extract.
4.3.2 Effects of Molmol and Haddi Extracts on HT1080 Cells
Molmol and haddi extracts also inhibited the growth of HT1080 cells in cultures in a dose 
and time-dependent fashion. Ethanolic molmol extract at the lower concentration levels 
was not toxic to HT1080 cells, and mitogenesis was noticed to occur, at the 0.65-83.33
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fig/ml range, evidenced by the increase in the number of cells that was higher than in the 
control. However, there were fewer viable cells at the highest concentration (666.6 
pg/ml) used in the second series, possibly due to different batches of the plant extracts 
used. The major impact of this extract seemed dependent on using high to very high 
concentration levels.
Hexane haddi extract seemed to perform better in terms of apparent cytotoxicity at the 
highest concentration level of 666.6 pg/ml and for all exposure times, whereas its effect 
was either very negligible, or mitogenic, at concentrations between 0.65 and 333.3 pg/ml. 
Hexane haddi extract was also not toxic to HT1080 cells, unlike ethanolic molmol 
extract, producing a contradictory toxic effect on this cell line. Flavex molmol was also 
not very toxic to HT1080 cells, where very high percentage viabilities were recorded, 
even at the high concentration range.
The study carried out by Qureshi et al. (1993) reported results obtained in Ehrlich ascites 
carcinoma cell-bearing mice revealed the cytotoxic and antitumour activity of Myrrh was 
equivalent to that of the standard cytotoxic drug cyclophosphamide, and that on the basis 
of the nonmutagenic, antioxidative, and cytotoxic potential of Commiphora, its use in 
cancer therapy seemed to be appropriate, and suggested further investigations. The 
results of the present study also indicate the cytotoxic activity of this plant extract on the 
S I80 and HT1080 cell lines in vitro. In addition, Al-Harbi et al. (1993) found that 
treatment of C. molmol (250 and 500 mg/kg/day) was cytotoxic in Ehrlich solid tumour, 
and that the antitumour potential of C. molmol was comparable to cyclophosphamide.
More recently, Tipton et al. (2003) investigated the in vitro cytotoxic and anti­
inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells, and
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reported that fibroblasts resident in the gingival tissue can participate in local 
inflammation through the production of cytokines, and that their results suggested that 
myrrh oil may reduce fibroblast production of such proinflammatory cytokines, and 
therefore reduce the participation of these cells in gingival inflammation associated with 
gingivitis and periodontitis.
Ethanolic haddi extract also showed dose and time-dependent effects on HT1080 cells. 
This extract was not toxic to HT1080 cells at the lower concentration range of 0.65 to
333.3 pg/ml, but was toxic at the 666 pg/ml concentration, and for all exposure times 
tested. A similar effect was noted at the 266.6 and 366.6 pg/ml concentrations, where 
even mitogenesis occurred after 24 hours of exposure.
Hexane haddi extract was more effective against HT1080 cells than the ethanolic extract. 
Cell viability was very low at 333.3 and 666.6 pg/ml concentration levels, at all exposure 
times. Mitogenesis occurred at the lowest concentration levels (0.65 and 10.42 pg/ml), 
thus indicating that these concentrations were not toxic to HT1080 cells; rather, they were 
growth promoters. In the second series, a similar trend was noted in which all 
concentrations (266.6 to 666.6 pg/ml) were toxic, though to varying degrees, depending 
upon time of exposure. Using high hexane haddi extract concentrations substantiated this 
pattern, in which percentage viability declined with concentration and exposure time.
Ethyl acetate haddi extract was not toxic to HT1080 at the lower concentration range, 
where mitogenesis occurred after 72 hours of exposure.
Essential oil haddi (Aldrich) extract was also not very toxic to HT1080 cells, and a high 
percentage viability persisted throughout the various concentration levels and exposure
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times. Only by subjecting HT1080 cells to very high concentrations of this extract was 
cytotoxicity increased. However, even at this high concentration range, exposure for 72 
hours to 600.17 and 900.26 pg/ml was less toxic than exposure for 24 and 48 hours.
Differences in the bioactivity of the hexane haddi extract and its essential oil (Aldrich) 
are probably due to the selectivity of compounds extracted. The solvent hexane 
specifically extracts only nonpolar compounds, whereas for the essential oil, steam 
distillation extracts both nonpolar and semipolar compounds, as they condense with the 
volatile steam vapours. According to Mr. Ahmed Ali (School of Biosciences, personal 
communication), although the gc-ms profile for both the hexane and essential oil is 
broadly the same, there are major unidentified compounds present in the essential oil 
which do not occur in large amounts in the hexane extract. The presence of these 
unidentified compounds could be responsible for reducing the cytoxic properties of the 
essential oil.
4.3.3 Effects of Molmol and Haddi Extracts on Chick Fibroblast Cells
Ethanolic molmol extract was toxic to normal fibroblast cells, especially at the higher 
range of concentrations, and after exposure for 48 and 72 hours. This indicates that the 
action of this extract was dose and time-dependent.
Hexane molmol extract seemed to have mitogenic effects at all concentrations (266.45-
666.6 pg/ml) after 24 hours of exposure, but cytotoxicity appeared with increasing 
concentration and exposure time.
Ethyl acetate molmol extract was toxic to normal fibroblast cells only at the higher 
concentration range (> 366pg/ml) and longer exposure time.
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Flavex molmol was not at all toxic at all concentrations and for various exposure times; 
rather, it was mitogenic as a whole. This is further evidence of the differing quality and 
nature of this commercial extract.
Ethanolic haddi extract at a concentration range of 266.5 and 666.6 pg/ml was not toxic 
to normal fibroblast cells after 24 hours of exposure at the three lowest concentrations; 
rather, its addition resulted in mitogenesis, and its toxicity at the higher concentration 
range was far lower than at the other exposure times. Hexane haddi extract was not 
effective against these cells, especially at the lower concentration range, where 
mitogenesis occurred after 48 and 72 hours of exposure. Ethyl acetate haddi extract was 
also not effective against normal fibroblast, resulting in mitogenesis in most of the 
treatments, and very low toxicity at the higher concentration levels. Aldrich haddi also 
proved ineffective against these cells. Only at very high concentrations was it toxic to the 
normal fibroblast cells. This differential impact on normal fibroblasts is encouraging in 
terms of exploring the therapeutic use of myrrh extracts.
4.4 Differential Effects of Molmol and Haddi Extracts
Molmol and haddi extracts seemed to have differential effects on the cell lines used in the 
present study. The experiments above clearly indicated that ethanolic molmol extract 
was more effective against S I80 cells than against HT1080 cells after 72 hours of 
exposure, but it was not very effective against normal chick fibroblasts, which showed 
mitogenesis at the lower range of concentration. Ethanol haddi extract, on the other hand, 
was not toxic to S I80 cells, but was more toxic to HT1080 cells and normal fibroblast 
cells.
242
Hexane molmol extract, on the other hand, showed a different pattern of cytotoxicity 
effect. It was more effective against HT1080 cells than against S I80 cells at the lower 
concentrations, but showed mitogenesis at the higher range of concentration. 
Nonetheless, it was toxic to S180 and normal fibroblast cells at the higher concentration 
levels. In contrast, hexane haddi extract concentrations were much more toxic to S180 
cells than to HT1080 and normal fibroblast cells.
Ethyl acetate molmol extract was also more toxic to S I80 cells than to HT1080 and 
normal fibroblast cells, at the lowest concentration level of 266.45 pg/ml, but all cell 
lines exhibited recovery signs, indicating that mitogenesis had occurred even at the higher 
concentration range. Ethyl acetate haddi extract had mitogenic effects on HT1080 at 
lower concentrations, but was toxic at higher concentration ranges. In contrast, it was 
highly toxic to S180 cells at the lower concentrations, but unusually induced mitogenesis 
at the higher concentration levels, where cell numbers increased consistently.
4.5 Differential Effects of Molmol and Haddi Extrcts on SI80,
HT1080 and Normal Fibroblast Cells
Ethanolic molmol extract was more active against S I80 than hexane molmol extract. 
However, as for ethyl acetate molmol extract, S I80 cells viability increased with the 
increasing concentration of the treatments.
Ethanolic molmol extract was also more active against HT1080 cells, particularly at 
higher concentration levels, than hexane molmol and ethyl acetate molmol extracts. In 
the case of those two extracts, mitogenesis occurred at higher concentrations.
243
I
*■
I-
Ethanolic and hexane molmol extract showed similar patterns of increasing cell death in 
normal fibroblast cells with increasing concentrations, though ethyl acetate molmol 
extract was not very effective against these cells at all concentrations.
Hexane haddi extract was more toxic to S180 than ethyl acetate haddi extract, the latter 
induced only low mortality.
Ethyl acetate haddi extract was active against S I80 cells, at the slightly higher 
concentration range (466pg/ml), but not against normal fibroblast cells, even at the 
highest concentration (666pg/ml).
Hexane haddi extract was also more active against HT1080 cells than ethanolic haddi and 
ethyl acetate haddi extracts. In all cases, cell death was dose and time-dependent.
Ethanolic haddi extract produced more cell death than the hexane extract in normal 
fibroblasts at all concentrations. Treatment of the normal fibroblasts with hexane haddi 
extract resulted in mitogenesis at lower concentrations, but was slightly more effective at 
the higher concentration levels.
4.6 Morphological Changes in Treated Cells and Interpretations of 
Apoptosis
Apoptosis can be identified using routine histological staining methods, such as the 
haematoxylin and eosin (H&E) staining technique. Bowen (1981) reported that 
histological assessments of cells and tissues is mainly based on very delicate membrane 
and pH changes which result in changes in membrane permeability and give rise to 
various staining patterns.
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One of the characteristics of classical apoptosis is the presence of darkly stained 
hyperchromatic nuclei, known as pyknotic nuclei. During apoptosis, the nuclear 
chromatin generally marginates, clumps and aggregates at the nuclear membrane, a 
process followed by dilation of the nuclear membrane. In late apoptotic cells, the 
pyknotic chromatin becomes progressively less visible and is dispersed or lost. Bowen et 
al. (1991) reported nuclear pyknosis in cells undergoing necrosis, although the necrotic 
cells do not show characteristic chromatin margination.
Sandritter & Riede (1975) stated that the first changes leading to necrosis include 
degenerative swelling, caused by failure of the sodium pump, and ATP activity, which in 
turn causes inflow of charged ions such as sodium, calcium and water, and outflow of 
potassium ions into the extracellular space. This leads to changes in the cell membrane 
permeability, which at the light microscopy level could be reflected in the cell’s reaction 
to dyes. Other plasma membrane changes during apoptosis are related to membrane 
bending and induction of blebbing and fragmentation. Furthermore, the apoptotic cells 
and fragments tend to lose rather than gain water, which might lead to changes in the pH 
and surface permeability of the cells. Such changes are reflected through reactions to 
histological stains (Bowen, 1981). Ballard has illustrated that apoptotic cell nuclei are 
intensively chromophilic and could be easily identified in iron/haematoxylin stained 
sections. This hyperchromasia of pyknotic nuclei is caused by chromatin condensation 
and also by exposure to negative charge phosphate groups. Sandritter & Riede (1975), 
for instance, found that pyknotic nuclei bind more eosin, due to the increase in free basic 
histone groups.
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IThe haematoxylin-eosin staining results achieved in this work showed that all three cell 
lines exhibited their normal appearance when grown in cultures without any treatment 
with the molmol and haddi extracts. Untreated S180 cells, for example, were rounded or 
polygonal, and formed a confluent monolayer of cells that were attached to the 
substratum by their pseudopodial attachments. All cells had healthy nuclei and stained 
uniformly.
Untreated HT1080 cells were epithelial-like, with a polygonal appearance, also forming a 
confluent layer and attached to the substratum. Nuclei appeared healthy, and some cells 
showed mitotic activity. Pseudopodia were evident, connecting cells with each other.
Untreated normal fibroblast cells were also epithelial-like, with polygonal morphology. 
The cells formed a confluent monolayer, remaining attached to the substratum by their 
pseudopodial attachments. The nuclei appeared rounded or ellipsoidal.
Treatment of these cells with ethanolic molmol or hexane haddi extracts brought about 
changes in the morphology of some of these cells and their nuclei. Apoptotic changes 
started after 6 hours of treatment, and advanced as treatment time increased. For 
instance, treatment of SI 80 cells with ethanolic molmol extract for 6 hours brought about 
visible changes that are characteristic of apoptosis, as described above. Apoptotic cells 
became pyknotic, apoptotic bodies were formed, and the cell membrane broke up. 
Pyknosis, a regular feature of apoptosis, can be seen as a nucleus that is darkly stained. 
The earliest detectable change is often chromatin clumping that has been shown to consist 
of low molecular fragments (Wyllie, 1980; Wyllie & Morris, 1982), and expansion of the 
outer nuclear envelope. Fragments are produced through the cleavage of nuclear 
chromatin by calcium- and magnesium-dependent endonuclease which is present in the
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nucleus (Cohen & Duke, 1984). Formation of apoptotic bodies is also one of the major 
morphological characteristics seen during the process of apoptosis. Bowen (1993) 
indicated that a considerable amount of membrane bending takes place during the 
formation of spherical bodies, which is accompanied by localised changes in calcium 
concentration. Pseudopodial attachment disappeared and apoptotic cells assumed various 
spherical morphologies. Bowen (1993) reported that specialised areas of membrane such 
as microvilli and junctional complexes are lost during apoptosis. Treatment for 12 hours 
brought about all these changes, in addition to the appearance of vacuoles in the 
cytoplasm of the apoptotic cells, especially in the endoplasmic reticulum. Bowen (1993) 
maintained that whilst the cytoplasm contained within apoptotic fragments appears 
normal, early vacuolar changes have been observed within apoptotic thymocytes. 
Robertson et al. (1978) reported vacuolation and dilation of the nuclear envelope, 
endoplasmic reticulum and Golgi in these cells. In this investigation, after 24 hours of 
treatment, changes became more evident, and the cells changed their morphology, 
becoming elongated or ellipsoidal. Recently, Zhao et al. (2003) also found that the 
treatment of melanoma culture with boswellic acid (BC-4) caused dramatic changes in 
cell morphology, with cells becoming elongated, whereas untreated cells remained 
rounded-up or in clumps.
As for HT1080 cells, the earliest changes during apoptosis were visible within six hours 
of treatment with ethanolic molmol. While some cells had pyknotic nuclei, others had 
their nuclear material dispersed, and apoptotic bodies mainly consisted of nuclear 
fragments. Some other cells appeared to have broken membranes, and the cytoplasm 
appeared disintegrated, or had become vacuolated. After 12 hours of treatment, these
247
changes persisted, and apoptotic bodies, consisting mainly of nuclear fragments and 
cytoplasm fragments, were formed. Some cells showed condensed cytoplasm, some 
without pyknotic nuclei, whereas others showed cytoplasm disintegration. After 24 hours 
of treatment, the cytoplasm disintegrated in some cells, accompanied by the formation of 
vacuoles, and blebs on the outer cytoplasmic membrane. However, free apoptotic bodies 
were not found.
Ethanolic molmol extract did not seem to have a direct effect on the normal fibroblasts. 
After 6 hours of treatment, all cells remained intact and unchanged, containing normal 
nuclei. Even after 12 hours, the majority of cells had normal nuclei, and only a few were 
apoptotic, with the formation of apoptotic bodies. The majority of cells were not 
affected, even after 24 hours, a few were apoptotic, and most of the non-apoptotic cells 
kept their pseudopodial attachments.
It can thus be said that molmol extract targeted cancerous cells and induced apoptosis, 
whereas at particular concentrations it did not target or induce cell death in the non- 
cancerous normal fibroblast cells.
With regard to hexane haddi extract, the earliest changes in S180 cells were visible within 
six hours of treatment. Cytoplasm became condensed, eventually breaking up into 
several membrane-bound apoptotic bodies, with smooth surfaces, consisting mainly of 
nuclear fragments. Apoptotic cells had pyknotic nuclei, and the cytoplasm in some cells 
formed blebs on the outer cell membrane, whereas in others it disintegrated and became 
vacuolated. After 12 and 24 hours of treatment, these changes became more evident, 
with some cells being highly vacuolated, whereas others had condensed cytoplasm. This
248
might suggest the incidence of a non-apoptotic programmed cell death (Amin et al., 
2000).
As for HT1080 cells, changes were visible within 6 hours of treatment with hexane haddi. 
Treated cells showed pyknotic nuclei, and apoptotic bodies consisted mainly of nuclear 
fragments. Some apoptotic cells showed cytoplasmic disintegration and the formation of 
vacuoles, some with blebbing. After 12 hours of treatment, these changes persisted and 
became more evident, with some cells showing disintegrated nuclear material. Almost all 
HT1080 cells were affected after a 24 hour treatment.
Normal fibroblast cells after 6 hours of treatment with hexane haddi extract were not 
affected, and only after a further 6 hours of treatment some cells became apoptotic. 
These changes persisted after 24 hours of treatment.
It can be argued that while hexane haddi extract was effective in inducing apoptosis in 
S I80 cells and HT1080, it also induced apoptosis in normal fibroblasts at low rate, but 
little more than ethanolic molmol extract did.
S I80 cells and HT1080 cells grown in control media showed very low percentages of 
apoptotic cells. However, treating them with ethanolic extracted molmol and hexane 
haddi extracts resulted in substantially higher numbers of apoptotic cells. This pattern of 
the occurrence of apoptosis reflects the possible suitability of both extracts in treating 
cancer cells. Hexane extracted haddi resulted in higher frequencies of apoptosis among 
normal fibroblast cells than did ethanolic molmol extract. This substantiates the 
conclusion that ethanolic molmol extract is more suitable than the hexane haddi extract, 
since the former selectively targets cancer cells better than the latter, which also results in 
higher frequencies of apoptosis in the non-cancerous cells.
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Results also showed that higher frequencies of apoptosis are obtained with increasing 
concentrations of these extracts and increasing exposure time. This substantiates the 
finding that the action of these extracts is dose and time-dependent.
4.7 DNA Fragmentation Assay and Interpretation of Programmed 
Cell Death
Detection of in situ DNA fragmentation is currently one of the most frequently used 
techniques to detect apoptosis. According to Enari et al. (1998), the fragmentation of 
DNA is induced by caspase-mediated cleavage of an inhibitor (ICAD) and ensuing 
activation of caspase-activated DNase (CAD), which subsequently leads to the 
characteristic intemucleosomal DNA double strand breaks. Kerr et al. (1972), Wyllie et 
al. (1980) and Arends et al. (1990) regarded DNA fragmentation into multiples of 180- 
200 base pairs (BP) as a feature of programmed cell death. However, it appears that large 
fragments in the range of 50-150 kbp are also generated (Bortner et al., 1995). 
Oberhammer et al. (1993) and Zakeri et al. (1993) reported forms of programmed cell 
death that lack the prototypical intemucleosomal pattern of DNA fragmentation. In 
addition, necrotic cell death is accompanied by late random DNA fragmentation through 
the release of lysosomal DNase, though this concept has been challenged. Techniques 
detecting fragmentation may therefore not be specific for apoptosis, but also detect DNA 
damage in a variety of cell injuries, including single strand breaks. It may therefore be 
the scale of double DNA strand breaks that is the basis for the relative specificity of in 
situ DNA fragmentation techniques for apoptotic cell death (Ansari et al., 1993).
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Only HT1080 cells and normal fibroblast cells were used in this experiment. Untreated 
HT1080 and normal fibroblast cells grown in the control medium showed normal cells, 
with intact nuclear material (see Section 4.5), and no DNA fragmentation.
It is clear however that some cells die in a programmed or genetically induced manner, 
without resulting in DNA fragmentation. This has been seen especially where kinases or 
caspases have been inhibited (Amin et al., 2000). The form of cell death produced is 
aberrant since there is no cell shrinkage, rather a vacuolation. These cells however are 
Annexin V positive and thus do enter programmed cell death.
A. Ethanolic Extracted Molmol (234 pg/ml)
Treatment of HT1080 cells with ethanolic molmol extract for 3 hours was not adequate to 
produce signs of DNA strands breaking. It was only after 6 and 12 hours of treatment 
that some cells showed signs of disintegration, detected by blebbing of the outer 
membrane of the treated cells. DNA fragmentation and cytoplasmic disintegration were 
further accentuated after 24 hours of treatment with this extract. Complete disintegration 
of HT 1080 cells and further disintegration of the DNA material was noted at the end of 
the experimental period (48 hours). Thus, apoptosis is a synthetic process and requires 
some hours to produce an end point.
Normal fibroblast cells treated with the ethanolic molmol extract for up to 12 hours was 
not sufficient to bring about apoptotic changes. It was only after 24 hours treatment that 
some signs of fragmentation of DNA material were detected, along with the formation of 
a few membrane blebs on the outer cell membrane. Treatment for 48 hours did not result 
in any further disintegration of the DNA material. HT1080 cells treated with hexane 
haddi extract for 3 hours did not show any sign of DNA strand breaks.
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B. Hexane Extracted Haddi (201 pg/ml)
Treatment of the cells with this extract for 3 hours did not result in any apoptotic changes. 
Treatment for 6 and 12 hours, however, resulted in the production of clear signs of 
disintegration, such as the formation of blebs. Further signs of apoptotic disintegration 
were noted after 24 hours, but complete cellular disintegration and more DNA 
disintegration was observed at the end of the experimental period (48 hours). Normal 
fibroblast cells treated for up to 48 hours did not show signs of disintegration and DNA 
fragmentation. Hence, it can be said that this extract could not induce apoptosis in these 
normal cells, but targeted cancerous cells (HT1080).
4.8 Demonstration of Apoptotic Cells in Culture Using TUNEL 
Technique
Both HT1080 cells and normal fibroblast cells grown in control culture showed only a 
slight incidence of apoptotic cells. Incubating HT1080 cells in a medium containing 
either 666 pg/ml or 234 pg/ml ethanolic molmol extract resulted in developing more 
apoptotic cells with time, though lower percentages of apoptotic cells were observed 
using the weaker extract. In contrast, normal fibroblast cells grown in a medium 
containing 234 pg/ml ethanolic molmol extract, showed only a slight occurrence of 
apoptosis compared to that using HT1080 cells.
HT1080 cells grown in a medium containing either 666 pg/ml or 201 pg/ml hexane haddi 
extract showed a considerable increase in the number of apoptotic cells, especially using 
the stronger haddi solution, and in both cases, there were increases with time of exposure. 
Normal fibroblast cells grown in a medium containing 201 pg/ml hexane haddi extract
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showed only a slight increase in the frequency of apoptotic cells compared to the control 
and HT1080 cells results.
4.9 Scanning Electron Microscopy
The morphological changes that occur during apoptosis can be conveniently analysed 
using scanning electron microscopy (SEM). Bowen et al. (1981) indicated that fine 
structural changes in cells observed at electron microscopy level can reflect underlying 
biochemical changes. Plasma membrane and cytomembrane changes can provide reliable 
and early signs as to the probability of cell death.
SEM is widely employed to study and time events in apoptotic cell cultures. Cells 
experiencing apoptosis primarily round off, and lose contact with the neighbouring cells 
as they condense. Then, the cytoplasm becomes convoluted and blebs outwards, 
eventually giving rise to apoptotic bodies. Bowen et al. (1993) reported a substantial 
degree of membrane bending taking place during apoptotic body formation, accompanied 
by localised changes in the calcium concentration. The results of the present study 
clearly showed these changes in the cell lines used, in comparison with control cultures.
The results showed that cells treated with ethanolic molmol and hexane haddi extracts 
demonstrated symptoms of classical apoptosis such as shrinkage, blebbing, 
fragmentation, and loss of microvilli and filopodial attachments, compared to untreated 
cells which did not show such symptoms.
SEM micrographs showed that cells grown in control cultures had normal growth 
patterns. For example, the S I80 cells were found adhering to the substratum, and 
interdigitating with each other through filopodial attachments. Delicate microvilli were
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also noted on the surfaces of viable cells. Exposure to either ethanolic molmol or hexane 
haddi extracts resulted in symptoms of apoptosis, including signs of fragmentation 
(blebbing) and membrane pitting, formation of apoptotic cells and apoptotic bodies, and 
loss of most microvilli and filopodial attachments.
HT1080 cells exposed to either extract also resulted in symptoms of apoptosis, including 
the formation of apoptotic bodies, blebbing, and loss of most filopodial attachments
The results also showed normal fibroblast cells were not affected by treatment with both 
extracts.
4.10 Transmission Electron Microscopy
The effects of ethanolic molmol extract at two concentration levels (234 and 666 pg/ml) 
and hexane haddi extract, also at two concentration levels (201 and 666 pg/ml), on 
HT1080 cells were investigated using transmission electron microscopy. Results showed 
that treating these cells with these two extracts at the two concentration levels induced 
apoptosis, and in the case of ethanolic molmol extract, the following apoptotic changes: 
formation of apoptotic cells, blebbing, condensation of chromatin alongside nuclear 
membrane (chromatin margination), formation of apoptotic bodies, cytoplasm 
vacuolation, loss of filopodia, swollen mitochondria, formation of cytoplasmic debris, 
and damaged cell membranes occurred. These results were similar to those produced 
treating these cells with ethanolic molmol extract.
Treating HT1080 cells with hexane haddi extract resulted in the same apoptotic changes 
as above, in addition to some other changes. These include extensive damage to cells, 
necrosis, disintegration of cell membranes, formation of apoptotic cells, blebbing,
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formation of apoptotic bodies, chromatin margination, loss of filopodia, cytoplasmic 
vacuolation, swollen mitochondria, formation of cell debris, and phagocytosis.
4.11 Annexin V Assay to Detect Apoptotic Plasma Membrane Changes
Control, live, untreated S I80 and HT1080 cells did not show changes in membrane 
phosphatidylserine asymmetry. However, when they were grown in media containing 
either ethanolic molmol or hexane haddi extract, they showed the characteristic 
symptoms of apoptosis, described earlier in this chapter.
For example, S I80 cells grown in culture containing 666 pg/ml ethanolic molmol extract 
showed signs of induced apoptosis and positive results for changes in membrane 
phosphatidylserine asymmetry. The majority of these cells appeared green, and only a 
few appeared red with PI. It is possible that secondary necrosis after the death of 
apoptotic cells had occurred, leading to changes in permeability of the plasma membrane 
that allowed the penetration of propidium iodide into the cells. When grown in cultures 
containing 234 pg/ml ( L C 5 0 )  ethanolic molmol extract, they also showed signs of 
apoptosis, that is, positive results for changes in membrane phosphatidylserine 
asymmetry.
HT1080 cells grown in culture containing either 666 pg/ml or 234 pg/ml ethanolic 
molmol extract also showed positive results for changes in membrane phosphatidylserine 
asymmetry. However, none of these cells in both treatments showed signs of secondary 
necrosis.
This may indicate that apoptosis and death of S I80 were faster than in the case of 
HT1080, resulting in secondary necrosis in the former rather than the latter.
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SI80 cells grown in culture containing either 666 pg/ml or 201 pg/ml hexane haddi 
extract showed positive results for changes in membrane phosphatidylserine asymmetry. 
The majority of these cells appeared green, and only some showed possible secondary 
necrosis.
HT1080 cells grown in culture containing either 666 pg/ml or 201 pg/ml hexane haddi 
extract also showed positive results for changes in membrane phosphatidylserine 
asymmetry. Cells appeared green with Annexin V FITC, showing positive labelling on 
the cell surface, but none showed positive for necrosis at the stronger concentration level. 
However, a number of cells (around 2-3% of the total number of cells) treated with the 
weaker concentration level showed PI uptake suggesting secondary necrosis.
4.12 Trans-fl-Ocimene and y-Bisabolene as Inducers of Cell Death
Both molmol and haddi extracts consist of a large number of biochemical constituents. 
Two of these components, trans-fi-ocimene and y-bisabolene were found as major peaks 
in haddi plant extracts (Mr. Ahmed Ali, Personal communication, 2003). Accordingly, it 
was decided to run a viability test, SEM, and an Annexin V test to investigate their 
effects on both cancer cell lines, and to test whether or not they induce apoptosis in both.
4.12.1 MTT Viability Assay
Cytotoxicity of trans-ft-ocimene to S I80 cells increased with increasing concentrations, 
as well as increasing time of exposure. However, toxicity of the 50 mM /nms-p-ocimene 
increased after 48 hours, but decreased slightly after 72 hours, though higher than after 24 
hours of exposure, possibly indicating mitogenesis.
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In contrast to exposure to /ra«.y-P-ocimene, exposure of S I80 cells to y-bisabolene 
resulted in higher percentage toxicity at lower concentrations (50 and 100 g/ml y- 
bisabolene), though toxicity percentages declined in all concentrations at the end of the 
72 hour exposure, especially at the higher concentrations. This pattern of cytotoxicity 
may indicate that /raws-p-ocimene performed better than y-bisabolone in inducing 
apoptosis in S I80 cells.
The apparent cytotoxicity of /nms-p-ocimene to HT1080 cells also increased with 
increasing concentration and increasing time of exposure, except at the lowest 
concentration (50 mM), where it seems that trans-p-ocimene was not lethal.
7nms-p-ocimene at 50 mM concentration did not have significant toxic effect on HT1080 
cells after 48 hours of exposure; rather, it induced mitogenesis and resulted in a higher 
percentage viability than at the end of the 24 hour exposure.
The apparent cytotoxicity of y-bisabolene to HT1080 cells generally increased with 
decreasing concentration throughout the experimental period, but extending exposure to 
all concentrations for 72 hours resulted in lower cytotoxicity than after 48 hours, a further 
indication of mitogenesis during this period. Hence, it can be said that trans-p-ocimene 
performed better than y-bisabolene in inducing apoptosis and cell death in S180 than in 
HT1080 cells.
The results of the time course assay showed that exposing SI80 cells to a higher 
concentration of /raws-p-ocimene or y-bisabolene resulted in higher cytotoxicity than 
using lower concentrations. The apparent cytotoxicity of /nms-P-ocimene to HT1080 
cells was also higher at the higher concentration level; in fact, mitogenesis was induced at 
the lower concentration.
The apparent cytotoxicity of y-bisabolene to HT1080 cells was generally higher at the 
higher concentration than at the lower. Thus, it can be said that the apoptotic effect of 
these two biochemicals is, in general, dose and time-dependent action.
y-bisabolene is synthesised from famesyl pyrophosphate. Famesyl pyrophosphate is an 
intermediate in the biosynthetic reaction of cholesterol and non-syterol isoprenoids 
(Hamada et al., 2002). Bisabolene is a sesquiterpene, or an isoprenoid similar to famesol. 
Furanosesquiterpenes have been extracted from the resin of C. sphaerocarpa, along with 
many other constituents (Dekebo et al., 2002). Famesylpyridinium, an analogue of 
isoprenoid famesol, was found to initially induce morphological changes similar to those 
of typical apoptosis in human leukaemia HL-60 cells (Hamada et al., 2002). Famesol 
(and also geranylgeraniol) was also found to induce actin-based cytoskeleton 
disorganisation, growth inhibition, and apoptosis (Miquel et al., 1996). Miquel et al. 
(1996) quoted two groups of researchers (Haug et al., 1994; Ohizumi et al., 1995) who 
stated that exposure of cells to free isoprenoids such as famesol and geranylgeraniol 
resulted in the inhibition of cell proliferation. Ocimene is also an isoprenoid found in 
fruits, vegetables and herbs. It was reported by Tatman & Mo (2002) that the I C 5 0  value 
of ocimene reflecting its relative tumour-suppressive potency is 250pmol/l, which is far 
less than the concentrations used in the present work. [The I C 5 0  value is the 
concentration of an isoprenoid required to suppress the net 48 hour increase in the B16 
melanoma population by 50% (Tatman and Mo, 2002)].
Other biochemicals extracted from plants have also been used to induce apoptosis in 
cancer cells lines. For example, aspirin (in the past, extracted from the bark and leaves of 
black willow - Salix nigra-trees), acetylsalicylic acid, is known, has been found to exert
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anti-carcinogenic effects in humans. Aspirin has been most intensively used in studies of 
large bowel cancer, where most studies (for example, Kune et al., 1988; Rosenberg et al., 
1991; Thun et al., 1991, 1993; Suh and Petcelli; 1993; Greenberg et al., 1993; Logan et 
al., 1993; Giovannucci et al., 1994; Muscat et al., 1994; Peleg et al., 1994; 
Schrelnemachers and Eversen, 1994), though not all (for example, Paginini-Hill et al., 
1989, 1991; Paginini-Hill, 1995), have reported an inverse association to the incidence of 
cancer. An essential finding relating to aspirin is that the effect seems to require 
continued aspirin use (Baron, 1995). Infrequent or previous use of aspirin has generally 
not been associated with a reduced risk (Kune et al., 1988; Rosenberg et al., 1991; Thun 
et al., 1991, 1993; Greenberg et al., 1993; Logan et al., 1993; Giovannucci et a l, 1994; 
Schreinemahers & Everson, 1994). This pattern, according to Baron (1995), parallels the 
experimental literature on the subject, where cancer in laboratory animals increases 
rapidly after exposure to aspirin is stopped (Baron & Greenberg, 1991).
Pique et al. (2000) cited a number of studies showing that aspirin, as well as other non­
steroidal anti-inflammatory drugs (NSAIDs) induce apoptosis in several cell types, 
including human rectal tumour cell lines (Piazza et al., 1995; Shiff et al., 1996; Elder et 
al., 1996; Castano et a l, 1999), fibroblasts (Lu et al., 1995; Schwenger et a l, 1997), B- 
cell chromic lymphocytic leukaemia cells (Bellosillo et a l, 1998), and myeloid 
leukaemia cell lines (Klampfer et al., 1999). Pique et al. (2000) also reported that 
administration of NSAIDs induces apoptosis in colon cancer cells in vivo (Pasricha et al., 
1995; Boolbol et al., 1996). Pique et al. (2000) concluded that their results demonstrate 
that aspirin-induced apoptosis involved release of cytochrome c from mitochondria, 
preceding caspase activation and loss of mitochondrial transmembrane potential (A'Pm),
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and recommended that the elucidation of the mechanisms involved in the induction of 
cytochrome c release by aspirin warrants further investigation.
Stark et al. (2001) indicated that their experimental data demonstrate that aspirin induces 
degradation of IicBa and, consequently, nuclear translocation of p50/p65 NF-kB 
complexes in colon cancer cells. They concluded that this nuclear translocation is 
predominantly responsible for the ability of aspirin to induce apoptosis. They also 
indicated that the NF-kB and death response to aspirin appear relatively cell-specific, as 
they were evident in numerous colon cancer cell lines but not in cell lines of non-colonic 
origin.
4.12.2 Scanning Electron Microscopy
S I80 cells and HT1080 grown in control cultures showed normal growth (see Section 
4.8).
Exposure of S I80 cells to /ra«.y-/?-ocimene induced apoptosis, with the formation of 
blebbing apoptotic bodies, fragmentation, and loss of microvilli and filopodial 
attachments. This is similar to the effects of both ethanolic molmol and hexane haddi 
extracts (see Section 4.8).
Exposure of S I80 cells to y-bisabolene was not as effective as exposure to trans-fi- 
ocimene in inducing symptoms of apoptosis. In fact, only about 50% of cells showed 
signs of apoptosis. This might be attributed to the low bisabolene concentration used in 
this experiment (5 mM), which seems not to have cytotoxic effect on S I80 cells. 
Bisabolene at 50 mM ‘killed’ most of the S I80 cells. Changes obtained after 5 mM 
might suggest early stages of necrosis. Accordingly, /ram,-/?-ocimene (at L C 5 0
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concentration, 100 mM) was more effective in bringing about apoptosis in S I80 cells 
than y-bisabolene (at LC50 concentration, 5 mM), though this effect can be attributed to 
the big differences in the concentrations of the two biochemicals used.
HT1080 cells exposed to trans-[$-ocimene (LC50 concentration, 100 mM) also showed 
visible signs of apoptosis, as did HT1080 cells treated for 12 hours with 5mM y- 
bisabolene.
4.12.3 Annexin V Assay
Untreated S I80 and HT1080cells showed normal growth similar to that shown in Section 
4.10.
S I80 cells grown in culture containing 100 mM ocimene showed positive results for 
changes in membrane phosphatidylserine asymmetry. Cells appeared apple green with 
Annexin V-FITC, indicating positive labelling on the cell surface and within the 
cytoplasm. However, some cells showed signs of possible secondary necrosis after the 
death of apoptotic cells and the disintegration of plasma membrane. S180 cells grown in 
culture containing 5 mM y-bisabolene also showed positive results for changes in 
membrane phosphatidylserine asymmetry, but a small number showed signs of possible 
secondary necrosis. This indicates that ocimene performed better than bisabolene in 
inducing apoptosis and secondary necrosis.
Results of HT 1080 cells exposed to these two biochemicals are similar to those described 
above, except that more secondary necrosis can be detected for both biochemicals.
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4.13 In d u c tio n  of P ro g ram m ed  Cell D eath  an d  its In te rp re ta tio n
The data show that bisabolene induces a higher level of cell death than ocimene. It is not 
entirely clear, however, exactly what forms this cell death may take. It is clear from 
popidium iodide distribution that some necrosis results. Part of this may be due, of 
course, to secondary necrosis of previously apoptotic cells. Another possibility is that a 
Type 2 cell death, as defined by Clarke (1990), is taking place. Bisabolene treatment 
may thus induce some classical apoptosis (Type 1 cell death), and a non-apoptotic 
programmed cell death (Type 2), sometimes called a vacuolar cell death, as well as 
classical necrosis in due course.
Such a spectrum would lead us to a possible re-classification of cell death along the 
following lines (see Figures 4.1 A-C).
\  NON-APOPTOTIC
PROGRAMMED CELL DEATH
(TYPE 2 CELL DEATH?)
NECROSISAPOPTOSIS
(TYPE 1 CELL DEATH
Figure 4.1 (A)
Diagram suggesting possible disposition of different types of cell death
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B ANNEXIN V ++VE 
GREEN RAFTING
RED AND GREEN 
VACUOLATED CELLS
APOPTOSIS
A N N E X I N  V  + V E
ANNEXIN V -VE 
PI (RED)
RED AND GREEN CELLS
(SECONDARY NECROSIS)
( G R E E N )
C . NON-APOPTOTIC CELL DEATH
Bisabolene
Secondary Necrosis
APOPTOSIS NECROSIS
OCIMENE & BISABOLENE
Figure 4.1 (B, C)
Diagram suggesting further possible disposition of different types of cell death
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Chapter Five 
Conclusions and Recommendations
5.1 C onclusions
1. In vitro studies revealed that ethanol molmol and hexane haddi extracts have 
cytotoxic effects on murine S I80 sarcoma cells and HT1080 human fibrosarcoma 
cells.
2. It can be concluded that ethanolic molmol and hexane haddi extracts are both 
apoptosis inducers in S I80 cells and HT1080 cells.
3. Morphological analysis revealed that cancer cells subjected to ethanolic molmol and 
hexane haddi extracts exhibited signs characteristic of apoptosis.
4. Both extracts performed better at higher concentration levels than at lower 
concentration levels.
5. In cases where more than one concentration and more than one exposure time were 
involved, apoptotic changes in S I80 and HT1080 cells were found to be time- 
dependent.
6. Commercial preparations of both plants did not perform well, and their cytotoxicity to 
these cells is questionable.
7. Molmol extracts at particular concentrations targeted cancer cells but not normal 
fibroblast cells, whereas haddi extracts targeted both cancer and normal cells.
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8. In the TUNEL experiment, it can be said that the apoptotic changes are a time- 
dependent function.
9. The Annexin V assay showed that apoptosis and death of S I80 cells was faster than 
that of HT1080 cells, and resulted in secondary necrosis in S I80 cells rather than in 
HT1080 cells.
10. SEM results using rra«s-p-ocimene and y-bisabolene are similar to those obtained 
using haddi extracts. Thus, it is likely that both chemicals are major constituents of 
haddi.
11. 7ra«s-p-ocimine (at LC50 concentration, 100 mM) was more effective in bringing 
about apoptosis in S I80 cells and HT1080 cells than y-bisaboline (at LC50 
concentration, 5 mM).
12. 7ra«s-p-ocimene performed better than y-Msabolene in inducing apoptosis in S I80 
than in HT1080.
5.2 R ecom m endations
1. The extracts should be tested in parallel against a wider range of human tumour cell 
lines.
2. More components should be isolated from haddi and molmol extracts and tested 
separately.
3. Further in vitro and in vivo investigations of molmol, haddi and their constituent 
biochemicals should be undertaken to identify the best preparation of constituents that 
would have maximum cytotoxic effects.
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Appendix I 
Summaries of S180
Table 1.1 Summary of SI 80 Ethanolic Molmol after 24 hours (see Figure 3.9)
Concentration (iig/ml)
0.65 10.45 83.33 333.30
10.45 P=0.0013+ - - -
83.33 P=0.0006+ P=0.0036+ -
333.30 P=0.0004+ P=0.0004+ P=0.0023+ -
666.60 P=0.0007+ P=0.0023+ P=0.0062+ P=0.0341%
♦Significant Differences.
Table 1.2 Summary of SI 80 Ethanolic Molmol after 48 hours (see Figure 3.9)
Concentration (jig/ml)
0.65 10.45 83.33 333.30
10.45 N.S.++ - - -
83.33 P=0.0004+ P=0.0009+ - -
333.30 P=0.0004+ P=0.0004+ P=0.0004+ -
666.60 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0004+
♦Significant Differences. 
♦♦Non-significant Differences
Table 1.3 Summary of S180 Ethanolic Molmol after 72 hours (see Figure 3.9)
Concentration (fig/ml)
0.65 10.45 83.33 333.30
10.45 N.S.M - - -
83.33 P=0.0004+ P=0.0004+ - -
333.30 P=0.0004+ P=0.0004+ P=0.0004+ -
666.60 P=0.0004+ P=0.0004^ P=0.0004+ P=0.0004+
♦Significant Differences.
♦♦ Non-significant Differences
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Table 2.1 Summary of S180 Ethanolic Molmol after 24 hours (see Figure 3.10)
Concentration Oig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0004% - - -
466.24 P=0.0004+ P=0.0007+ - -
566.10 P=0.0004% P=0.0041^ N.S.++ -
666.60 P=0.0004+ P=0.0023+ N.S.++ N .s++
♦Significant Differences.
**Insignificant Differences.
Table 2.2 Summary of SI 80 Ethanolic Molmol after 48 hours (see Figure 3.10)
Concentration (jig/ml)
266.50 366.00 466.24 566.10 |
366.00 P=0.0081 ♦ - - -
466.24 P=0.0027+ N.S** - -
566.10 P=0.0047+ N.S** N.S.+% -
666.60 P=0.0041 + N.S.++ N.S.++ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
Table 2.3 Summary of S180 Ethanolic Molmol after 72 hours (see Figure 3.10)
Concentration (jig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0081 ♦ - -
466.24 P=0.0134+ N.S.++ - -
566.10 N .S*+ 'N.S** N.S.++ -
666.60 N.S** N.S.++ N.S.+^ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 3.1 Summary of S180 Hexane Molmol after 24 hours (see Figure 3.11)
Concentration (Mg/ml)
0.65 10.45 83.33 333.30
10.45 N.S** - - -
83.33 N.S.++ N.S.+% - -
333.30 P=0.0047% P=0.0047% P=0.0217+ -
666.60 P=0.0027+ P=0.0004+ P=0.0004+ P=0.0036+
♦Significant Differences.
♦♦ Insignificant Differences
Table 3.2 Summary of SI 80 Hexane Molmol after 48 hours (see Figure 3.11)
Concentration (iig/ml)
0.65 10.45 83.33 333.30
10.45 N .S .^ - - -
83.33 P=0.0004+ P=0.0004+ - -
333.30 P=0.0004+ P=0.0004+ P=0.0004+ -
666.60 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0006+
♦Significant Differences. 
♦♦Insignificant Differences
Table 3.3 Summary of SI 80 Hexane Molmol after 72 hours (see Figure 3.11)
Concentration (iig/ml)
0.65 10.45 83.33 333.30
10.45 P=0.0004+ - - -
83.33 P=0.0004+ P=0.0004+ - -
333.30 P=0.0004% P=0.0004+ P=0.0134+ -
666.60 P=0.0004+ P=0.0004+ P=0.0047+ P=0.0008^
♦Significant Differences. 
♦♦Insignificant Differences
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Table 4.1 Summary of S180 Hexane Molmol after 24 hours (see Figure 3.12)
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.++ - - -
466.24 N .S*+ 'N.S** - -
§66.10 P=0.0341 + P=0.0134+ N.S.++ - 1
666.60 N.S..++ N .S .^ N.S.++ N.S.++ |
♦Significant Differences. 
♦♦Insignificant Differences.
Table 4.2 Summary of S180 Hexane Molmol after 48 hours (see Figure 3.12)
Concentration (}ig/ml)
266.50 366.00 466.24 566.10
366.00 N.S** - - -
466.24 N.S.%+ N .S*# - -
566.10 N.S.++ N.S.++ N.S.++ -
666.60 N.S** N.S.+% N.S.++ N.S.**
♦♦Insignificant Differences.
Table 4.3 Summary of S180 Hexane Molmol after 72 hours (see Figure 3.12)
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.++ - - -
466.24 N.S.++ N.S.++ - -
566.10 P=0.0273+ P=0.0423+ N.S.++ -
666.60 P=0.0036+ P=0.0062+ P=0.0134+ 'N.S**
♦Significant Differences. 
♦♦Insignificant Differences.
284
Table 5.1 Summary of S180 Ethyl Acetate Molmol after 24 hours (see Figure 3.13)
Concentration (jig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0004+ - - -
466.24 P=0.0004+ P=0.0004+ - -
566.10 P=0.0004+ P=0.0062+ N.S** -
666.60 P=0.0004+ P=0.0015+ N.S.** N.S.**
* Significant Differences.
♦♦Insignificant Differences.
Table 5.2 Summary of S180 Ethyl Acetate Molmol after 48 hours (see Figure 3.13)
Concentration (iig/ml) |
266.50 366.00 466.24 566.10
366.00 P=0.0023% - - j
466.24 P=0.0047+ N.S.** - |
566.10 P=0.0134+ N.S.** N.S.** 1
666.60 P=0.0062+ N.S.** N.S.%+ N.S**  |
♦Significant Differences.
♦♦ Insignificant Differences.
Table 5.3 Summary of S180 Ethyl Acetate Molmol after 72 hours (see Figure 3.13)
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0004+ - - -
466.24 P=0.0011 + N.S.++ - -
566.10 P=0.0134+ N.S.+% N.S** -
666.60 P=0.0134+ 'N.S** N.S.** N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 6.1 Summary of S180 Flavex Molmol after 24 hours (see Figure 3.14)
Concentration ( i^g/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - 1
466.24 N.S.++ N.S** - 1
566.10 N.S.** N.S** N.S.** 1
666.60 'N.S** N.S** N.S.** N.S.** |
♦♦Insignificant Differences.
Table 6.2 Summary of SI 80 Flavex Molmol after 48 hours (see Figure 3.14)
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.++ - - -
466.24 N.S.** N.S.++ - -
566.10 P=0.0423+ P=0.0171 ♦ N.S.** -
666.60 N.S.+t P=0.0273 N.S.** N.S.**
♦Significant Differences.
♦♦Insignificant Differences.
Table 6.3 Summary of S I80 Flavex Molmol after 72 hours (see Figure 3.14)
Concentration (fig/ml) I
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 P=0.0015+ P=0.0273+ -
"
566.10 P=0.0004+ P=0.0027+ N.S.**
"
666.60 P=0.0008+ P=0.0062+ N.S.** N.S.** |
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 7.1 Summary of S180 Ethanolic Haddi after 24 hours (see Figure 3.15)
Concentration (|Lig/m l)
0.65 10.45 83.33 333.30
10.45 N.S** - - .
83.33 P=0.0217+ N.S** - .
333.30 P=0.0134+ N.S.#% 'N.S** -
666.60 P=0.0027+ N.S** N.S** N.S.++
♦Significant Differences.
♦♦Insignificant Differences.
Table 7.2 Summary of S180 Ethanolic Haddi after 48 hours (see Figure 3.15)
Concentration (iig/ml)
0.65 10.45 83.33 333.30
10.45 P=0.0006+ - - -
83.33 N.S.** N.S.** - -
333.30 P=0.0011 + N.S.** P=0.0134% -
666.60 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0027+
♦Significant Differences. 
♦♦Insignificant Differences.
Table 7.3 Summary of S180 Ethanolic Haddi after 72 hours (see Figure 3.15)
Concentration (ng/ml)
0.65 10.45 83.33 333.30
10.45 P=0.0081 ♦ - - -
83.33 P=0.0047+ N.S.** - -
333.30 N.S.++ ?=0.02\7* P=0.0134+ -
666.60 P=0.0004% P=0.0004+ P=0.0004+ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 8.1 Summary of S180 Ethanolic Haddi after 24 hours (see Figure 3.16)
Concentration 0ig/ml)
266.50 366.00 466.24 566.10 |
366.00 N.S.++ - - -
466.24 'N.S** N.S** - -
§66.10 P=0.0171% N .S .^ N.S** -
666.60 P=0.0011 + P=0.0104% P=0.0015+ P=0.0134+
* Significant Differences. 
♦♦Insignificant Differences.
Table 8.2 Summary of S180 Ethanolic Haddi after 48 hours (see Figure 3.16)
Concentration (iig/ml)
266.50 366.00 466.24 566.10 |
366.00 P=0.0423+ - - .
466.24 P=0.0273+ N.S** - -
566.10 P=0.0004+ P=0.0217+ N.S.** -
666.60 P=0.0004+ P=0.0021* N.S.** N.S.++ |
♦Significant Differences. 
♦♦Insignificant Differences.
Table 8.3 Summary of S180 Ethanolic Haddi after 72 hours (see Figure 3.16)
Concentration (Mg/ml) |
266.50 366.00 466.24 566.10 1
366.00 P=0.0027+ - - -
466.24 P=0.0004# P=0.0004+ -
'
566.10 P=0.0004% P=0.0004+ P=0.0104^
"
666.60 P=0.0004+ P=0.0004+ P=0.0134+ P=0.0008+ 1
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 9.1 Summary of S180 Hexane Haddi after 24 hours (see Figure 3.17)
Concentration (|ig/ml)
0.65 10.45 83.33 333.30
10.45 P=0.0217% - - -
83.33 P=0.0004+ P=0.0006+ - -
333.30 P=0.0006^ P=0.0008+ P=0.0062+ -
666.60 P=0.0006+ P=0.0008+ P=0.0062+ N.S.++
♦Significant Differences.
♦♦Insignificant Differences.
Concentration (iig/ml)
0.65 10.45 83.33 333.30
10.45 P=0.0104+ - - -
83.33 P=0.0004+ P=0.0004+ - -
333.30 P=0.0004% P=0.0004+ P=0.0004+ -
666.60 P=0.0004+ P=0.0004+ P=0.0004+ N.S**  |
♦Significant Differences. 
♦♦Insignificant Differences.
Table 9.3 Summary of SI 80 Hexane Haddi after 72 hours (see Figure 3.17)
Concentration (jig/ml)
0.65 10.45 83.33 333.30
10.45 N.S** - - -
83.33 ?=0.0041* P=0.0047+ - -
333.30 P=0.0004+ P=0.0004+ P=0.0004+ -
666.60 P=0.0004+ P=0.0004+ P=0.0004^ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 10.1 Summary of S18Q Hexane Haddi after 24 hours (see Figure 3.18)
Concentration (fig/ml)
266.50 366.00 466.24 566.10 |
366.00 P=0.0004% - - - 1
466.24 P=0.0006+ 'N.S** -
566.10 P=0.0004+ P=0.0104+ N .S*+ -
666.60 P=0.0004+ N.S.++ N.S.++ N.S.*+
♦Significant Differences.
♦* Insignificant Differences.
Table 10.2 Summary of S180 Hexane Haddi after 48 hours (see Figure 3.18)
Concentration (jig/ml)
266.50 366.00 466.24 566.10
366.00 N .S*+ - - -
466.24 P=0.0104% N.S.++ - -
566.10 P=0.0011 + P=0.0171 ♦ N.S.++ -
666.60 P=0.0006+ P=0.0062+ 'N.S** N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
Table 10.3 Summary of S180 Hexane Haddi after 72 hours (see Figure 3.18)
Concentration (iig/ml) I
266.50 366.00 466.24 566.10 |
366.00 N.S** - - - 1
466.24 ?= om \7* N.S.^+ - -
566.10 P=0.0015+ N.S** N.S** -
666.60 P=0.0004+ N.S.++ N.S.++ N.S.**
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 11.1 Summary of S180 Ethyl Acetate Haddi after 24 hours (see Figure 3.19)
ation (iig/ml)
266.50 366.00 466.24 566.10 |
366.00 N.S** - - 1
466.24 'N.S.** N.S.+% - |
566.10 N.S.+t N .S .^ N .S .^ -
666.60 'N.S** N .S .^ N .S .^ N.S.++
♦♦Insignificant Differences.
Table 11.2 Summary of S180 Ethyl Acetate Haddi after 48 hours (see Figure 3.19)
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N .S .^ - - 1
466.24 P=0.0341 + N .S .^ - 1
566.10 P=0.0217+ P=0.0273+ N.S.++ 8
666.60 P=0.0027+ P=0.0036+ N.S.++ N.S.++ 1
♦Significant Differences. 
♦♦Insignificant Differences.
Table 11.3 Summary of S180 Ethyl Acetate Haddi after 72 hours (see Figure 3.19)
Concentration Oig/ml) |
266.50 366.00 466.24 566.10
366.00 N.S** - - -
466.24 P=0.0004+ P=0.0011 + - -
566.10 P=0.0011 + P=0.0081 + N.S.++ _
666.60 P=0.0008+ P=0.0036+ N.S.+t N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 12.1 Summary of S180 Essential Oil Aldrich Haddi after 24 hours (see Figure 
 120) _____________________________________
Concentration 0ig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0217+ - - -
466.24 P=0.0004+ P=0.0006+ - -
566.10 P=0.0006+ P=0.0008+ P=0.0062+ -
666.60 P=0.0006+ P=0.0008^ P=0.0062+ N .S ."
* Significant Differences.
♦♦Insignificant Differences.
Table 12.2 Summary of SI 80 Essential Oil Aldrich Haddi after 48 hours (see Figure 
 120)_____________________________________________________
Concentration (jig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0104+ - - |
466.24 P=0.0004+ P=0.0004+ - |
566.10 P=0.0004+ P=0.0004+ P=0.0004+ |
666.60 P=0.0004+ P=0.0004% P=0.0004+ N.S.++ 1
♦Significant Differences.
♦♦ Insignificant Differences.
Table 12.3 Summary of S I80 Essential Oil Aldrich Haddi after 72 hours (see Figure 
3.20
Concentration (iig/ml) |
266.50 366.00 466.24 566.10
366.00 N .S .^ - - -
466.24 P=0.0047+ P=0.0047+ - -
566.10 P=0.0004+ P=0.0004+ P=0.0004+ -
666.60 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0004%
♦Significant Differences. 
♦♦Insignificant Differences.
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Appendix II
Summaries of HT 1080
Table 1.1 Summary of HT1080 Ethanolic Molmol after 24 hours (see Figure 3.21)
Concentration (jig/ml)
0.65 10.45 83.33 333.30
10.45 N.S.** - - -
83.33 P=0.0193* P=0.0104* - -
333.30 P=0.0004* P=0.0004* P=0.0004*
P=0.0004*666.60 P=0.0004* P=0.0004* P=0.0004*
* Significant Differences.
** Insignificant Differences
Table 1.2 Summary of HT1080 Ethanolic Molmol after 48 hours (see Figure 3.21)
Concentration Oig/ml) |
0.65 10.45 83.33 333.30
10.45 N.S.** - - -
83.33 N.S.** N.S.** -
P=0.0004*
333.30 P=0.0004* P=0.0004* P=0.0004*
666.60 P=0.0004* P=0.0004* P=0.0004*
* Significant Differences.
**Insignificant Differences
Table 1.3 Summary of HT 1080 Ethanolic Molmol after 72 hours (see Figure 3.21)
Concentration (iig/ml)
0.65 10.45 83.33 333.30
10.45 N.S.** - - -
83.33 N.S.** N.S.** - -
333.30 P=0.0004* P=0.0004* P=0.0004* -
666.60 P=0.0004* P=0.0004* P=0.0004* N.S.**
*Significant Differences.
**Insignificant Differences
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Table 2.1 Summary of HT1080 Ethanolic Molmol after 24 hours (see Figure 3.22)
Concentration (jag/ml)
266.50 366.00 466.24 566.10
366.00 N.S.++ - - -
466.24 P=0.0011 + N.S** - -
566.10 P=0.0004% P=0.0171 + N.S.++ -
666.60 P=0.0004+ P=0.0015% 'N.S** N.S**
♦Significant Differences. 
♦♦Insignificant Differences.
Table 2.2 Summary of HT 1080 Ethanolic Molmol after 48 hours (see Figure 3.22)
Concentration (fig/ml)
266.50 366.00 466.24 566.10 |
366.00 N.S.** - - 1
466.24 N.S.** N.S.** - |
566.10 N.S.** N.S.** N.S.++ |
666.60 N.S.** N.S.** N.S.** N.S.++
♦♦Insignificant Differences. 
Table 2.3 Summary of]
........
Concentration (jig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 P=0.0171 + N.S.** -
566.10 N.S.** N.S.** N.S.**
666.60 N.S.** N.S.** N.S.** N.S.**
♦Significant Differences. 
♦♦Insignificant Differences
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Table 3.1 Summary of HT 1080 Ethanolic Molmol after 24 hours (see Figure 3.23)
Concentration (jag/ml)
366.68 391.12 416.72 441.34 |
391.12 P=0.0020+ - - -
416.72 P=0.0004% P=0.0004+ - -
441.34 P=0.0004+ P=0.0004+ P=0.0004+ -
466.62 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0004+
* Significant Differences.
Table 3.2 Summary of HT1080 Ethanolic Molmol after 48 hours (see Figure 3.23)
Concentration (jig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0027+ - - -
466.24 P=0.0006+ 'N.S** - -
566.10 P=0.0104+ N.S** N.S.** -
666.60 P=0.0341% N.S.** N.S.** N.S.++
♦♦Insignificant Differences.
Table 3.3 Summary of HT1080 Ethanolic Molmol after 72 hours (see Figure 3.23)
Concentration (jig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0004% - - -
466.24 P=0.0015% P=0.0134+ - -
566.10 P=0.0015+ P=0.0081 ♦ N.S.** -
666.60 P=0.0031 ♦ P=0.0036+ N.S.** N.S.** ]
♦Significant Differences. 
♦♦Insignificant Differences
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Table 4.1 Summary of HT 1080 Ethanolic Molmol after 12 hours (see Figure 3.24)
Concentration (jig/ml)
65 130 260 520
130 N.S.** - - -
260 N.S.** N.S.** - -
520 N.S.** N.S.** N.S.** -
1040 N.S.** N.S.** N.S.** N.S.**
♦Significant Differences.
Table 4.2 Summary of HT1080 Ethanolic Molmol after 24 hours (see Figure 3.24)
Concentration (tig/ml)
65 130 260 520
130 N.S.** - - -
260 N.S.** N.S.** - -
520 N.S.** N.S.** N.S.** -
1040 N.S.** N.S.** N.S.** N.S.**
**Insignificant Differences.
Table 4.3 Summary of HT 1080 Ethanolic Molmol after 48 hours (see Figure 3.24)
Concentration (iig/ml) |
65 130 260 520 1
130 N.S.** - -
260 N.S.** N.S.** - - n
520 N.S.** N.S.** N.S.** -
1040 N.S.** N.S.** N.S.** N.S.** I
**Insignificant Differences
Concentration (iig/ml)
65 130 260 520
130 N.S.** - - -
260 N.S.** N.S.** - -
520 N.S.** N.S.** N.S.** -
1040 N.S.** N.S.** N.S.** N.S.**
**Insignificant Differences
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Table 5.1 Summary of HT1080 Hexane Molmol after 24 hours (see Figure 3.25)
Concentration (jig/ml) |
0.65 10.45 83.33 333.30 I
10.45 P=0.0217+ - - |
83.33 P=0.0004+ P=0.0020+ - 1
333.30 P=0.0004+ P=0.0011^ N.S.++ I
666.60 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0004^ |
♦Significant Differences.
♦♦Insignificant Differences
Table 5.2 Summary of HT1080 Hexane Molmol after 48 hours (see Figure 3.25)
Concentration (jig/ml)
0.65 10.45 83.33 333.30
10.45 N.S .♦♦ - - -
83.33 P=0.0171 + P=0.0423+ - - 1
333.30 P=0.0217+ P=0.0423+ N.S.M
666.60 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0004+
♦♦Insignificant Differences.
Table 5.3 Summary of HT1080 Hexane Molmol after 72 hours (see Figure 3.25)
Concentration (iig/ml) |
0.65 10.45 83.33 333.30 1
10.45 N.S.#+ - - -
83.33 P=0.0273+ P=0.0423+ -
"
333.30 P=0.0081 + P=0.0071 + N.S.++ -
666.60 P=0.0004^ P=0.0004+ P=0.0004+ P=0.0004^ 1
♦Significant Differences. 
♦♦Insignificant Differences
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¥*
Table 6.1 Summary of HT 1080 Hexane Molmol after 24 hours (see Figure 3.26)
Concentration (iig/ml)
266.50 366.00 466.24 §66.10
366.00 N.S.** - - -
466.24 N.S.++ N.S.++ - -
§66.10 P=0.0273% N.S** N.S.** -
666.60 N.S.++ N.S** P=0.0273^ P=0.0047+
* Significant Differences.
**Insignificant Differences.
Table 6.2 Summary of HT 1080 Hexane Molmol after 48 hours (see Figure 3.26)
Concentration (iig/ml)
266.50 366.00 466.24 §66.10
366.00 N.S.** - - -
466.24 N.S.++ N.S.%+ - -
§66.10 N.S.%+ N.S.++ N.S.++ -
666.60 P=0.0423+ P=0.0341 + P=0.0171 ♦ P=0.0217+
♦Significant Differences.
♦♦Insignificant Differences.
Table 6.3 Summary of HT 1080 Hexane Molmol after 72 hours (see Figure 3.26)
Concentration (jig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
§66.10 N.S.++ N.S.** N.S.** -
666.60 P=0.0273+ P=0.0004+ N.S.++ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
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wTable 7.1 Summary of HT1080 Ethyl Acetate Molmol after 24 hour (see Figure 3.27)
Concentration (iig/ml)
266.50 366.00 466.24 566.10 |
366.00 N.S.++ - - - I
466.24 P=0.0006+ P=0.0171% - 1
566.10 P=0.0004+ P=0.0062+ N.S.++ -
666.60 P=0.0004+ P=0.0006+ 'N.S** N.S**  1
♦Significant Differences.
**Insignificant Differences.
Table 7.2 Summary of HT 1080 Ethyl Acetate Molmol after 48 hour (see Figure 3.27)
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S** - -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.**
♦♦Insignificant Differences.
Table 7.3 Summary of HT1080 Ethyl Acetate Molmol after 72 hour (see Figure 3.27)
Concentration (fig/ml) |
266.50 366.00 466.24 566.10 1
366.00 P=0.0273+ - - I
466.24 N.S.** N.S.** - I
566.10 N.S.** P=0.0134^ N.S.** I
666.60 N.S.** P=0.0273+ N.S.++ N.S.** I
♦Significant Differences. 
♦♦Insignificant Differences
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Table 8.1 Summary of HT1080 Flavex Molmol after 24 hours (see Figure 3.28)
Concentration (fig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.**
**Insignificant Differences.
Table 8.2 Summary of HT1080 Flavex Molmol after 48 hours (see Figure 3.28)
Concentration (jig/ml) |
266.50 366.00 466.24 566.10 1
366.00 N.S.** - - |
466.24 N.S.** N.S.** - I
566.10 N.S.** N.S.** N.S.** I
666.60 N.S.** N.S.** N.S.** N.S.** |
**Insignificant Differences.
Table 8.3 Summary of HT1080 Flavex Molmol after 72 hours (see Figure 3.28)
Concentration ftig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
566.10 P=0.0273* P=0.0217* N.S.** -
666.60 P=0.0171* P=0.0171* N.S.** N.S.**
* Significant Differences.
** Insignificant Differences
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Table 9.1 Summary of HT 1080 Ethanolic Haddi after 24 hours (see Figure 3.29)
Concentration (iig/ml)
0.65 10.45 83.33 333.30
10.45 N.S.** - - -
83.33 P=0.0171% N.S** - -
333.30 N.S** N .S .^ N.S.++ -
666.60 P=0.0004+ P=0.0004% P=0.0004+ P=0.0004^
♦Significant Differences. 
♦♦Insignificant Differences.
Table 9.2 Summary of HT 1080 Ethanolic Haddi after 48 hours (see Figure 3.29)
Concentration (iig/ml)
0.65 10.45 83.33 333.30 |
10.45 N.S.** - - -
83.33 ?=0.0027* P=0.0008% - -
333.30 P=0.0423+ N.S.** P=0.0004+
P=0.0004+666.60 P=0.0004% P=0.0004^ P=0.0004+
♦Significant Differences. 
♦♦Insignificant Differences.
Table 9.3 Summary of HT1080 Ethanolic Haddi after 72 hours (see Figure 3.29)
1
Concentration (iig/ml)
0.65 10.45 83.33 333.30
10.45 N.S.++ - - -
83.33 N.S.** N.S.** -
333.30 P=0.0047+ ?=0.0062* P=0.0081 + -
666.60 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0004+
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 10.1 Summary of HT1080 Ethanolic Haddi after 24 hours (see Figure 3.30)
Concentration ( i^g/ml) i
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S** - -
566.10 'N.S** N.S.** N.S.++ -
666.60 N.S** N.S.** N.S.** N.S**
♦♦Insignificant Differences.
Table 10.2 Summary of HT1080 Ethanolic Haddi after 48 hours (see Figure 3.30)
Concentration (iig/ml)
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.+% -
666.60 N.S.** N.S.** N.S.++ N .S .^
♦♦Insignificant Differences.
Table 10.3 Summary of HT 1080 Ethanolic Haddi after 72 hours (see Figure 3.30)
Concentration (jig/ml)
266.50 366.00 466.24 566.10 |
366.00 N.S.** - - |
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.++ -
666.60 P=0.0273+ N.S.** N.S.++ N.S.**
♦Significant Differences. 
♦♦Insignificant Differences.
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%Table 11.1 Summary of HT1080 Hexane Haddi after 24 hours (see Figure 3.31)
Concentration (jig/ml)
0.65 10.45 83.33 333.30
10.45 N.S.%+ - - -
83.33 P=0.0004+ P=0.0004+ - -
333.30 P=0.0004% P=0.0004% P=0.0004+ -
666.60 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0193+
♦Significant Differences.
♦♦Insignificant Differences.
Table 11.2 Summary of HT 1080 Hexane Haddi after 48 hours (see Figure 3.31)
Concentration ( i^g/ml)
0.65 10.45 83.33 333.30
10.45 P=0.0104+ - - -
83.33 P=0.0004% P=0.0004% - -
333.30 P=0.0004+ P=0.0004+ P=0.0004+ -
666.60 P=0.0004+ P=0.0004+ P=0.0004% N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
Table 11.3 Summary of HT1080 Hexane Haddi after 72 hours (see Figure 3.31)
Concentration (tig/ml)
0.65 10.45 83.33 333.30
10.45 N .S .^ - - -
83.33 P=0.0047+ P=0.0047+ - -
333.30 P=0.0004% P=0.0004+ P=0.0004^ -
666.60 P=0.0004+ P=0.0006+ P=0.0006+ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 12.1 Summary of HT 1080 Hexane Haddi after 24 hours (see Figure 3.32)
Concentration (jag/ml)
266.50 366.00 466.24 566.10
366.00 N.S.%+ - - -
466.24 P=0.0217% N.S.** - -
566.10 P=0.0341% N.S.** N.S** -
666.60 N.S** N.S.** N.S** N.S**
♦Significant Differences.
**Insignificant Differences.
Table 12.2 Summary of HT1080 Hexane Haddi after 48 hours (see Figure 3.32)
Concentration (fig/ml) |
266.50 366.00 466.24 566.10 1
366.00 N.S.** - - |
466.24 N.S.** N.S.++ - 1
566.10 P=0.0217+ N.S.** N.S.** 1
666.60 P=0.0171 + N.S.** N.S.+% N.S.** 1
♦Significant Differences. 
♦♦Insignificant Differences.
Table 12.3 Summary of HT1080 Hexane Haddi after 72 hours (see Figure 3.32)
Concentration (jag/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.++ N.S.+% - -
566.10 P=0.0104+ P=0.0062+ N.S.** .
666.60 P=0.0081 ♦ P=0.0217+ N.S.** N.S.”  |
♦Significant Differences. 
♦♦Insignificant Differences.
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lf-
Table 13.1 Summary of HT1080 Hexane Haddi after 24 hours (see Figure 3.33)
Concentration Oig/ml)
533.71 733.24 932.4 1133.22
733.24 P=0.0004* - - -
932.4 P=0.0004* P=0.0004* - -
1133.22 P=0.0004* P=0.0004* P=0.0004*
1333.2 P=0.0004* P=0.0004* P=0.0004* P=0.0004*
* Significant Differences.
Table 13.2 Summary of HT1080 Hexane Haddi after 48 hours (see Figure 3.33)
Concentration (M&/ml)
533.71 733.24 932.4 1133.22
733.24 P=0.0004* - - -
932.4 P=0.0004* P=0.0004* - -
1133.22 P=0.0004* P=0.0004* N.S.** -
1333.2 P=0.0004* P=0.0004* N.S.** N.S.**
* Significant Differences.
** Insignificant Differences.
Table 13.3 Summary of HT1080 Hexane Haddi after 72 hours (see Figure 3.33)
Concentration (iig/ml)
533.71 733.24 932.4 1133.22
733.24 N.S.** - - -
932.4 N.S.** N.S.** - -
1133.22 N.S.** N.S.** N.S.** -
1333.2 N.S.** N.S.** N.S.** N.S.**
** Insignificant Differences.
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fTable 14.1 Summary of HT 1080 Ethyl Acetate Haddi after 24 hours (see Figure 3.34)
Concentration Oig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.**
**Insignificant Differences.
Table 14.2 Summary of HT1080 Ethyl Acetate Haddi after 48 hours (see Figure 3.34)
Concentration (tig/ml) |
266.50 366.00 466.24 566.10 I
366.00 N.S.** - -
"
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.** j
**Insignificant Differences.
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
566.10 P=0.0171* N.S.** N.S.** -
666.60 P=0.0004* P=0.0006* N.S.** N.S.**
* Significant Differences.
**Insignificant Differences.
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Table 15.1 Summary of HT 1080 Essential Oil Aldrich Haddi after 24 hours (see
____________ Figure 3.35) ____________________ _____________________
Concentration (jag/ml)
266.50 | 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 P=0.0171 + N.S.++ - -
566.10 P=0.0423+ P=0.0423% 
P=0.0171 ♦
N.S.** -
666.60 P=0.0171 + N.S.++ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
Table 15.2 Summary of HT1080 Essential Oil Aldrich Haddi after 48 hours (see 
____________ Figure 3.35)______________________________ _____________
Concentration Oig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.++ - - 1
466.24 N.S.++ N.S** - |
566.10 N .S .^ N.S** N.S.++ 1
666.60 N.S.++ N.S.++ N.S.++ N.S.++
♦♦Insignificant Differences
Table 15.3 Summary of HT1080 Essential Oil Aldrich Haddi after 72 hours (see
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.++ - -
466.24 N.S.+^ N .S " - .
566.10 P=0.0423# N .S ." N .S ." -
666.60 N .S ." N .S ." N .S ." N .S ."
♦Significant Differences. 
♦♦Insignificant Differences
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Table 16.1 Summary of HT1080 Essential Oil Aldrich Haddi after 24 hours (see
____________ Figure 3.36)________________________ ______________________
Concentration Oig/ml)
600.17 900.26 1199.23 1500.97
900.26 P=0.0341* - - -
1199.23 P=0.0004* P=0.0341* - -
1500.97 P=0.0004* P=0.0027* N.S.** -
1799.82 P=0.0004* N.S.** N.S.** N.S.**
* Significant Differences.
**Insignificant Differences.
Table 16.2 Summary of HT 1080 Essential Oil Aldrich Haddi after 48 hours (see 
____________ Figure 3.36)________________________ ______________________
Concentration Oig/ml)
600.17 900.26 1199.23 1500.97
900.26 N.S.** - -
1199.23 P=0.0036* P=0.0011* -
1500.97 P=0.0036* P=0.0036* N.S.**
1799.82 P=0.0008* P=0.0004* N.S.** N.S.**
* Significant Differences.
** Insignificant Differences.
Table 16.3 Summary of HT 1080 Essential Oil Aldrich Haddi after 72 hours (see 
____________ Figure 3.36_______________________________________________
Concentration (pg/ml)
600.17 | 900.26 1199.23 1500.97
900.26 P=0.0081 - - -
1199.23 P=0.0004 P=0.0004 - -
1500.97 P=0.0004 P=0.0004 N.S.** -
1799.82 P=0.0004 P=0.0004 N.S.** N.S.**
* Significant Differences.
** Insignificant Differences.
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Appendix III 
Summaries of Normal Fibroblast Cells
Table 1.1 Summary of Normal Fibroblast Ethanolic Molmol after 24 hours (see
____________ Figure 3.37)________________________________  _____ _D
o’ s 5
s 3
'  1
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
§66.10 N.S.** N.S.** N.S.** -
666.60 P=0.0004* N.S.** P=0.0004* P=0.0015*
* Significant Differences.
**Insignificant Differences.
Table 1.2 Summary of Normal Fibroblast Ethanolic Molmol after 48 hours (see 
____________ Figure 3.37)_________________________________________________
Concentration 0ig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 P=0.0217* N.S.** - -
566.10 P=0.0273* P=0.0273* P=0.0423* -
666.60 P=0.0004* P=0.0004* P=0.0004* P=0.0011*
* Significant Differences.
**Insignificant Differences.
Table 1.3 Summary of Normal Fibroblast Ethanolic Molmol after 72 hours (see 
Figure 3.37)_________________________________________________
Concentration (Mg/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 P=0.0423* N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 P=0.0004* 1 P=0.0004* P=0.0004* P=0.0273*
* Significant Differences.
**Insignificant Differences.
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Table 2.1 Summary of Normal Fibroblast Ethanolic Molmol after 24 hours (see
Concentration ( i^g/ml)
366.68 391.12 416.72 441.34
391.12 P=0.0011 + - - -
416.72 P=0.0004+ P=0.0004+ - -
441.34 P=0.0004+ P=0.0004+ P=0.0004+
466.62 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0004+
♦Significant Differences.
Table 2.2 Summary of Normal Fibroblast Ethanolic Molmol after 48 hours (see 
____________ Figure 3.38)_____________________________________________
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0004+ - - -
466.24 P=0.0004+ P=0.0004+ - -
566.10 P=0.0004+ P=0.0004% P=0.0011 + -
666.60 P=0.0004% P=0.0004+ P=0.0004+ P=0.0006+ |
♦Significant Differences.
Table 2.3 Summary of Normal Fibroblast Ethanolic Molmol after 72 hours (see 
____________ Figure 3.38)_________________________________________________
Concentration Oig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.++ - - 1
466.24 N.S.++ N.S.++ - -
566.10 N.S.++ N.S.++ N.S.++ -
666.60 P=0.0273+ P=0.0273+ N.S.++ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences
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Table 3.1 Summary of Normal Fibroblast Hexane Molmol after 24 hours (see Figure
3.39)
Concentration (jig/ml)
266.50 366.00 466.24 566.10 |
366.00 N.S.** - - -
466.24 N .S .^ N.S.** - |
566.10 'N.S** N.S.** N.S.++ |
666.60 N.S** N.S.** N.S.++ N.S.++
♦♦Insignificant Differences.
Table 3.2 Summary of Normal Fibroblast Hexane Molmol after 48 hours (see Figure
Concentration (Mg/ml)
266.50 366.00 466.24
366.00 N.S.** - -
466.24 N.S.++ N.S.%+ -
566.10 N .S .^ N.S.** N.S.++
666.60 P=0.0004+ P=0.0004^ P=0.0062+
566.10
P=0.0431 ♦
♦Significant Differences. 
♦♦Insignificant Differences.
Table 3.3 Summary of Normal Fibroblast Hexane Molmol after 72 hours (see Figure 
____________ 339)_____________________________ ________________________ _
Concentration Gig/ml)
266.50 1 366.00 466.24 566.10
366.00 N.S.++ j - - -
466.24 N.S.++ | N.S.** -
566.10 P=0.0273+ N.S.** N .S .^
666.60 P=0.0004+ P=0.0004^ P=0.0004+ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 4.1 Summary of Normal Fibroblast Ethyl Acetate Molmol after 24 hours (see
____________ Figure 3.40)_________________________________________ ________
Concentration ftig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0423+ - - -
466.24 P=0.0062+ P=0.0423^ - -
566.10 N.S.++ N.S.++ N.S.+^ -
666.60 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0081^
* Significant Differences. 
♦♦Insignificant Differences.
Table 4.2 Summary of Normal Fibroblast Ethyl Acetate Molmol after 48 hours (see 
____________ Figure 3.40)__________________________________________________
Concentration (fig/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0020+ - - -
466.24 P=0.0104+ N.S.++ - ”
566.10 P=0.0004% P=0.0273+ N.S.++ -
666.60 P=0.0004+ P=0.0027+ N.S.++ N.S.++
♦Significant Differences.
♦♦Insignificant Differences.
Table 4.3 Summary of Normal Fibroblast Ethyl Acetate Molmol after 72 hours (see 
____________ Figure 3.40)_________________________________________________
Concentration (M,g/ml)
266.50 366.00 466.24 566.10
366.00 P=0.0020+ - - -
466.24 P=0.0062+ N.S.++ - -
566.10 P=0.0004+ P=0.0104^ N.S.++ -
666.60 P=0.0004+ | P=0.0004+ N.S.++ N.S.++
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 5.1 Summary of Normal Fibroblast Flavex Molmol after 24 hours (see Figure 
____________ 141)______________________________
Concentration ftig/ml)
266.50 366.00 466.24 566.10 |
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.** |
**Insignificant Differences.
Table 5.2 Summary of Normal Fibroblast Flavex Molmol after 48 hours (see Figure 
____________ 141)___________ _________________ _
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.**
**Insignificant Differences.
Table 5.3 Summary of Normal Fibroblast Flavex Molmol after 72 hours (see Figure
3 /n )
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.**
** Insignificant Differences.
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Table 6.1 Summary of Normal Fibroblast Ethanolic Haddi after 24 hours (see Figure
3 /12)
Concentration ftig/ml)
266.50 366.00 466.24 566.10 |
366.00 N .S .^ - -
466.24 N .S .^ P=0.0273+ -
566.10 N.S.++ N.S.++ N.S.++
666.60 P=0.0008+ P=0.0004+ P=0.0047+ N.S.++
♦Significant Differences.
♦♦Insignificant Differences.
Table 6.2 Summary of Normal Fibroblast Ethanolic Haddi after 48 hours (see Figure
3 /12)
Concentration ftig/ml)
266.50 1 366.00 466.24 566.10
366.00 P=0.0273+ j - -
466.24 'N.S** N.S.++ - -
566.10 N.S** N.S.++ N.S.++ -
666.60 P=0.0004+ P=0.0004+ P=0.0062+ N.S.**
♦Significant Differences. 
♦♦Insignificant Differences.
Table 6.3 Summary of Normal Fibroblast Ethanolic Haddi after 72 hours (see Figure 
____________ 3.42)   _ _ _________
Concentration (iig/ml)
266.50 1 366.00 466.24 566.10
366.00 N.S.++ | - -
466.24 N.S.++ N.S.++ - _
566.10 P=0.0020% P=0.0134+ N .S .^ -
666.60 P=0.0004+ P=0.0004+ P=0.0047+ P=0.0047+
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 7.1 Summary of Normal Fibroblast Hexane Haddi after 24 hours (see Figure
3 /13)
Concentration Qig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** -
466.24 N.S.** N.S.** -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.**
**Insignificant Differences.
Table 7.2 Summary of Normal Fibroblast Hexane Haddi after 48 hours (see Figure
3A13)
Concentration 0ig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** -
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 P=0.0036* P=0.0341* N.S.** N.S.**
* Significant Differences.
**Insignificant Differences.
Table 7.3 Summary of Normal Fibroblast Hexane Haddi after 72 hours (see Figure
3 /13)
Concentration (jig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - -
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 P=0.0020* P=0.0062* N.S.** N.S.**
♦Significant Differences.
**Insignificant Differences.
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wTable 8.1 Summary of Normal Fibroblast Ethyl Acetate Haddi after 24 hours (see
__________Figure 3.44)_____________________________
Concentration (jag/ml)
266.50 366.00 466.24 566.10
366.00 N .S ." - - -
466.24 N .S ." N .S ." - -
566.10 N .S ." N .S ." N .S ." -
666.60 N .S ."  | N .S ." N .S ." N .S ."
♦♦Insignificant Differences.
Table 8.2 Summary of Normal Fibroblast Ethyl Acetate Haddi after 48 hours (see 
____________ Figure 3.44)___________________________________________
Concentration Oig/ml)
266.50 366.00 466.24 566.10
366.00 N .S ."
466.24 N .S ." N .S ."
566.10 N .S ." N .S ." N .S ."
666.60 N .S ."  | N .S ." P=0.0134+ N .S ."
♦Significant Differences.
**Insignificant Differences.
Table 8.3 Summary of Normal Fibroblast Ethyl Acetate Haddi after 72 hours (see 
____________ Figure 3.44)_____________________ __________
Concentration (ng/ml)
266.50 366.00 466.24 | 566.10
366.00 N .S ." - - -
466.24 N .S ." N .S ." - -
566.10 N .S ." N .S ." N .S ." -
666.60 P=0.0273* P=0.0081% N .S "  | N .S ."
♦Significant Differences. 
♦♦Insignificant Differences.
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Table 9.1 Summary of Normal Fibroblast Essential Oil Aldrich Haddi after 24 hours
____________ (see Figure 3.45)______________________________________________
Concentration (iig/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - _
§66.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.**
**Insignificant Differences.
Table 9.2 Summary of Normal Fibroblast Essential Oil Aldrich Haddi after 48 hours
Concentration (jig/ml)
266.50 366.00 466.24 566.10 |
366.00 N.S.** - - .
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.**
**Insignificant Differences.
Table 9.3 Summary of Normal Fibroblast Essential Oil Aldrich Haddi after 72 hours 
____________ (see Figure 3.45)_________ ____________________________________
Concentration (ftg/ml)
266.50 366.00 466.24 566.10
366.00 N.S.** - - -
466.24 N.S.** N.S.** - -
566.10 N.S.** N.S.** N.S.** -
666.60 N.S.** N.S.** N.S.** N.S.**
* insignificant Differences.
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Table 10.1 Summary of Normal Fibroblast Essential Oil Aldrich Haddi after 24 hours
____________ (see Figure 3.46)______________________________________________
Concentration (iig/ml)
533.71 733.24 932.4 1133.22
733.24 N.S.%+ - - -
932.4 N.S.+% N.S.++ - -
1133.22 P=0.0036+ P=0.0062+ N.S.++ -
1333.2 P=0.0015+ P=0.0015+ P=0.0171 ♦ N.S.++
♦Significant Differences.
**Insignificant Differences.
Table 10.2 Summary of Normal Fibroblast Essential Oil Aldrich Haddi after 48 hours 
____________ (see Figure 3.46)______________________________________________
Concentration (iig/ml)
533.71 733.24 932.4 1133.22
733.24 N.S.++ - -
932.4 N.S.++ P=0.0423+ - -
1133.22 P=0.0008+ P=0.0004+ P=0.0047^
1333.2 P=0.0008+ P=0.0004+ P=0.0062+ N.S.++ |
♦Significant Differences. 
♦♦Insignificant Differences.
Table 10.3 Summary of Normal Fibroblast Essential Oil Aldrich Haddi after 72 hours 
____________ (see Figure 3.46)
Concentration (iig/ml)
533.71 733.24 932.4 1133.22
733.24 P=0.0004+ - -
932.4 P=0.0004+ P=0.0004+ -
1133.22 P=0.0004+ P=0.0004+ P=0.0062+
1333.2 P=0.0004+ P=0.0004+ P=0.0004+ P=0.0171 +
♦Significant Differences.
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¥Appendix IV 
Differential effect o f extracts on cell lines viability
Table 1.1 Comparison of differential effect of Ethanolic Molmol Extract on viability 
of different cell lines after 72 hours (see Figure 3.47)____________
Cell Lines
Cell Lines
S180 HT1080
HT1080 N.S.** -
Normal Fibroblast N.S.** N.S.**
** Insignificant Differences.
Table 1.2 Comparison of differential effect of Hexane Molmol Extract on viability 
____________ of different cell lines after 72 hours (see Figure 3.48)________________
Cell Lines
Cell Lines S180 HT1080
HT1080 N.S.** -
Normal Fibroblast N.S.** N.S.**
**Insignificant Differences.
Table 1.3 Comparison of differential effect of Ethyl Acetate Molmol Extract on 
viability of different cell lines after 72 hours (see Figure 3.49)_________
Cell Lines
Cell Lines
S180 HT1080
HT1080 P=0.0122* -
Normal Fibroblast P=0.0216* N.S.**
* Significant Differences.
**Insignificant Differences.
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Table 2.1 Comparison of differential effect of Ethanolic Haddi Extract on viability
____________ of different cell lines after 72 hours (see Figure 3.50)________________
Cell Lines
Cell Lines
S180 HT1080
HT1080 N.S.** -
Normal Fibroblast N.S.** N.S.**
**Insignificant Differences.
Table 2.2 Comparison of differential effect of Hexane Haddi Extract on viability of 
____________ different cell lines after 72 hours (see Figure 3.51)
Cell Lines
Cell Lines
S180 HT1080 |
HT1080 N.S.** |
| Normal Fibroblast I P=0.0367* N.S.**
* Significant Differences.
**Insignificant Differences.
Table 2.3 Comparison of differential effect of Ethyl Acetate Haddi Extract on 
____________ viability of different cell lines after 72 hours (see Figure 3.52)
Cell Lines
Cell Lines
S180 HT1080
HT1080 N.S.** -
Normal Fibroblast P=0.0122* N.S.**
♦Significant Differences.
**Insignificant Differences.
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Table 3.1 Comparison of differential effect of different Molmol Extracts on viability
____________ of S180 cell line after 72 hours (see Figure 3.53) ___________
Molmol Extract Ethanolic 1 Hexane Ethyl Acetate
Hexane N.S.** -
Ethyl Acetate N.S.** I N.S.** -
Flavex P=0.0374* j N.S.** P=0.0374*
* Significant Differences. 
**Insignificant Differences.
Table 3.2 Comparison of differential effect of different Molmol Extracts on viability 
____________ of HT1080 cell line after 72 hours (see Figure 3.54) _______
Molmol Extract Ethanolic Hexane Ethyl Acetate
Hexane N.S.** • -
Ethyl Acetate N.S.** N.S.** -
| Flavex P=0.0250* | P=0.0250* P=0.0250*
* Significant Differences.
**Insignificant Differences.
Table 3.3 Comparison of differential effect of different Molmol Extracts on viability 
____________ of normal fibroblast cell line after 72 hours (see Figure 3.55)__________
Molmol Extract Ethanolic Hexane Ethyl Acetate
Hexane N.S.** - -
Ethyl Acetate N.S.** N.S.** -
Flavex N.S.** P=0.0104* N.S.**
* Significant Differences.
**Insignificant Differences.
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Table 4.1 Comparison of differential effect of different Haddi Extracts on viability
____________of S180 cell line after 72 hours (see Figure 3.56) ________________*—— — — — — — — — —
Molmol Extract Ethanolic Hexane Ethyl Acetate
Hexane N.S.** I -
Ethyl Acetate N.S.** N.S.** -
Flavex N.S.** N.S.** N.S**
**Insignificant Differences.
Table 4.2 Comparison of differential effect of different Haddi Extracts on viability 
____________ of HT1080 cell line after 72 hours (see Figure 3.57) ___________
Molmol Extract Ethanolic Hexane Ethyl Acetate
Hexane N.S.** - -
Ethyl Acetate N.S.** N.S.** -
Flavex N.S.** N.S.** N.S.**
**Insignificant Differences.
Table 4.3 Comparison of differential effect of different Haddi Extracts on viability 
____________ of normal fibroblast cell line after 72 hours (see Figure 3.58)__________
Molmol Extract Ethanolic Hexane Ethyl Acetate
1 Hexane N.S.** - -
Ethyl Acetate P=0.0163* N.S.** -
| Flavex P=0.0065* N.S.** N.S.**
♦Significant Differences.
**Insignificant Differences.
